Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.8461840667943605,2.543514057843008,0.0,0.0,0.0,19/29,9.42%,GRIA2;GABRB3;GABRA5;GABRB1;GRIA4;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GABRB2;GRIN2D;GLRA3;GRIK2;GRIK5;GABRG2;GLRA2
prerank,glutamate receptor activity (GO:0008066),0.8784414757097184,2.3773799885350093,0.0,0.0,0.0,13/19,4.69%,GRIA2;GRM5;GRIA4;GRM7;GRM1;GRID1;GRID2;GRM8;GRIA1;GRIK1;GRIN2D;GRIK2;GRIK5
prerank,ligand-gated cation channel activity (GO:0099094),0.6420595749948537,2.300692300259927,0.0,0.0,0.0,23/75,8.42%,GRIA2;GRIN1;GRIA4;KCNJ3;ASIC2;KCNJ6;KCNN2;GRIN2A;ASIC4;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;KCNJ11;KCNN1;ASIC1;KCNJ10;TRPM2;GRIA3;KCNN3;KCNK1
prerank,ligand-gated channel activity (GO:0022834),0.7693407526255897,2.2974311010777515,0.0,0.0,0.0,14/29,7.38%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3
prerank,ligand-gated ion channel activity (GO:0015276),0.7673416365064851,2.295428695333663,0.0,0.0,0.0,14/30,7.38%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3
prerank,ionotropic glutamate receptor activity (GO:0004970),0.8402822459251097,2.2574744162524527,0.0,0.0,0.0,12/17,10.09%,GRIA2;GRIN1;GRIA4;GRIN2A;GRIA1;GRIK1;GRIN2B;GRIN2D;GRIK2;GRIK5;GRIA3;GRIN3A
prerank,GABA-A receptor activity (GO:0004890),0.8413660293576423,2.249596950022294,0.0,0.0,0.0,10/18,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRD;GABRG2
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.7588015872250028,2.2491105547958403,0.0,0.0,0.0,11/28,8.57%,GABRA5;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GRIK2;GRIK5;GABRG2
prerank,GABA receptor activity (GO:0016917),0.7900890120439867,2.2212427978871703,0.0,9.572906786179689e-05,0.001,10/21,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRD;GABRG2
prerank,ligand-gated anion channel activity (GO:0099095),0.8349907050644522,2.213450020991472,0.0,8.615616107561719e-05,0.001,12/17,9.42%,GABRB3;GABRA5;GABRB1;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;GLRA3;GABRG2;GLRA2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.8139833756672605,2.2068803043956917,0.0,7.832378279601565e-05,0.001,11/19,8.57%,GABRA5;GABRA2;GRID1;GRID2;GABRG3;GABRA3;GRIK1;GABRA4;GRIK2;GRIK5;GABRG2
prerank,voltage-gated cation channel activity (GO:0022843),0.5793143844799405,2.189322398897067,0.0,0.00014359360179269534,0.002,33/97,11.72%,KCND2;HCN1;GRIN1;CACNA1A;KCNH7;CACNA1B;KCNQ3;KCNC2;GRIN2A;KCNH5;KCNH8;GRIN2B;CACNA2D1;GRIN2D;CACNG2;KCNJ11;CACNA1E;HCN2;KCND3;KCNC3;KCNH1;KCNQ5;CACNB2;LRRC55;KCNC1;KCNK1;CACNG3;OPRM1;GRIN3A;CACNG8;CACNB4;KCNQ2;KCNA2
prerank,cell adhesion mediator activity (GO:0098631),0.7401222409814199,2.1837025088550472,0.0,0.00013254794011633415,0.002,17/24,14.57%,DSCAM;BSG;LRRC4C;PLXNB3;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ESAM;NINJ1;NTNG1;ROBO3;CNTN4;CNTN2;JAM3;BCAM
prerank,potassium channel activity (GO:0005267),0.575575037111071,2.1504583348253172,0.0,0.0001230802301080246,0.002,27/89,8.42%,KCND2;HCN1;KCNH7;KCNQ3;KCNC2;KCNN2;KCNH5;GRIK1;KCNH8;KCNMB2;KCNMB3;GRIK2;GRIK5;KCNJ11;KCNN1;KCNK13;KCNK10;KCNMB4;HCN2;KCND3;KCNC3;KCNH1;KCNQ5;KCNK9;LRRC55;KCNC1;KCNK1
prerank,chloride channel activity (GO:0005254),0.6047367760158562,2.0996646895713105,0.0,0.0003446246443024688,0.005,18/59,10.99%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GABRB2;GLRA3;TTYH2;ANO5;GABRD;GABRG2;ANO4;GLRA2;CLCN1
prerank,retinoid binding (GO:0005501),-0.7338686008460089,-2.0939904338292883,0.0,0.0022525638826010196,0.002,7/22,5.81%,NR2F2;ALDH1A2;PTGDS;RBP1;CYP26B1;RBP4;ABCA4
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.8658233027984967,2.093653279729092,0.0,0.0003230856040335645,0.005,9/12,8.57%,GABRB3;GABRA5;GABRB1;GABRA2;GABRG3;GABRA3;GABRA4;GABRB2;GABRG2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.8325241044733285,2.0743970031912857,0.0021929824561403508,0.0005574810422539937,0.009,9/13,9.42%,GABRA5;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;GLRA3;GABRG2;GLRA2
prerank,voltage-gated potassium channel activity (GO:0005249),0.561011657620097,2.0727284940628166,0.0,0.000526509873239883,0.009,22/80,8.42%,KCND2;HCN1;KCNH7;KCNJ3;KCNQ3;KCNC2;KCNJ6;KCNN2;KCNH5;KCNH8;KCNJ11;KCNN1;HCN2;KCNJ10;KCND3;KCNC3;KCNH1;KCNQ5;KCNN3;LRRC55;KCNC1;KCNK1
prerank,platelet-derived growth factor binding (GO:0048407),-0.8737662825000458,-2.0480830963320438,0.0,0.005068268735852294,0.009,7/11,3.45%,COL1A2;COL3A1;COL5A1;COL1A1;PDGFRA;PDGFRB;COL6A1
prerank,anion channel activity (GO:0005253),0.5828195878718815,2.039994559575507,0.0,0.0009069069586907074,0.016,18/61,10.27%,GABRB3;GABRA5;GABRB1;ANO3;GABRA2;GLRA1;GABRG3;GABRA3;GABRA4;LRRC8B;GABRB2;GLRA3;ANO5;GABRD;GABRG2;ANO4;GLRA2;VDAC2
prerank,amyloid-beta binding (GO:0001540),0.5610818889537197,2.03830934987177,0.0,0.0008615616107561719,0.016,29/79,13.89%,GRIA2;ITM2A;GRIN1;CACNA1A;GRIA4;CACNA1B;NLGN1;MAPK8IP2;GRIN2A;GRIA1;APBB1;GRIN2B;APBA2;PFDN5;APBB3;TGFB2;FZD6;CLU;PFDN6;ATP1A3;GRIA3;ITM2C;TLR2;APBB2;FZD4;ITGAM;SORL1;INSR;CD36
prerank,histone acetyltransferase activity (GO:0004402),-0.6413139393653913,-1.9820563201099992,0.0,0.013515383295606117,0.035,15/30,16.89%,KAT2B;EP300;KAT6B;BAZ1A;CREBBP;HAT1;ATF2;TADA3;KAT14;MCM3AP;EPC2;KAT8;BRCA2;ARRB1;EPC1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.7032536840671966,1.945109237625834,0.0,0.004923209204320983,0.107,3/21,3.12%,GRM5;GRM1;GRIA1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.8295693237940215,1.9354453089891412,0.0022123893805309734,0.005717636144109142,0.126,6/10,8.57%,GABRA5;GABRA2;GABRG3;GABRA3;GABRA4;GABRG2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.7387569595145079,1.9166086171059316,0.0,0.0069283912864975495,0.164,6/16,2.83%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.7387569595145079,1.9166086171059316,0.0,0.0069283912864975495,0.164,6/16,2.83%,PTPRG;PTPRB;PTPRN2;PTPRD;PTPRR;PTPRT
prerank,protease binding (GO:0002020),-0.4894173746556999,-1.884604631622486,0.0,0.04871169396124705,0.149,39/99,19.93%,COL1A2;COL3A1;TIMP3;STIM1;COL1A1;ITGAV;CFLAR;CCBE1;PRKN;GSK3B;ITGB1;LCOR;DPP4;ANXA2;TRIP4;BCL2;F3;ADAMTSL4;LDLR;SELENOS;CHMP3;LONP2;RHBDD2;FAP;RIOK3;FN1;SRI;BRCA2;BDKRB2;ECM1;SERPINE1;BFAR;DERL1;SYVN1;VCP;PARK7;ITGB3;TIMP2;CARD16
prerank,glycine binding (GO:0016594),0.7860753252099105,1.8748734153916573,0.008438818565400843,0.01192401269286542,0.273,6/11,10.09%,GRIN1;GLRA1;GRIN2B;GLRA3;GLRA2;GRIN3A
prerank,Toll-like receptor binding (GO:0035325),0.7853632408386283,1.848694845614964,0.0020161290322580645,0.0163033966343091,0.347,7/11,13.89%,TIRAP;S100A9;S100A8;TOLLIP;TLR2;DAB2IP;CD36
prerank,sodium channel activity (GO:0005272),0.5764252135932266,1.8452749270820457,0.002136752136752137,0.016369670604367267,0.359,12/37,8.42%,HCN1;SCN1A;ASIC2;ASIC4;GRIK1;GRIK2;GRIK5;SCN4B;ASIC1;HCN2;SCN3A;KCNK1
prerank,calcium-activated potassium channel activity (GO:0015269),0.7576814052917823,1.8073736691474942,0.0022522522522522522,0.024154495158699822,0.494,6/11,7.72%,KCNN2;KCNMB2;KCNMB3;KCNN1;KCNMB4;KCNN3
prerank,amino acid binding (GO:0016597),0.587198006371952,1.807158178504984,0.0,0.023351290553598317,0.494,9/31,10.09%,GRIN1;GRM7;AARS2;GLRA1;GRIN2B;GLRA3;NOS3;GLRA2;GRIN3A
prerank,glutamate receptor binding (GO:0035254),0.6793214999753088,1.8034334559607426,0.0021929824561403508,0.02372166301615327,0.512,9/17,10.21%,CAMK2A;IGSF11;SHISA6;SHANK3;HIP1;SHISA7;HOMER1;SHANK2;HOMER2
prerank,R-SMAD binding (GO:0070412),-0.6760889873972314,-1.794994964836688,0.0038535645472061657,0.14506511403950567,0.438,10/18,14.60%,SMAD3;LDLRAD4;SMAD6;DDX5;SMAD2;PMEPA1;JUN;SMAD4;PPM1A;SMURF1
prerank,SUMO transferase activity (GO:0019789),-0.6832649850732824,-1.7908892115020283,0.0019011406844106464,0.12670671839630734,0.449,8/16,15.42%,PIAS1;HDAC4;RANBP2;NSMCE2;PIAS3;UBE2I;PIAS4;TOPORS
prerank,semaphorin receptor binding (GO:0030215),0.6163356276824314,1.7803691854514612,0.002150537634408602,0.03054374871680752,0.617,8/23,4.44%,RIT2;SEMA3C;SEMA6A;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,inward rectifier potassium channel activity (GO:0005242),0.6064214619061002,1.7628362212457576,0.0,0.036104816250750835,0.688,8/24,8.42%,KCNJ3;KCNJ6;KCNN2;KCNJ11;KCNN1;KCNJ10;KCNN3;KCNK1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6429512493115757,-1.74878626191881,0.01098901098901099,0.187445494516442,0.64,7/18,7.85%,PDLIM5;BAIAP2L1;RAB10;ANXA2;TMOD3;ANXA1;CNN3
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6347243263129595,1.7408152851204353,0.010526315789473684,0.04373077872777539,0.771,5/19,5.39%,NRG3;GRM5;NRG1;GAS6;CD24
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6746723604838216,-1.7299867244331375,0.0018148820326678765,0.20244917894876663,0.694,6/15,21.06%,ALDH1A1;ALDH1A2;ALDH2;ALDH1L1;ALDH7A1;ALDH4A1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.5565010512754964,-1.7265786066934603,0.005836575875486381,0.18833936907302967,0.711,17/33,25.47%,PCF11;SCAF8;DHX9;AR;CTR9;TBP;RPRD2;WDR43;GTF2B;HNRNPU;CDC73;DRAP1;WAC;CCAR2;AGO1;RTRAF;RECQL5
prerank,ankyrin binding (GO:0030506),0.6337146490139226,1.7252768076082723,0.004149377593360996,0.04986921323435725,0.82,8/19,11.30%,SLC4A1;SPTBN4;SPTB;SLC8A1;KCNJ11;NRCAM;KCNQ2;SPTBN1
prerank,chemorepellent activity (GO:0045499),0.5943810457890839,1.7218715667112716,0.013856812933025405,0.049822877147728345,0.829,9/25,4.44%,NRG3;SEMA3C;SEMA6A;NRG1;SEMA4A;SEMA4F;SEMA6D;SEMA4D;SEMA7A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6931533367733067,-1.7183787227290048,0.0071301247771836,0.18639966128523436,0.741,6/13,21.06%,ALDH1A1;ALDH1A2;ALDH2;ALDH1L1;ALDH7A1;ALDH4A1
prerank,histone demethylase activity (GO:0032452),-0.5826586644452223,-1.7127736305465602,0.0057361376673040155,0.1805122784102544,0.761,11/27,15.84%,KDM7A;KDM4B;PHF8;KDM5B;KDM6A;PHF2;FBXL19;KDM3B;KDM3A;JARID2;KDM2A
prerank,ion channel activity (GO:0005216),0.467727365302939,1.7127462257688681,0.0,0.05296210679453913,0.858,18/80,7.38%,GRIA2;GRIN1;GABRB1;GRIA4;GRID1;GRID2;GRIN2A;ASIC4;GRIA1;GRIK1;GRIN2B;GRIN2D;UNC80;GRIK2;GRIK5;TMEM63B;TRPM2;GRIA3
prerank,cAMP binding (GO:0030552),0.7113462335887207,1.7120444842139242,0.009153318077803204,0.05183340933900646,0.859,6/11,13.00%,HCN1;PDE4B;PDE10A;PDE2A;PDE4D;PDE4A
prerank,androgen receptor binding (GO:0050681),-0.5887614140958188,-1.7095157977576256,0.0,0.17250885067586139,0.78,16/25,25.26%,FOXP1;DDX5;EP300;TGFB1I1;NSD1;PRPF6;PRMT2;WIPI1;KDM3A;RNF14;PARK7;ARID5A;RNF6;TRIM68;KDM1A;ZBTB7A
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6856399460696443,-1.7079496257744882,0.009157509157509158,0.1615781400404193,0.789,4/13,2.70%,BMP6;BMP5;BMP7;BMP4
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5459235080563074,1.706637815714823,0.0091324200913242,0.052918021039602775,0.869,8/32,11.72%,KCNQ3;KCNC2;KCNC3;KCNH1;KCNQ5;KCNC1;KCNQ2;KCNA2
prerank,poly-pyrimidine tract binding (GO:0008187),-0.5852708721493965,-1.6910712261524057,0.013725490196078431,0.17988331576771,0.842,8/23,6.46%,RBMS1;RBMS3;ATXN1;HNRNPH1;DIS3L2;KHDRBS1;RBMS2;U2AF2
prerank,I-SMAD binding (GO:0070411),-0.6781894891145557,-1.6855930837951056,0.0056179775280898875,0.17795254672548055,0.858,10/13,21.37%,SMAD3;TGFBR1;SMAD6;TGFB1I1;SMAD2;AXIN1;SMAD4;SMURF1;SMAD9;SMAD1
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.38928866825070657,-1.6847080381050912,0.0,0.16851993546708877,0.861,75/232,21.13%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;RNF43;UBR2;TRIM44;PIAS1;KCMF1;PRKN;ARIH1;WWP2;TRIP12;RNF115;RNF217;HUWE1;UBR5;UHRF2;RBBP6;DTX4;RC3H1;MEX3C;SH3RF1;UFL1;NSMCE2;RNF19A;WWP1;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;HLTF;RNFT1;XIAP;PIAS3;RNF216;HERC2;UBR1;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;PIAS4;TRIM25;DTX3L;NHLRC3;SH3RF2;SMURF1;UBR4;TRIM39;SH3RF3;TOPORS;MSL2;RNF181;HECTD1;BFAR;MYLIP;SYVN1;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;ANAPC11;TRIM63;ARIH2
prerank,transforming growth factor beta binding (GO:0050431),-0.5900222046478086,-1.6808954958894817,0.0018832391713747645,0.1652321859766748,0.876,12/23,16.39%,TGFBR3;TGFBR1;LTBP1;ITGAV;TGFBR2;THBS1;TWSG1;CD109;ACVR1;TGFB3;LRRC32;VASN
prerank,poly(U) RNA binding (GO:0008266),-0.6014032899406181,-1.670500443416588,0.019455252918287938,0.17426084480677334,0.902,7/20,5.06%,RBMS1;RBMS3;ATXN1;HNRNPH1;DIS3L2;KHDRBS1;RBMS2
prerank,BMP receptor binding (GO:0070700),-0.68564162095329,-1.6673839670865576,0.012612612612612612,0.1701871291301981,0.905,4/12,2.70%,BMP6;BMP5;BMP7;BMP4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.3969455595491519,-1.6634776549155899,0.0,0.16775969515671094,0.91,58/188,17.19%,ZBTB20;PBX1;BNC2;TCF7L2;SMAD3;SOX5;CREB3L2;NFKB1;PRDM5;SMAD6;FOXC1;PER3;FOXO3;HDAC4;BCOR;NCOR1;TFEB;TBL1X;BRD7;TBL1XR1;YAP1;KMT2D;HMGB1;GABPB2;STAT3;FOXC2;RUNX1;DHX9;REST;AR;DHX36;FOXK1;TBP;NFYC;CHD3;GABPA;NR1H3;JUN;CALCOCO1;SMAD4;GLIS2;ZBED4;TBX18;MEF2C;ARID5B;IRF1;SOX13;GLI1;ATF6;SOX6;HINFP;RXRA;KLF15;FOXK2;VSX1;SFPQ;SIX1;NFYB
prerank,DNA-binding transcription factor binding (GO:0140297),-0.39544750870586937,-1.6601906502635642,0.0,0.16438353095647915,0.913,54/189,14.63%,FHL2;TCF7L2;SMAD3;PRRX1;PRDM5;RBPJ;PIAS1;EP300;HDAC4;RERE;NCOR1;RBBP8;WWP2;GSK3B;YAP1;MEF2A;HMGB1;SMAD2;CBX5;SKI;CREBBP;NBN;STAT3;BCL2;DHX9;CRTC3;AR;RUNX1T1;TBP;PIAS3;DACT1;ATF2;TEAD3;CHD4;MIER1;EIF4E;GABPA;JUN;HCFC1;CRTC1;ID2;TLE4;TLE1;MEF2C;HES1;SIK1;TCF3;PIAS4;RB1;BHLHE41;CGGBP1;TCERG1;STAT1;HDAC1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.34815035064690153,-1.6596990170748191,0.0,0.15762827714837588,0.913,183/732,18.30%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;NR3C2;TFEB;MXI1;HOXB3;MEOX2;FOXN3;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;JDP2;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;CEBPG;HOXB5;ZBTB37;GTF2IRD1;AR;DHX36;ZNF496;FOXK1;MAFG;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;ZNF18;CARF;SNAPC3;HOXB9;ZNF697;RXRA;HOXC5;KLF15;RUNX2;MNT;FOXK2;SALL1;PRDM15;ATOH8;IKZF2;KLF6;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;NFYB;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6984333707492454,1.6558004493171525,0.019189765458422176,0.08374820683017045,0.961,2/11,6.29%,HCN1;HCN2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.3465512066307639,-1.6557733801602075,0.0,0.157287721541619,0.92,184/731,18.30%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;CREB3L2;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;NR3C2;TFEB;MXI1;HOXB3;MEOX2;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;JDP2;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;CEBPG;HOXB5;ZBTB37;GTF2IRD1;AR;DHX36;ZNF496;FOXK1;MAFG;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;ZNF18;CARF;SNAPC3;HOXB9;ZNF697;RXRA;HOXC5;KLF15;RUNX2;MNT;FOXK2;SALL1;PRDM15;ATOH8;PRMT5;IKZF2;KLF6;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;NFYB;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1
prerank,glucose transmembrane transporter activity (GO:0005355),0.615346478639353,1.6521042423370094,0.01312910284463895,0.08432534265276033,0.963,4/17,4.30%,SLC2A1;SLC2A3;SLC2A5;SLC5A11
prerank,thyroid hormone receptor binding (GO:0046966),-0.5473370111772755,-1.6455238894974975,0.01338432122370937,0.16800372291065938,0.935,18/28,27.07%,NCOR1;TRIP12;MED17;NSD1;MED12;NCOA6;MED1;PRMT2;GTF2B;TRIP6;MED16;ARID5A;HMGN3;MED13;GTF2H1;TAF7;GAS2L1;JMJD1C
prerank,ubiquitin protein ligase activity (GO:0061630),-0.38030262060792636,-1.6367257550785281,0.0,0.17628564945235578,0.955,72/228,21.13%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;RNF43;UBR2;TRIM44;KCMF1;PRKN;ARIH1;WWP2;TRIP12;RNF115;RNF217;HUWE1;UBR5;UHRF2;RBBP6;DTX4;RC3H1;MEX3C;SH3RF1;RNF19A;UBE4B;WWP1;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;UBE2K;HLTF;RNFT1;XIAP;RNF216;HERC2;UBR1;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;TRIM25;DTX3L;NHLRC3;SH3RF2;SMURF1;UBR4;TRIM39;SH3RF3;TOPORS;MSL2;RNF181;HECTD1;BFAR;MYLIP;SYVN1;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;ANAPC11;TRIM63;ARIH2
prerank,G protein-coupled receptor activity (GO:0004930),0.3806220667563937,1.6321878941085584,0.0,0.09781876336756051,0.983,57/239,19.09%,ADGRL4;PAX8;GRM5;ADGRL3;ADGRB3;MTNR1B;HCAR2;GRM1;ADGRB1;GRM8;ADRB1;S1PR5;HCRTR1;GPR101;GPR149;LGR5;MTNR1A;GPR35;P2RY1;ADGRA1;APLNR;ELOVL4;GPR26;GPR17;ADRA1D;ADRA1A;ADGRL2;GPR75;TRHR;GPR176;HCRTR2;OPRM1;MRGPRE;CELSR2;F2RL2;F2R;CNR1;GRPR;GPR85;RORB;GRM3;OPRK1;ADGRG1;OPRL1;NPFFR2;NPR1;CALCRL;ADCYAP1R1;ADGRE1;GPR45;CYSLTR1;C3AR1;NTSR2;GPR22;ADGRE5;S1PR1;ADORA2A
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6139783782366364,-1.6279095473209526,0.011406844106463879,0.18423373447504107,0.965,6/18,5.30%,TGFBR3;SMAD3;TGFBR1;SMAD6;TGFBR2;SMAD2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.711640411897622,-1.608002060934068,0.009416195856873822,0.21365985567930412,0.983,7/10,22.26%,SETD5;NSD3;NSD1;SETD3;SETD2;ASH1L;PRDM9
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.33362943533530254,-1.6065902513120798,0.0,0.20928731930666258,0.984,203/831,18.69%,ZBTB20;NFIA;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;AEBP1;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;ZBTB7C;MAF;SOX5;TEAD1;FOXD1;PRRX1;NFKB1;PRDM5;HOXB6;ZNF148;HIVEP2;ZKSCAN2;RBPJ;THRB;GLI2;ZNF423;GLIS3;HOXC6;FOXP4;NR1D2;ZFHX3;ZEB1;RARB;FOXC1;KLF9;ZIC2;FOXO3;HDAC4;CREB5;ARNT;CUX1;OSR1;NR3C2;TFEB;MXI1;HOXB3;MEOX2;ELF1;NFIB;KCNIP3;NR6A1;TOP1;NFIX;RREB1;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;ZNF182;SMAD2;PRRX2;HOXA5;PBX3;TBX15;SKI;ZBTB16;ZIC5;STAT3;TEF;HOXA7;NSD1;TFDP2;JDP2;HOXC8;DNMT3A;ELF4;FOXC2;RUNX1;HOXC4;SKIL;HIVEP3;DHX9;ZEB2;HOXA3;REST;VEZF1;CEBPG;HOXB5;ZBTB37;GTF2IRD1;ZBTB8A;AR;DHX36;ZNF496;FOXK1;CDC5L;MAFG;TBP;SP2;NFYC;ZBTB1;CHD2;KDM6A;ATF2;TEAD3;HOXB4;UBP1;ZNF467;ZFAT;ZNF569;RFX2;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;ZBTB24;CREBRF;NFATC4;TBX18;RORA;MEF2C;NRF1;TFCP2;HES1;TEAD2;ZNF692;IRF9;TCF3;TCF7L1;RB1;BHLHE41;ZBTB34;CCAR1;PATZ1;IRF1;SOX13;GLI1;ATF6;SOX6;SIX5;TRPS1;ZFP3;STAT1;CC2D1B;HINFP;ZNF367;HDAC1;MED8;ZSCAN18;ZKSCAN1;MKX;PRDM2;ZNF18;CARF;SNAPC3;HOXB9;ZNF697;RXRA;HOXC5;KLF15;RUNX2;BBX;MNT;FOXK2;SALL1;PRDM15;ATOH8;IKZF2;KLF6;GTF2B;ZNF112;FOXL1;HEYL;MYBL1;SIX1;STAT5A;TBX2;NR4A1;ZFP37;NFYB;TWIST2;NR4A2;CC2D1A;STAT5B;NFIC;ZFHX4;HNRNPU;POU6F2;TFCP2L1;ZKSCAN7;ZNF436;NFATC3
prerank,metalloendopeptidase activity (GO:0004222),-0.4344510975063407,-1.6057897654392088,0.0,0.20331330905890235,0.985,21/76,12.77%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;ADAMTS5;ECE1;ADAMTSL4;ADAMTS9;NRDC;MMP14;ADAM9;MBTPS2;ADAM19;ADAMTS15;MMP2;ADAM33;NLN
prerank,calcium ion binding (GO:0005509),0.3631236478681761,1.6033874771916474,0.0,0.1223622620990611,0.992,61/323,11.21%,SPOCK2;ADGRL3;SPOCK1;GRIN1;NRXN1;CDH12;CDH8;SYT1;PCLO;SYT6;S100A16;RASGRP3;KCNIP4;MMP12;SYT7;CDH7;CDH19;CDH20;S100A9;S100A8;S100G;DNER;SYT12;SYT11;CDH18;RYR2;MCTP1;CDH2;RYR3;MEX3B;SNCA;KCNIP1;SLC8A1;ENPP2;RCN2;CDH10;PITPNM1;SLC25A23;HSPA5;SLIT3;SLIT1;TRPM2;CPNE1;MELK;CIB2;TUBB4A;THBS3;SYT10;DYSF;S100A2;PCDHB6;TPT1;ARSA;DCHS1;PVALB;ASTN2;GALNT3;AIF1;CALM1;PCDHA4;SYT2
prerank,cyclic nucleotide binding (GO:0030551),0.5581693737852216,1.5997532995505408,0.017391304347826087,0.12302298348936969,0.995,8/21,13.00%,HCN1;PDE4B;PDE10A;PDE2A;PDE11A;KCNH1;PDE4D;PDE4A
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4696688221934585,1.598669715174464,0.008565310492505354,0.12128437765963021,0.996,12/49,7.68%,SYT1;PCLO;SYT6;SYT7;SYT12;SYT11;MCTP1;CPNE9;CPNE8;CPNE1;SYT10;DYSF
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5960854478440898,-1.5972454919783476,0.01606425702811245,0.21331779968231654,0.99,5/18,3.24%,TGFBR3;TGFBR1;BMPR1A;LTBP1;TGFBR2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.5226118541411834,1.5954266326724449,0.0199203187250996,0.12193968664235687,0.996,8/30,11.74%,SLC39A10;SLC40A1;SLC39A2;SLC30A1;SLC30A3;SLC25A37;SLC39A8;SLC30A5
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5136963873467846,-1.5895248051732571,0.017964071856287425,0.221550557356468,0.991,15/34,15.54%,GAB2;FCHSD2;MYO1B;ADAP2;GBF1;ARAP1;MAPKAP1;CYTH3;ZFYVE1;DAPP1;IQGAP2;KIF16B;OGT;PARD3;ZFYVE16
prerank,SH2 domain binding (GO:0042169),-0.5234453030024694,-1.589524263554004,0.011214953271028037,0.2146271024390784,0.991,8/31,7.61%,AFAP1;DAG1;SH3PXD2B;ABL1;PAG1;IRS1;KHDRBS1;INPPL1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.5796877158596102,-1.5811209334328844,0.017578125,0.2235499004702527,0.994,9/19,18.94%,PRKN;LCOR;SELENOS;CHMP3;RHBDD2;DERL1;SYVN1;VCP;PARK7
prerank,calcium activated cation channel activity (GO:0005227),0.5954196797320758,1.5750370111171434,0.022321428571428572,0.1399101137467088,0.999,6/17,6.13%,KCNN2;KCNMB2;KCNMB3;KCNN1;TMEM63B;KCNMB4
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.44986066138454583,-1.5732209993217885,0.005836575875486381,0.23164969457395485,0.995,18/60,15.20%,LRRK1;CTDSPL;PPM1D;LRRK2;PPM1E;CDC14A;PPP4C;CAMK2G;SSU72;PPP2CB;PPM1H;PPM1M;MTMR3;PPM1A;CTDSPL2;DUSP1;CDC14B;PPP1CB
prerank,carboxylic acid binding (GO:0031406),0.4888581394858599,1.572221687254197,0.01616161616161616,0.14023290047414289,0.999,10/38,10.09%,GRIN1;GRM7;MAG;GLRA1;GRIN2B;GLRA3;NOS3;RTN4R;GLRA2;GRIN3A
prerank,nuclear receptor binding (GO:0016922),-0.4051927487753305,-1.566530927326756,0.0,0.2373558742580731,0.998,63/111,30.15%,FOXP1;TCF7L2;SMAD3;DDX5;EP300;NCOR1;TRIP12;TGFB1I1;BAZ2A;PPARGC1B;LCOR;BCAS3;MED17;DCAF1;TRIP4;NSD1;MED12;PRPF6;PPARGC1A;NCOA6;NCOA1;MED1;JUP;PRMT2;TADA3;HIF1A;WIPI1;MMS19;STAT1;KDM3A;LATS1;RXRA;GTF2B;NR4A1;CNOT1;NR4A2;STAT5B;RNF14;PARK7;TRIP6;MED16;TACC2;PPID;ARID5A;HMGN3;MED13;SMARCD3;MED14;GTF2H1;RNF6;TRIM68;KDM1A;PHB2;ZBTB7A;TAF7;GAS2L1;JMJD1C;ESR1;NCOA7;NR1H4;CALR;SNW1;THRAP3
prerank,frizzled binding (GO:0005109),-0.4976980337679199,-1.5654329409650318,0.02033271719038817,0.23298393380180268,0.998,15/34,25.50%,LRP6;WNT4;RNF43;WNT5B;WNT6;RYK;WNT9A;FZD7;WNT5A;FZD1;MYOC;DVL3;WNT16;DVL2;ZNRF3
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.502888580841065,-1.561616058934837,0.01768172888015717,0.23551468594167688,0.999,19/33,34.27%,PCF11;SCAF8;DHX9;CTR9;RPRD2;SPTY2D1;WDR43;GTF2B;HNRNPU;CDC73;WAC;CCAR2;AGO1;RTRAF;RECQL5;RRN3;ZNF326;ELOF1;URI1
prerank,hexose transmembrane transporter activity (GO:0015149),0.6289109820885065,1.5540043057791821,0.04112554112554113,0.15676831475717512,1.0,3/12,2.66%,SLC2A1;SLC2A3;SLC2A5
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.6168529369320594,-1.5506725129869463,0.017475728155339806,0.25092376092237145,1.0,6/14,19.73%,CYB5R4;NOX4;AIFM1;CYBA;MICAL1;NCF2
prerank,voltage-gated sodium channel activity (GO:0005248),0.5447815257582675,1.5496780080106245,0.030837004405286344,0.15831634169895048,1.0,9/22,15.79%,HCN1;SCN1A;SCN4B;HCN2;SCN3A;SCN2A;CACNA1I;SCN8A;SCN2B
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.32737317414133066,-1.5489040082228507,0.0,0.24847512366537397,1.0,111/597,13.72%,ZBTB20;PBX1;BNC2;FOXP1;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;MAF;SOX5;TEAD1;CREB3L2;NFKB1;PRDM5;HOXB6;THRB;SMAD6;GLI2;NR1D2;RARB;FOXC1;PER3;FOXO3;HDAC4;CREB5;ABL1;BCOR;NCOR1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;TBL1X;BRD7;ELF1;NFIB;TBL1XR1;NR6A1;NFIX;YAP1;GMEB1;RARG;KMT2D;HMGB1;NR3C1;KLF3;PRRX2;HOXA5;GABPB2;TBX15;ZIC5;STAT3;TEF;HOXA7;JDP2;HOXC8;ELF4;FOXC2;RUNX1;HOXC4;DHX9;REST;KDM5B;CEBPG;HOXB5;ZBTB37;AR;DHX36;FOXK1;MBD2;MAFG;TBP;SP2;NFYC;ATF2;HOXB4;UBP1;CHD3;RFX2;GABPA;NR1H3;JUN;CALCOCO1;SMAD4;GLIS2;MCM9;NFATC4;ZBED4;TBX18;MEF2C;ARID5B;TFCP2;HES1;TEAD2;IRF9;TCF7L1;BHLHE41;IRF1;YBX1;SOX13;GLI1;ATF6;SOX6
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.6513323059013704,-1.5473464273209037,0.025688073394495414,0.2454731491064461,1.0,7/12,20.79%,GAB2;IRS1;SHC1;FRS2;SH2B1;BLNK;PIK3R1
prerank,vinculin binding (GO:0017166),-0.6604819255928538,-1.5447854887377364,0.031598513011152414,0.24473282475722538,1.0,5/11,16.24%,DAG1;CTNNA1;TLN1;SYNM;SORBS3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5210569445499553,-1.5409557586266514,0.02355072463768116,0.2464412152512306,1.0,8/25,10.49%,GAB2;PLEKHA2;FCHSD2;ADAP2;MAPKAP1;ZFYVE1;DAPP1;KIF16B
prerank,neuropeptide binding (GO:0042923),0.5628597941517541,1.5409420122912854,0.02857142857142857,0.16528197940746406,1.0,5/18,15.06%,GPR149;OPRM1;SORL1;OPRK1;OPRL1
prerank,AMP binding (GO:0016208),-0.657253077877991,-1.5363298788309268,0.04275092936802974,0.24914404245698718,1.0,6/11,21.93%,PRKAG2;MPPED2;PFKP;PRKAG3;PFKM;PFKL
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.340722896693533,-1.5362336282032831,0.0,0.2436864563904739,1.0,105/346,21.19%,RNF220;PDZRN3;RNF152;PELI2;SMURF2;CBLB;UBE2N;RNF43;UBE2E2;UBR2;TRIM44;KCMF1;BCOR;PRKN;BIRC6;FBXW8;ARIH1;KLHL13;BTRC;WWP2;TRIP12;RNF115;RNF146;RNF217;HUWE1;UBR5;UHRF2;RBBP6;RNF213;DTX4;RC3H1;MEX3C;SH3RF1;RNF214;RNF19A;WWP1;UBE2H;ASB2;TRAF3IP2;RNF8;CDC42;RNF145;FBXO10;UBE2K;HLTF;MAEA;RNFT1;XIAP;DDB2;FBXO3;ANAPC4;TNFAIP1;RNF216;HERC2;RNF103-CHMP3;TRAF2;UBR1;UBE2R2;GID4;RFWD3;TRIM5;UBR3;TRIM11;CUL3;TRIM25;DTX3L;NHLRC3;SH3RF2;UBE2B;SMURF1;UBR4;TRIM39;SH3RF3;CUL2;TOPORS;ERCC8;UBE2E1;MSL2;TRAF3;RNF181;HECTD1;RNF20;BFAR;FBXO22;UBE2S;MYLIP;UBA7;SYVN1;FBXW11;AREL1;TRAF6;RNF14;UBE2D3;LRSAM1;DTX2;COP1;RNF11;NFX1;PML;ANAPC11;CUL1;TRIM63;TTC3;ARIH2;SHARPIN
prerank,peptidoglycan binding (GO:0042834),0.6564204241930209,1.526520800805606,0.035864978902953586,0.17925549513203415,1.0,3/10,10.01%,PGLYRP1;TLR2;NOD1
prerank,RNA polymerase II complex binding (GO:0000993),-0.4934708167367472,-1.5263065432069423,0.022556390977443608,0.25841913430950586,1.0,14/32,25.47%,PCF11;SCAF8;DHX9;CTR9;RPRD2;WDR43;GTF2B;HNRNPU;CDC73;WAC;CCAR2;AGO1;RTRAF;RECQL5
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5829770354964909,1.5256676061304084,0.03505154639175258,0.17678581513016065,1.0,7/15,7.08%,HS6ST3;HS3ST6;HS3ST5;HS3ST2;HS6ST2;NDST4;HS3ST4
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6374942359993538,-1.5251325146127244,0.03244274809160305,0.2550783753145372,1.0,5/12,3.24%,TGFBR3;TGFBR1;BMPR1A;LTBP1;TGFBR2
prerank,histone methyltransferase activity (GO:0042054),-0.4883675901712289,-1.519767454675758,0.022388059701492536,0.2608660683616457,1.0,17/32,24.48%,SETD7;KMT5B;KMT2C;NSD3;SMYD3;SETD2;PRMT2;N6AMT1;SETDB1;EHMT1;PRMT5;PRMT8;KMT5A;NTMT1;EZH2;PRDM9;KMT2E
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.6220906031256379,-1.5186320523620769,0.03867403314917127,0.25747274462271863,1.0,7/12,26.22%,CYFIP2;LARP1;GEMIN5;EIF4E;EIF4E3;NCBP3;NCBP2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5383773711764659,1.5179644009320503,0.031315240083507306,0.18352887897051284,1.0,5/22,6.46%,SYT1;AP2M1;APBB1;APBB3;CLU
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6197284801497818,-1.5147312956051335,0.03377110694183865,0.25966545083411957,1.0,6/12,16.31%,SULF1;GNS;SULF2;ARSK;ARSI;GALNS
prerank,ligand-gated calcium channel activity (GO:0099604),0.5600937366126654,1.5088310821361772,0.04073319755600815,0.19179318746111004,1.0,7/19,6.45%,GRIN1;GRIN2A;RYR2;RYR3;GRIN2B;GRIN2D;TRPM2
prerank,potassium channel regulator activity (GO:0015459),0.4421242913920266,1.501800430128134,0.021611001964636542,0.1978615400992947,1.0,12/49,8.45%,DPP10;KCNIP4;KCNIP1;WNK2;KCNMB2;KCNMB3;DPP6;KCNMB4;KCNAB1;AKT1;LRRC55;SGK3
prerank,tau-protein kinase activity (GO:0050321),-0.5394490079127277,-1.4995774154543449,0.052830188679245285,0.28666127969980576,1.0,10/20,19.80%,ROCK2;ROCK1;GSK3B;MARK3;MARK4;BRSK1;MARK1;SIK3;PRKAA1;TAOK1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.45944940313518806,1.4994328723941677,0.028634361233480177,0.19746684417956192,1.0,14/42,12.10%,DSCAM;BSG;LRRC4C;PLXNB3;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;ESAM;NTNG1;ROBO3;CNTN4;CNTN2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.47625752102959307,-1.497621921820646,0.02594810379241517,0.2851039188664623,1.0,17/34,25.85%,STK3;FAM20A;CCNT2;CAB39L;CCNT1;IGF2;MAP2K1;CCNK;RICTOR;DDX3X;MTCP1;TAOK1;CAB39;ALS2;DBF4;IRGM;INCENP
prerank,single-stranded DNA binding (GO:0003697),-0.38783427073655335,-1.4895399301212924,0.0057361376673040155,0.29595223934481085,1.0,48/93,32.86%,RBMS1;RAD23B;RBBP8;TOP1;HMGB1;SMC6;WDR48;RAD51B;TDP2;MLH1;DHX9;FUBP1;DHX36;PCBP2;SSBP2;MCM9;RTF1;RAD51D;NABP2;APTX;MCM6;BRCA2;CTC1;MSH3;DMC1;SPRTN;WBP11;HNRNPU;POLR2H;PARK7;STN1;SSBP1;ERCC1;CRY2;LONP1;MCM4;POLR2D;MCMDC2;IGHMBP2;SAMHD1;TWNK;NEIL3;RNF138;RPA2;PCBP1;RAD51;CDC45;POLA1
prerank,methylation-dependent protein binding (GO:0140034),-0.42041810343964275,-1.487493886287388,0.02524271844660194,0.2950008662100693,1.0,30/57,30.87%,KDM7A;CBX5;PYGO1;PHF8;CHD8;PHF2;ZCWPW2;MPHOSPH8;TDRD3;KAT8;ING5;PHF1;L3MBTL2;MORC3;MSL3;RRP8;BPTF;MSH6;ZMYND8;MORC4;ING1;NCAPD3;SPIN1;CXXC1;KMT2E;ATRX;ZMYND11;GLYR1;WDR5;CDYL
prerank,FAD binding (GO:0071949),-0.5106176084761043,-1.4863418836411317,0.030131826741996232,0.29195730767267664,1.0,11/24,18.28%,MICAL3;DDO;MICAL2;MTHFR;AIFM1;SQOR;PRODH;KDM1B;NQO2;MICAL1;SQLE
prerank,acetyltransferase activity (GO:0016407),-0.4858143865319463,-1.4853915806157194,0.04397705544933078,0.28857391121466874,1.0,11/31,16.29%,KAT2B;EP300;KAT6B;CREBBP;PAFAH2;PAFAH1B2;SAT1;KAT8;NAA15;ESCO1;GTF2B
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.4278091072426821,-1.484128303896925,0.01904761904761905,0.28593482784766694,1.0,27/53,27.41%,MICAL3;AOX1;DDO;MICAL2;POR;NOX4;MTHFR;AIFM1;SQOR;PRODH;KDM1B;PPOX;DPYD;ACOX1;NQO2;MICAL1;SQLE;SDHA;NOS1;ACOX3;ILVBL;CRY2;KDM1A;GSR;MTO1;ACADVL;GFER
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.47931474135289304,-1.4822259034925689,0.029354207436399216,0.28455414450295863,1.0,16/32,29.50%,FTO;KDM7A;KDM4B;PHF8;TMLHE;EGLN3;BBOX1;ALKBH1;KDM2A;TYW5;JMJD4;TET2;EGLN2;PHYHD1;HSPBAP1;TET3
prerank,potassium:proton antiporter activity (GO:0015386),-0.6576949368814781,-1.47861131612336,0.04059040590405904,0.2866387540609797,1.0,3/10,6.17%,SLC9A1;SLC9A8;SLC9A2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6419562581082029,1.4775252427065386,0.056433408577878104,0.22400601879660473,1.0,5/10,9.15%,IGSF11;SHISA6;SHANK3;SHISA7;SHANK2
prerank,carboxy-lyase activity (GO:0016831),0.5144068911946552,1.4757243149516273,0.04065040650406504,0.2228325124647127,1.0,6/23,10.44%,FAHD1;DDC;PISD;MVD;UXS1;GAD1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.43283084897581453,-1.4746594030355176,0.014141414141414142,0.2899507865493804,1.0,14/48,18.39%,TRPM3;PIEZO2;NALCN;ATP6V1B2;SLC41A1;TRPM6;SLC12A7;CALHM2;SLC12A2;PKD2;TRPM4;CALHM5;TRPV2;TRPM7
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.353223607741432,-1.4694644927686673,0.0,0.2963998642189175,1.0,46/173,18.69%,ZBTB20;FOXP2;FOXP1;AEBP1;NFKB1;PRDM5;ZNF148;FOXP4;ZFHX3;ZEB1;FOXO3;MXI1;KCNIP3;ZKSCAN3;NR3C1;SKI;ZBTB16;JDP2;SKIL;ZEB2;REST;ZBTB37;GTF2IRD1;FOXK1;SP2;ZBTB1;JUN;NFATC4;TBX18;HES1;ZNF692;TCF3;BHLHE41;ZBTB34;PATZ1;SOX13;TRPS1;PRDM2;MNT;FOXK2;HEYL;TBX2;ZFP37;CC2D1A;ZNF436;NFATC3
prerank,RNA polymerase binding (GO:0070063),-0.5376245736776107,-1.467486834583182,0.04664179104477612,0.29536282319646323,1.0,9/18,15.53%,CCNT2;PABPN1;CCNT1;SCAF8;DHX9;PHRF1;STOM;TCERG1;ANP32B
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.46512232453444396,1.4653399139994197,0.04054054054054054,0.2305538870383516,1.0,17/34,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFB9;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.46512232453444396,1.4653399139994197,0.04054054054054054,0.2305538870383516,1.0,17/34,21.30%,NDUFC1;NDUFA4;NDUFA1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;NDUFB2;NDUFB9;NDUFA7;NDUFA12;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;NDUFB7
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6186261678121807,-1.4653242732495988,0.05301645338208409,0.2948678785675786,1.0,6/12,24.28%,SLC9A1;SLC9A8;SLC9A2;LETM1;SLC9B2;SLC9A9
prerank,hexosaminidase activity (GO:0015929),-0.6052841760247769,-1.4617651782206549,0.06914893617021277,0.2969272502073042,1.0,6/12,19.93%,CEMIP;OGA;HEXD;CEMIP2;HEXA;NAGA
prerank,alanine transmembrane transporter activity (GO:0022858),0.5958496960860089,1.4609635035475967,0.06570841889117043,0.23320071729828123,1.0,4/12,16.03%,SLC6A6;SLC7A8;SLC36A1;SLC3A2
prerank,neuropeptide receptor activity (GO:0008188),0.4852191398463709,1.45673985164158,0.052845528455284556,0.23558151592176427,1.0,7/29,11.38%,SORCS3;TACR1;SORCS1;TACR3;HCRTR2;OPRM1;GRPR
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.4424993727519279,-1.4544105196591297,0.02895752895752896,0.3079325220136925,1.0,21/44,24.48%,SETD7;KMT5B;SETD5;KMT2C;KMT2D;NSD3;NSD1;SMYD3;SETD3;SETD2;N6AMT1;SETDB1;EHMT1;KMT5C;ASH1L;KMT5A;KMT2A;EZH2;PRDM9;CXXC1;KMT2E
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5549724954982993,1.4541064406383428,0.05934065934065934,0.2322716254997967,1.0,4/16,8.66%,ANO3;TTYH2;ANO5;ANO4
prerank,intracellular chloride channel activity (GO:0061778),0.5549724954982993,1.4541064406383428,0.05934065934065934,0.2322716254997967,1.0,4/16,8.66%,ANO3;TTYH2;ANO5;ANO4
prerank,glycerophospholipid flippase activity (GO:0140333),0.6251054665028712,1.4538743387019486,0.06147540983606557,0.22901633093300214,1.0,7/11,11.06%,ATP8A1;ATP11A;ATP10A;ATP10B;ATP11C;ATP8A2;ABCB4
prerank,sialyltransferase activity (GO:0008373),0.5253540883495595,1.4513009658767295,0.06451612903225806,0.22950173755612513,1.0,7/20,12.68%,ST6GALNAC3;ST8SIA4;ST3GAL6;ST8SIA1;ST8SIA6;ST8SIA3;ST6GAL2
prerank,regulatory RNA binding (GO:0061980),-0.4504863848634628,-1.449806229894939,0.044921875,0.3121706992995382,1.0,8/38,8.05%,DICER1;PUM2;ZC3H7A;RC3H1;DHX9;PUM1;TUT4;RBM10
prerank,rRNA binding (GO:0019843),0.44343855682581507,1.4477877731941398,0.025896414342629483,0.23093708906821034,1.0,18/42,18.59%,RPL23;RPF2;RPLP0;MRPS18A;RPL12;MRPS7;RPL5;ERI1;FASTKD5;RPS14;RPS3;UTP23;RPS5;MDM2;PPAN;RPS9;CIRBP;MRPL18
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5922694403951604,-1.4474597027245777,0.06517690875232775,0.31245791432139897,1.0,8/13,19.37%,PDGFRA;PDGFRB;PDGFC;VEGFA;ERN1;VEGFD;ITGA5;ITGB3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6040136121444261,-1.444580533506647,0.07366482504604052,0.3139132682365033,1.0,6/12,14.77%,KDM7A;KDM4B;PHF8;PHF2;KDM3B;KDM3A
prerank,chemokine binding (GO:0019956),-0.4773375637813756,-1.4401596318023695,0.050387596899224806,0.31878747829721926,1.0,9/30,21.57%,ITGAV;PDPN;CCR9;HMGB1;ITGB1;ITGA4;CX3CR1;ITGB3;FGF2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.33023251986450186,-1.4398808889524317,0.0019801980198019802,0.3146080889366091,1.0,65/254,18.69%,NFIA;HLF;NFAT5;TCF4;SMAD3;PRRX1;NFKB1;RBPJ;MDM4;FOXC1;FOXO3;HOXB3;MEOX2;ELF1;NFIB;RREB1;GMEB1;MEF2A;NR3C1;SMAD2;HOXA5;PLSCR1;ZBTB16;STAT3;HOXA7;TFDP2;ELF4;FOXC2;RUNX1;HOXC4;VEZF1;CEBPG;AR;CDC5L;NFYC;ATF2;UBP1;GABPA;JUN;HIF1A;SMAD4;GLIS2;CREBRF;MEF2C;NRF1;TFCP2;TCF3;IRF1;ATF6;HINFP;PRDM2;KLF15;FOXK2;PRDM15;KLF6;ZNF112;MYBL1;SIX1;NR4A1;SMARCD2;NFYB;NR4A2;NFIC;TFCP2L1;NFATC3
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.47024238350922426,1.437622430981189,0.038696537678207736,0.2429857142806157,1.0,7/32,9.57%,SLC7A5;SLC6A6;SLC1A1;MFSD12;SLC7A8;SLC43A2;SLC36A1
prerank,retinoic acid binding (GO:0001972),-0.5980264783235906,-1.430670001747314,0.09568480300187618,0.33075682667592254,1.0,2/12,3.51%,NR2F2;CYP26B1
prerank,metal ion binding (GO:0046872),0.31045838814438176,1.4222399683527376,0.002012072434607646,0.26230180807470876,1.0,88/477,12.29%,SPOCK2;ADGRL3;SPOCK1;GRIN1;NRXN1;CDH12;CDH8;SYT1;MT2A;PCLO;SYT6;S100A16;RASGRP3;KCNIP4;MMP12;SYT7;CDH7;CDH19;CDH20;S100A9;S100A8;S100G;DNER;SYT12;SYT11;CDH18;RYR2;MCTP1;CDH2;PDE2A;PGP;RYR3;MEX3B;SNCA;KCNIP1;NUDT3;SLC8A1;ENPP2;RCN2;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;CDH10;PITPNM1;SLC25A23;HSPA5;CSGALNACT1;SLIT3;SLIT1;NUDT12;TRPM2;CPNE1;MELK;CIB2;TUBB4A;HPRT1;THBS3;SYT10;DYSF;S100A2;IDH3G;PCDHB6;TPT1;ARSA;TPPP;ACVR1C;DCHS1;PIF1;PVALB;ASTN2;GALNT3;IMPA1;AIF1;APEX1;CALM1;PCDHA4;BRSK2;SYT2;SNN;HACL1;RET;SPARCL1;SNCB
prerank,histone acetyltransferase binding (GO:0035035),-0.5023371151283449,-1.419165129543971,0.06554307116104868,0.35103511378928137,1.0,14/21,28.90%,GLI3;KANSL1L;MEF2A;BCAS3;TRIP4;HIF1A;STAT1;CITED2;PCNA;EID1;TRIM68;ZBTB7A;TAF7;EGR1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.6232627543922091,-1.4176520595715145,0.08834586466165413,0.3495697575311457,1.0,4/10,15.84%,KDM7A;KDM4B;PHF8;KDM2A
prerank,GTPase binding (GO:0051020),-0.33444984734672706,-1.4172966163981133,0.007889546351084813,0.3454445570646358,1.0,71/195,23.03%,AKAP13;RNF152;AFDN;PLCE1;ABCA1;ERC1;LRRK2;FLNA;DOCK7;MAPKAP1;SGSM2;RADIL;DNM1L;PDE6D;RANBP2;STRN3;PAK2;TMEM127;RAB3GAP1;BRAF;BRK1;USP6NL;UNC13B;IQGAP2;TNFAIP1;LZTR1;CDC42EP5;RUSC2;USP33;TBC1D20;GGA3;EXOC2;NCKAP1;ARFIP2;YBX3;FGD1;BECN1;YBX1;ARHGDIB;FGD4;ANKRD27;RANBP9;WASF1;RCC1;WHAMM;STOML2;RASA1;GNB1;PICALM;CCDC186;CDC42EP4;AMBRA1;ANKFY1;RABGGTB;RHOH;CHM;TRIOBP;RTKN;RABGAP1;TBC1D7;TRIP11;CHML;DVL3;BNIP3;GGA2;ALS2;ATG14;RAPGEF4;TNPO3;XPO5;RGP1
prerank,transcription cis-regulatory region binding (GO:0000976),-0.31089607735962543,-1.416923482791523,0.0021008403361344537,0.34156782873873026,1.0,93/406,17.31%,ZBTB20;PBX1;BNC2;FOXP1;AEBP1;TCF7L2;GLI3;SMAD3;SOX5;TEAD1;CREB3L2;NFKB1;PRDM5;SMAD6;FOXC1;PER3;FOXO3;HDAC4;BCOR;NCOR1;ARNT;CUX1;OSR1;TFEB;MXI1;TBL1X;BRD7;FOXN3;TBL1XR1;RREB1;YAP1;MEF2A;KMT2D;HMGB1;NR3C1;SMAD2;GABPB2;STAT3;TFDP2;HOXC8;FOXC2;RUNX1;REST;VEZF1;ZBTB8A;AR;DHX36;TAF4;FOXK1;CDC5L;TBP;NFYC;ATF2;CHD3;GABPA;NR1H3;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;CREBRF;ZBED4;XRN2;TBX18;RORA;MEF2C;ARID5B;TFCP2;TCF3;RB1;IRF1;SOX13;GLI1;ATF6;SOX6;TRPS1;ZFP3;HINFP;HDAC1;PRDM2;SNAPC3;RXRA;KLF15;BBX;MNT;FOXK2;VSX1;SFPQ;SIX1;ZFP37;NFYB;TWIST2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.6178967148527557,1.4158414209704155,0.09071274298056156,0.2686349102337744,1.0,3/11,12.77%,KCNJ3;KCND3;KCNJ8
prerank,sequence-specific DNA binding (GO:0043565),-0.29991842419203785,-1.414601221566949,0.0,0.34210438539689214,1.0,96/590,12.24%,ZBTB20;PBX1;FOXP2;FOXP1;NR2F2;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;TCF7L2;GLI3;SMAD3;MAF;TEAD1;FOXD1;PRDM5;HOXB6;ZNF148;SMG6;RBPJ;THRB;GLI2;ZNF423;NR1D2;RARB;FOXC1;FOXO3;SMG1;HDAC4;CREB5;ABL1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;ELF1;NFIB;NR6A1;NFIX;GMEB1;RARG;MEF2A;ZKSCAN3;NR3C1;KLF3;PRRX2;HOXA5;TBX15;ZIC5;TEF;HOXA7;JDP2;HOXC8;BCL2;ELF4;FOXC2;HOXC4;ZEB2;KDM5B;CEBPG;HOXB5;ZBTB37;HNRNPD;SAFB2;FOXK1;MBD2;PPARGC1A;MAFG;SP2;SMG7;ATF2;HOXB4;UBP1;UPF1;RFX2;GABPA;JUN;HIF1A;CALCOCO1;SMAD4;GLIS2;NFATC4;TBX18;RORA;MEF2C;FBXL19;TFCP2;TELO2;HES1;TEAD2;IRF9
prerank,metallopeptidase activity (GO:0008237),-0.3558548674645631,-1.4083913687241234,0.01953125,0.35166671667185656,1.0,26/113,12.77%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;ADAMTSL5;PAPPA;ADAMTS5;BRCC3;MYSM1;ECE1;ANPEP;ADAMTSL4;ADAMTS9;NRDC;MMP14;ADAM9;LAP3;MBTPS2;ADAM19;ADAMTS15;MMP2;ADAM33;NLN
prerank,DNA binding (GO:0003677),-0.2957844656618633,-1.4053982267020726,0.0,0.35369641068295615,1.0,269/694,30.96%,PBX1;RBMS1;FOXP2;DENND4A;NR2F2;EGFR;HLF;ZIC4;TCF4;TCF7L2;SMAD3;TEAD1;FOXD1;PRDM5;ZNF148;HIVEP2;INO80;RBPJ;THRB;GLI2;ZNF423;RARB;FOXC1;ZIC2;FOXO3;EP300;HDAC4;ABL1;ARNT;CUX1;RAD23B;MEOX2;RBBP8;NFIB;NUPR1;NR6A1;TOP1;CCNT1;BCLAF3;KHDRBS1;EZH1;RARG;MEF2A;KMT2D;HUWE1;HMGB1;ZKSCAN3;SMC6;SMAD2;RBM6;HOXA5;CREBBP;ZBTB16;NBN;STAT3;WDR48;HOXA7;RAD51B;TDP2;MLH1;DNMT3A;BCL2;FOXC2;CHD8;DHX9;ZEB2;KDM5B;HDGFL2;CEBPG;FUBP1;DHX36;ZNF496;SAFB2;PCBP2;AIFM1;WRN;TAF4;PPARGC1A;CDC5L;NFYC;DDB2;CHD2;CHD4;CHD3;RFX2;NR1H3;SSBP2;JUN;DDX60;HIF1A;CALCOCO1;SMAD4;MCM9;BCLAF1;XRN1;RTF1;XRCC4;ZMYM4;RORA;RAD51D;ARID5B;PDS5B;ERCC3;SPTY2D1;TFCP2;HES1;WDR76;NABP2;TCF3;TCF7L1;CCDC25;PATZ1;APTX;CGGBP1;IRF1;TSHZ3;YBX1;SOX13;ZMYM3;GLI1;ATF6;PARP4;SOX6;PHF1;STAT1;PRKDC;RBM5;HINFP;CRLF3;MCM6;BRCA2;CTC1;ILF2;DDX3X;PRDM2;MSH3;CARF;SNAPC3;TOPORS;RXRA;FOXK2;DMC1;SFPQ;MRE11;FOXL1;SPRTN;CAMTA2;SIX1;TBX2;NR4A1;NFYB;ZDHHC1;POGK;NR4A2;WBP11;HNRNPU;TAF6L;MSL3;SDE2;DCLRE1A;POLR2H;PARK7;BPTF;GTF3C4;ELK4;MSH6;RNF11;H1-0;TERT;PCNA;SMC1A;TAF12;NFYA;ZBTB49;ZIC3;STN1;SURF6;USF1;XRCC6;CXXC5;ARID5A;SSBP1;DRAP1;MYRF;PRDM9;SPHK1;IRF2;CLSPN;MAFK;MAFB;DEDD;DNASE2;RAD51C;HDAC2;ERCC1;HSF1;NR2F1;TFAP4;MBD3;ZNF35;ARID3B;GTF3C1;SIRT3;TSHZ2;FOXE1;SNAPC1;CRY2;ZBTB7A;CREBZF;QRICH1;SPO11;KIN;ATAD5;PPARA;OGG1;ZNF219;HOXB2;NR2C1;ENDOV;ORC1;GTF3C6;TIPIN;MBD6;MAFF;SOX12;LONP1;GTF2H4;ZNF292;DNASE1L1;SAP30L;MCM4;APP;SOX10;SAFB;POLR2D;MPG;SLTM;CDK9;MCMDC2;TIMELESS;CGAS;ZBTB4;IGHMBP2;E2F1;SUPV3L1;ZMYND11;EGR1;ZFPL1;FOXO4;POLRMT;NR1H4;GLYR1;NFE2L2;SAMHD1;HIC1;CALR;THRAP3;ZNF76;BATF;PSIP1;MLX;MLXIPL;GTF2A1;CR2;FANCG;TWNK;FOXD2;NR5A2;SOX8
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.6074636219664165,-1.4045438076370484,0.07832422586520947,0.350764627154769,1.0,4/11,20.59%,UBR5;UBE4B;UBE2K;ANAPC11
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5195369328379891,1.4040879553487755,0.07627118644067797,0.28420611951437047,1.0,6/20,11.74%,SLC39A10;SLC39A2;SLC30A1;SLC30A3;SLC39A8;SLC30A5
prerank,methylated histone binding (GO:0035064),-0.3951174249702084,-1.4002324016169791,0.036072144288577156,0.3559621203846978,1.0,31/62,30.87%,KDM7A;CBX5;PYGO1;PHF8;CHD8;PHF2;ZCWPW2;MPHOSPH8;TDRD3;KAT8;ING5;PHF1;L3MBTL2;MORC3;MSL3;RRP8;BPTF;MSH6;ZMYND8;MORC4;ING1;NCAPD3;SPIN1;CXXC1;KMT2E;TAF7;ATRX;ZMYND11;GLYR1;WDR5;CDYL
prerank,sodium:proton antiporter activity (GO:0015385),-0.5994023022351685,-1.3992935742754389,0.07942238267148015,0.3538496289080877,1.0,5/11,24.28%,SLC9A1;SLC9A8;SLC9A2;SLC9B2;SLC9A9
prerank,lipoprotein particle binding (GO:0071813),0.5013792985112581,1.39826411400806,0.07692307692307693,0.2903223305578645,1.0,7/20,14.41%,PLTP;SCARF1;HSPD1;SORL1;SCARB1;CD36;STAB2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5765059493523237,-1.397564813787675,0.09208103130755065,0.3536803389990094,1.0,6/13,24.28%,SLC9A1;SLC9A8;SLC9A2;LETM1;SLC9B2;SLC9A9
prerank,phospholipase activator activity (GO:0016004),-0.6062548118462578,-1.397508969057189,0.09090909090909091,0.3495731913175521,1.0,3/10,11.22%,ARHGAP6;PDPK1;STX4
prerank,small GTPase binding (GO:0031267),-0.335785494236442,-1.397347928510383,0.009689922480620155,0.3457007076695396,1.0,65/170,24.36%,AKAP13;RNF152;AFDN;PLCE1;ABCA1;ERC1;LRRK2;FLNA;DOCK7;MAPKAP1;SGSM2;DNM1L;PDE6D;RANBP2;STRN3;PAK2;TMEM127;RAB3GAP1;BRAF;BRK1;USP6NL;UNC13B;IQGAP2;TNFAIP1;LZTR1;CDC42EP5;RUSC2;USP33;TBC1D20;GGA3;EXOC2;NCKAP1;ARFIP2;YBX3;FGD1;ARHGDIB;FGD4;ANKRD27;RANBP9;WASF1;RCC1;WHAMM;PICALM;CCDC186;CDC42EP4;ANKFY1;RABGGTB;RHOH;CHM;TRIOBP;RTKN;RABGAP1;TBC1D7;TRIP11;CHML;DVL3;GGA2;ALS2;RAPGEF4;TNPO3;XPO5;RGP1;GCC1;RAB8A;KIF3A
prerank,voltage-gated ion channel activity (GO:0005244),0.5373171864620484,1.396983560969934,0.10212765957446808,0.28843430418178206,1.0,5/14,14.61%,KCND2;HCN1;CACNA1E;VDAC2;VDAC3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.3378732168546948,-1.3953278899055206,0.014028056112224449,0.34607694270127926,1.0,49/181,14.63%,TCF7L2;SMAD3;PRRX1;RBPJ;MDFIC;PIAS1;EP300;HDAC4;RERE;NCOR1;ARNT;RBBP8;WWP2;GSK3B;ANXA4;MEF2A;BAZ2A;BCAS3;CREBBP;STAT3;TRIP4;DHX9;AR;TAF4;PPARGC1A;TBP;PIAS3;NCOA1;DACT1;MED1;JUP;ATF2;TEAD3;CHD4;MIER1;JUN;TADA3;HIF1A;PARP9;ID2;HES1;TCF3;PIAS4;RB1;BHLHE41;DTX3L;TCERG1;STAT1;HDAC1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.39438802178766896,1.3851294118328201,0.06196581196581197,0.3041894622192771,1.0,25/57,21.30%,NDUFC1;COX7A1;NDUFA4;COX4I1;NDUFA1;COX6A1;NDUFA2;NDUFC2;NDUFA13;NDUFA3;COX6B1;NDUFB2;UQCRH;NDUFB9;NDUFA7;COX10;NDUFA12;COX8A;NDUFB4;NDUFB8;NDUFA10;NDUFS3;NDUFA6;COX5B;NDUFB7
prerank,monocarboxylic acid binding (GO:0033293),-0.5136312493019186,-1.3838464667845243,0.09363295880149813,0.36601513017110565,1.0,4/18,15.55%,NR2F2;CYP26B1;NAPEPLD;RXRA
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6180502556843177,-1.3824077665724774,0.08610567514677103,0.36500702309286637,1.0,3/10,11.00%,SLC6A13;SLC6A12;SLC6A1
prerank,pentosyltransferase activity (GO:0016763),-0.43575878767944454,-1.3805360482761626,0.07969639468690702,0.36483767436472375,1.0,12/36,13.63%,LARGE1;TNKS2;UPP2;ZC3HAV1;PARP10;PARP14;PARP9;PPAT;PARP1;QTRT2;SIRT5;PARP4
prerank,active ion transmembrane transporter activity (GO:0022853),0.4346106004104683,1.3801864153750494,0.06609808102345416,0.308588393996574,1.0,9/37,9.69%,SLCO1C1;SLC4A1;SLCO4C1;COX7A1;NDUFA4;COX4I1;COX6A1;SLCO5A1;SLCO2B1
prerank,muscle alpha-actinin binding (GO:0051371),-0.5419960994773739,-1.3784592428207203,0.0916030534351145,0.36533770470935284,1.0,6/15,12.34%,PDLIM5;PDLIM7;PALLD;SYNPO2;PDLIM2;PKD2
prerank,cytochrome-c oxidase activity (GO:0004129),0.5416161337337,1.3728088560179974,0.09782608695652174,0.3170546727582713,1.0,8/15,21.28%,COX7A1;NDUFA4;COX4I1;COX6A1;COX6B1;COX10;COX8A;COX5B
prerank,double-stranded DNA binding (GO:0003690),-0.2948502281958107,-1.372509301419102,0.0,0.3749126830670663,1.0,101/531,17.06%,ZBTB20;PBX1;RBMS1;FOXP1;EGFR;HLF;PKNOX2;ZIC4;NFAT5;ZIC1;TCF4;GLI3;MAF;TEAD1;HOXB6;THRB;GLI2;NR1D2;RARB;FOXO3;CREB5;ABL1;ARNT;CUX1;OSR1;NR3C2;TFEB;MBNL2;MEOX2;ELF1;RBBP8;NFIB;NR6A1;TOP1;NFIX;GMEB1;RARG;HMGB1;NR3C1;KLF3;SMAD2;PRRX2;HOXA5;TBX15;ZIC5;WDR48;TEF;HOXA7;RAD51B;JDP2;HOXC8;ELF4;FOXC2;HOXC4;DHX9;KDM5B;HDGFL2;CEBPG;HOXB5;ZBTB37;FOXK1;MAFG;SP2;ATF2;HOXB4;UBP1;RFX2;GABPA;JUN;DDX60;GLIS2;NFATC4;TBX18;MEF2C;TFCP2;HES1;TEAD2;IRF9;TCF7L1;BHLHE41;APTX;CGGBP1;YBX1;ATF6;STAT1;PRKDC;MSH3;HOXB9;RXRA;KLF15;RUNX2;BBX;DMC1;VSX1;KLF6;MRE11;SPRTN;CAMTA2;SIX1;TBX2;NR4A1
prerank,peptidase inhibitor activity (GO:0030414),-0.4360717619011386,-1.3662448468338282,0.07321772639691715,0.38485053934238417,1.0,9/33,11.79%,CAST;PROS1;GPC3;TFPI;ITIH2;RECK;RENBP;SERPIND1;PSMF1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.40268169423202205,1.3648172933252898,0.06237816764132553,0.3275053032056253,1.0,11/51,9.69%,SLCO1C1;SLC7A5;SLC4A1;SLCO4C1;MFSD2A;SLC35A1;SLCO5A1;SLC7A8;SLC25A14;SLC35C1;SLCO2B1
prerank,four-way junction DNA binding (GO:0000400),-0.5167861607671564,-1.3621544154345742,0.10784313725490197,0.3895697844436796,1.0,8/17,23.22%,ABL1;HMGB1;RAD51B;WRN;RAD51D;FANCM;MSH6;RAD51C
prerank,low-density lipoprotein particle binding (GO:0030169),0.5187707418373327,1.3593573226042912,0.10515463917525773,0.33310401917402405,1.0,6/16,14.41%,PLTP;SCARF1;SORL1;SCARB1;CD36;STAB2
prerank,manganese ion binding (GO:0030145),-0.40312508244465417,-1.3580498814178963,0.07662082514734773,0.39483527359591347,1.0,20/48,23.92%,LARGE1;MPPED2;B4GALT1;ABL1;XPNPEP1;TDP2;WRN;ME1;ABL2;FAM20C;PPM1M;PCK2;XYLT2;SOD2;NEK4;GALNT1;B4GALT7;MPPE1;XXYLT1;PRIMPOL
prerank,poly-purine tract binding (GO:0070717),-0.4651226543408691,-1.3573165195158177,0.09716599190283401,0.39226099009380117,1.0,6/27,5.06%,RBMS1;RBMS3;RBPMS;ATXN1;KHDRBS1;RBMS2
prerank,ATPase binding (GO:0051117),-0.3706724526674845,-1.3541276416011192,0.038834951456310676,0.3958162120304505,1.0,27/71,22.46%,EGFR;ANK2;ABCA1;TMTC4;SNTA1;PTPN3;ATP6V0A4;CHMP4A;AR;NCSTN;SELENOS;RALA;PKD2;SNX10;METTL21A;NOP58;SNU13;CLPP;DERL1;TCIRG1;SYVN1;ATP5IF1;ATP1B3;PEX26;S100A1;PIH1D1;WFS1
prerank,anion transmembrane transporter activity (GO:0008509),0.5535238757254559,1.3521671910339796,0.13541666666666666,0.34173459586132465,1.0,4/12,10.65%,SLC4A1;ABCG2;SLCO2B1;SLC39A8
prerank,protein serine/threonine kinase activity (GO:0004674),-0.301269731717272,-1.3511179138032277,0.009652509652509652,0.39812288285065706,1.0,110/335,22.14%,ROCK2;GRK5;EGFR;TGFBR1;BMPR1A;CDK8;TLK1;CLK1;MAPK4;MYLK;ARAF;STK3;FAM20A;ROCK1;SMG1;CAMK1D;LRRK2;PRKAA2;TGFBR2;CSNK1A1;TOP1;GSK3B;STK17B;TBK1;IRAK3;NRK;MARK3;CDK16;BCR;CDK7;SLK;PAK2;ALPK1;MAP4K4;TAOK3;EIF2AK3;CAMK2D;IRAK2;MTOR;BRAF;MAP3K5;PDPK1;CAMK2G;MARK4;MAP2K1;CDK13;GRK3;WNK4;CCNK;CLK2;MAP3K20;WNK1;CSNK1E;HIPK1;BRSK1;PRKCD;DMPK;FAM20C;PRKAB2;CLK3;CDK11B;ULK2;RIOK3;MKNK2;SIK1;EIF2AK4;RPS6KC1;STK33;CPNE3;MAPK6;EIF2AK2;PRKDC;BMP2K;ACVR1;ERN1;LATS1;PRKCZ;MAP3K14;CSNK2A1;PIK3R4;GRK6;MARK1;DAPK1;SIK3;TRIO;IKBKE;DAPK2;PRKACA;PRKD1;PRKAA1;NEK4;CSNK1D;STK16;MAP3K1;CDK10;CDK2;NEK6;FASTK;IRAK1;TAOK1;NRBP2;BCKDK;CDK6;MAST2;AKT2;MKNK1;ATR;MAP3K12;PRKCA;SIK2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3871018052729929,1.349183335792018,0.057971014492753624,0.3431922981245867,1.0,15/60,8.39%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK;ACVRL1;EPHA10
prerank,transcription coregulator binding (GO:0001221),-0.3990018597183329,-1.3464351856686418,0.07936507936507936,0.4049570184153093,1.0,20/50,21.59%,SMAD3;THRB;PER3;CCNT2;VGLL4;LCOR;ZBTB16;AR;UBE2I;SMAD4;RORA;TEAD2;EHMT1;USP11;PHF1;CNOT2;NEK6;TERT;ZBTB49;EZH2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.4901710462612125,-1.3447629648922803,0.12404580152671756,0.40474160731807385,1.0,5/18,12.67%,ALDH1A1;ALDH1A2;ALDH2;AKR1B1;ALDH6A1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4926953537514711,1.3389085252345563,0.1172566371681416,0.35828199131741845,1.0,6/18,21.42%,SRD5A2;HSD17B7;HSD11B1;HSD17B2;HSD17B10;HSD3B7
prerank,transcription coactivator binding (GO:0001223),-0.48665444017534626,-1.337568177048179,0.11637080867850098,0.41752880538211756,1.0,8/20,12.15%,SMAD3;THRB;CCNT2;VGLL4;AR;SMAD4;RORA;TEAD2
prerank,GTPase activator activity (GO:0005096),-0.3016993873829517,-1.332029947195834,0.001976284584980237,0.4258710928347806,1.0,84/313,16.79%,AKAP13;RANBP3L;ALDH1A1;ARHGAP29;DENND4A;DOCK5;ARHGAP10;ARHGAP42;DOCK11;ERRFI1;PLCE1;ASAP3;SIPA1L1;DENND2A;FARP1;ARHGAP28;ASAP1;STXBP5;ARHGAP20;LRRK2;ARHGEF10L;ARHGEF17;ARAP1;TBC1D16;SMAP1;SBF2;IQSEC2;ARHGAP24;BCR;SGSM2;DNM1L;RANBP2;SEC23A;NRP1;ARFGEF1;RAB3GAP1;CYTH3;GMIP;RAPGEF3;VAV2;ARHGAP17;USP6NL;RAB3IL1;IQGAP2;ARFGAP1;ARFGAP3;TBC1D2B;HERC2;TBC1D20;TBC1D8B;RAB3IP;RCC1L;JUN;RP2;ARHGEF18;FNIP1;DENND4C;ARHGAP32;MON1A;SERGEF;SEC23B;FGD1;DNMBP;TBCK;DENND5A;GRTP1;TBC1D22B;FGD4;ANKRD27;RCC1;TBC1D9;ACAP2;RAPGEF2;FARP2;RASA1;SH3BP5L;NGEF;ARRB1;ARHGAP18;DOCK1;ARHGEF11;ARHGEF6;RIC8B;TBCD
prerank,alpha-actinin binding (GO:0051393),-0.45338680102314266,-1.3286205161945825,0.11047619047619048,0.4301721246603167,1.0,9/24,12.34%,CACNA1C;DAG1;PDLIM5;PDLIM7;CACNA1D;PALLD;SYNPO2;PDLIM2;PKD2
prerank,lipoprotein particle receptor binding (GO:0070325),0.44723914377166074,1.3281166804644784,0.10772357723577236,0.3746111910963482,1.0,6/27,9.08%,SYT1;AP2M1;APBB1;APBB3;CLU;RELN
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5624153574531227,-1.3171636332711385,0.1381118881118881,0.4541592536964936,1.0,7/11,39.76%,SLC22A5;SLC22A4;SLC25A47;SLC25A29;SLC25A20;SLC22A3;SLC25A45
prerank,transcription corepressor binding (GO:0001222),-0.44891561983266537,-1.3153200977652098,0.1225296442687747,0.45431121757713894,1.0,13/27,28.18%,PER3;LCOR;ZBTB16;RORA;EHMT1;USP11;PHF1;CNOT2;NEK6;EZH2;ZBTB7A;HDAC3;ESR1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.5634953177042603,-1.3141052758328091,0.14048059149722736,0.4528418838357089,1.0,3/10,9.25%,DSE;GLCE;RENBP
prerank,SH3 domain binding (GO:0017124),-0.3726078411122654,-1.3138160896531865,0.08771929824561403,0.449169901897884,1.0,19/62,17.95%,DPYSL3;AFAP1;CBLB;ABL1;PRKN;WASF2;KHDRBS1;SYNJ2;PLSCR1;VASP;PTPN22;PTPN12;ADAM9;ABI1;WIPF1;CYBA;SOCS7;AFAP1L2;MICAL1
prerank,pre-mRNA binding (GO:0036002),-0.43769393868516304,-1.3124758276075135,0.12987012987012986,0.44829239212164,1.0,8/28,9.95%,CELF2;DDX5;CELF1;U2AF2;SRSF6;RNPC3;SLU7;SLBP
prerank,phospholipase binding (GO:0043274),-0.5320469569200765,-1.3081563064951287,0.13680154142581888,0.4546778946427492,1.0,3/13,7.95%,ARHGAP6;PRKN;PDPK1
prerank,tropomyosin binding (GO:0005523),-0.5030629567804712,-1.3072291306125525,0.14022140221402213,0.452586398412131,1.0,3/16,10.46%,CALD1;TMOD3;S100A6
prerank,miRNA binding (GO:0035198),-0.43681729928552326,-1.3069961566698767,0.11133200795228629,0.4490214958016301,1.0,12/30,29.37%,PUM2;ZC3H7A;RC3H1;PUM1;TUT4;RBM10;YBX1;RBM4;ZNF346;AGO1;ZC3H7B;ZC3H10
prerank,RNA cap binding (GO:0000339),-0.49480641690236826,-1.3051538396617857,0.14620938628158844,0.44962415040137965,1.0,8/16,31.16%,CYFIP2;LARP1;GEMIN5;EIF4E;EIF4E3;NCBP3;NCBP2;LSM1
prerank,lipase activator activity (GO:0060229),-0.5682220362085811,-1.3050944222543577,0.1694915254237288,0.44572095880630713,1.0,2/10,7.95%,ARHGAP6;PDPK1
prerank,poly(A) binding (GO:0008143),-0.47385343318604534,-1.301677949429085,0.1214574898785425,0.44981265531344955,1.0,5/21,5.06%,RBMS1;RBMS3;RBPMS;KHDRBS1;RBMS2
prerank,Tat protein binding (GO:0030957),0.5467507532977679,1.2981112165101523,0.1782608695652174,0.43163198672847164,1.0,3/10,4.32%,ACTB;GABARAPL1;SMARCB1
prerank,receptor ligand activity (GO:0048018),0.3024091293494417,1.2977270979488018,0.020161290322580645,0.4272217353907956,1.0,37/245,10.54%,NRG3;KITLG;IL17F;SEMA3C;SEMA6A;MIF;AMH;IL7;NRG1;SEMA4A;SEMA4F;GAS6;SEMA6D;FGF10;SEMA4D;TAFA2;SEMA7A;BMP8A;IL12A;SCGB3A1;TGFB2;TAFA1;AMELX;WNT7B;FGF5;ENDOU;TNFSF13B;TIMP1;EPO;GPNMB;NMB;SST;POMC;THPO;BMP3;PDGFB;SCG2
prerank,water transmembrane transporter activity (GO:0005372),0.5520865528845531,1.2947873793863751,0.18672199170124482,0.4285914252848703,1.0,3/11,12.21%,AQP9;AQP11;AQP4
prerank,mRNA binding (GO:0003729),-0.29707234267888205,-1.2943203153317415,0.025896414342629483,0.4636158601765839,1.0,59/249,14.85%,RBMS1;SAMD4A;CELF2;SRRM2;RBFOX2;RBMS3;RBPMS;DDX5;CELF1;EIF4G3;LUC7L2;HNRNPR;PUM2;YTHDF3;SYNCRIP;PCF11;KHDRBS1;DDX6;RBMS2;EIF4ENIF1;RC3H1;ZC3H12C;SCAF8;NYNRIN;HNRNPM;DHX9;PTBP3;SF3B1;DENR;SRSF6;LARP1;SRBD1;PUM1;HDLBP;FUBP1;DCP1A;DHX36;PCBP2;CSDC2;GEMIN5;HNRNPK;SLBP;LSM14A;SF3B6;DAZAP1;YTHDC1;DCP1B;KHNYN;TPR;SNRNP70;YBX3;SERBP1;NSRP1;ACO1;RBM5;SRSF1;ZC3H12B;EDC3;DDX3X
prerank,acid-thiol ligase activity (GO:0016878),-0.5263817292324791,-1.2935828795198296,0.17077798861480076,0.46133704367287953,1.0,2/13,3.04%,ACSL1;ACSS3
prerank,CoA-ligase activity (GO:0016405),-0.5167945603565988,-1.2928270347499602,0.1623134328358209,0.45925628106451055,1.0,2/14,3.04%,ACSL1;ACSS3
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5451597541073345,-1.291176770146678,0.16544117647058823,0.45923901312628,1.0,7/12,20.79%,IGF1;IRS1;SHC1;IGF2;GNAS;ARRB1;PIK3R1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.5737266965471365,-1.2907947078710749,0.14177693761814744,0.45609563959130556,1.0,6/10,18.15%,EP300;HAT1;ATF2;KAT8;BRCA2;MSL3
prerank,DNA secondary structure binding (GO:0000217),-0.42378524859419175,-1.2900176799333067,0.12085769980506822,0.4540841491716782,1.0,12/31,23.22%,ABL1;RBBP8;HMGB1;RAD51B;WRN;MEF2C;RAD51D;FANCM;MSH6;KMT2A;CLSPN;RAD51C
prerank,5'-3' exonuclease activity (GO:0008409),-0.5133375700354961,-1.2882088041794044,0.1811320754716981,0.4544929423636134,1.0,6/14,23.05%,CPSF3;XRN1;XRN2;MRE11;DCLRE1A;EXOG
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5409012167199078,-1.2878622310523558,0.15851272015655576,0.451582271136733,1.0,4/12,9.28%,CDK8;CDK7;CDK13;CCNK
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5053437765473869,1.2838805342622426,0.1670103092783505,0.4473708754642747,1.0,3/14,0.51%,SPOCK2;SPOCK1;SPOCK3
prerank,vitamin D receptor binding (GO:0042809),-0.5122808606276935,-1.2828308486764506,0.16261682242990655,0.4596638172932705,1.0,10/14,30.15%,MED17;MED12;MED1;RXRA;MED16;MED13;MED14;TAF7;SNW1;THRAP3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.49880462338002574,1.281980949650094,0.19467213114754098,0.4463582354208384,1.0,5/14,23.53%,CAPN11;CAPN6;CAPN5;CAPN2;CAPN15
prerank,phosphotyrosine residue binding (GO:0001784),-0.405251752721114,-1.2734607613966957,0.14285714285714285,0.4786605169374992,1.0,16/37,25.52%,ABL1;IRS1;SHB;SHC1;PTPN3;VAV2;ABL2;YES1;NCK2;RASA1;PTPN11;PIK3R1;SHF;CRKL;SYK;SHC3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36380306006475477,1.2708125006219517,0.09563409563409564,0.46687827877419974,1.0,13/60,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;FLT3;ALK
prerank,MAP-kinase scaffold activity (GO:0005078),-0.536645685334993,-1.2671853769496844,0.2033898305084746,0.490523480893945,1.0,4/11,8.85%,AKAP13;KSR1;SH3RF1;MAP2K1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.5097539973757991,-1.2669704839263132,0.1575091575091575,0.4869841665380895,1.0,10/13,42.91%,TRMT11;METTL1;THUMPD3;TRMT1L;FTSJ1;TRMT1;TRMT10C;TRMT5;WDR4;TRMT10B
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.5165646424716348,-1.2663572245435113,0.16520210896309315,0.4845737223256628,1.0,9/12,41.02%,NQO2;CBR4;NDUFS7;DHRS4;CRYZ;CBR1;NQO1;DCXR;AIFM2
prerank,phospholipid transfer activity (GO:0120014),0.44923058449152553,1.2660757939116618,0.16666666666666666,0.4729005196297725,1.0,9/21,18.19%,PLTP;CERT1;PITPNM1;PRELID3A;PLEKHA3;PRELID2;CPTP;MTTP;PITPNB
prerank,kinase binding (GO:0019900),-0.2763845151929639,-1.2655137102754281,0.016563146997929608,0.48289563489647613,1.0,138/434,22.57%,PRKAG2;EGFR;SASH1;TCF7L2;SMAD3;PTN;ERRFI1;ANK2;GSN;PKD1;LIMS1;MAPK4;KIF13B;NBEAL1;NISCH;PDGFRB;KAT2B;IL31RA;FOXO3;PPP1R12A;GHR;TAX1BP1;PRKN;WWC2;TNS2;DLG4;IBTK;GSK3B;RPTOR;CNTLN;FLNA;IRAK3;MAPKAP1;IL15RA;DLG1;NR3C1;RND3;EIF4ENIF1;RBBP6;AXIN1;PAK2;SKI;SLC12A7;UBQLN1;STAT3;UFL1;TRIP4;SHC1;TPCN2;ADCY6;CDC42;VDAC1;SP100;PTPRK;PTPN22;ATF2;CCNK;WNK1;PLCG1;TOM1L2;RB1CC1;PTPN2;SLC12A2;TRAF2;RHOA;PRKCD;HIF1A;DNAJC3;PRKAB2;EXOC2;MAVS;KIZ;WWC1;PARP1;TRIM5;TELO2;RHOBTB2;SUFU;SIK1;RB1;RICTOR;MAML1;BECN1;MAPRE1;MOB1B;CDK5RAP1;ERCC6L2;CCND3;LATS1;CDC25B;PPP1CB;MAP2K7;TNIP2;RAB11FIP2;ADRA2A;TTC28;CACUL1;PRKACA;LRRC14;PTPN1;RHOBTB1;FBXW5;BLNK;TRAF6;RHOH;MAP3K1;MYOM1;PARK7;RHOC;MTCP1;PTPN11;NEK6;IRAK1;CARD16;MAP2K6;MVP;TRIP6;SPRED2;CAB39;PRKAG3;PFKM;DGKD;PIH1D1;USF1;CDK5RAP3;LRBA;GATA6;SMAD1;PRKAB1;MSN;TBL2;NBEAL2;PFKL;MAP3K12;CIR1;PRKRIP1;TICAM1;CHP1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.4068584660171408,-1.261991826156275,0.13821138211382114,0.4874476731984079,1.0,16/34,24.48%,SETD7;KMT5B;NSD3;SMYD3;SETD3;SETD2;N6AMT1;SETDB1;EHMT1;METTL21A;EEF2KMT;KMT5A;EZH2;PRDM9;CAMKMT;KMT2E
prerank,ubiquitin binding (GO:0043130),-0.34683168793644603,-1.2583640355723675,0.11605415860735009,0.49248673264756854,1.0,18/73,17.03%,SMAD3;UBE2N;PRKN;RAD23B;UBXN2B;WDR48;DDI2;NBR1;RNFT1;MARK4;USP33;GGA3;FBXW7;ILRUN;USP13;FAF2;SPRTN;AUP1
prerank,mRNA 3'-UTR binding (GO:0003730),-0.33920762059369614,-1.2575811660477685,0.0854368932038835,0.4904429909703736,1.0,34/79,29.26%,RBMS1;CELF2;RBMS3;DDX5;CELF1;PUM2;RBMS2;RC3H1;LARP1;PUM1;DHX36;CSDC2;GEMIN5;DAZAP1;YBX3;SERBP1;EXOSC9;CCT5;CPEB1;RNF20;HNRNPU;RBM4;ANGEL2;NUDT21;PABPC4;AUH;RSL1D1;FXR1;CPSF1;PCBP4;PARN;ZFP36L2;PABPC4L;CRYZ
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3199510379921788,1.2553547808414174,0.060240963855421686,0.49342590738684583,1.0,25/134,10.65%,SLCO1C1;SLC7A5;SLC6A6;SLC4A1;SLCO4C1;SLC7A1;ABCG2;MFSD2A;SLC35A1;SLC17A6;SLC1A1;SLC52A2;SLC25A42;SLC25A23;MFSD12;SLC1A2;SLCO5A1;SLC6A8;SLC7A8;SLC52A3;SLC66A1;SLC36A1;SLCO2B1;ABCC4;SLC39A8
prerank,alkali metal ion binding (GO:0031420),-0.5201219031435611,-1.2542249578777998,0.17153284671532848,0.49571247892417863,1.0,2/13,2.77%,ATP1A2;HDAC4
prerank,ATP binding (GO:0005524),-0.2869559233759879,-1.2490934465959869,0.048484848484848485,0.5045396548736653,1.0,84/266,24.03%,ATP1A2;PRKAG2;TGFBR1;BMPR1A;TLK1;ABCA1;MYO1B;KSR1;STK3;ABL1;ENPP1;TOP1;ABCD3;STK17B;N4BP2;IRAK3;MAP4K4;CHD8;DHX9;SMC4;MAP3K5;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;BRSK1;DMPK;HSPA14;CARS2;CDK11B;AK6;HSPA9;PEX6;ABCD4;MKNK2;PNPLA8;SIK1;MYO1F;PGK1;TBCK;MCM6;ACVR1;ERN1;LATS1;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;PXK;PFKP;HNRNPU;MLKL;EIF4G1;MSH6;NEK6;TAOK1;NME1;BCKDK;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;SIK2;SPHK1;GSS;GALK1;CDC42BPG;TRNT1;RRM1;MVK;CLPX
prerank,NAD binding (GO:0051287),-0.424057141707194,-1.248414320089696,0.15648854961832062,0.5027086365632222,1.0,9/26,15.19%,ALDH1A1;CRYL1;ALDH2;GLUD1;ZC3HAV1;ME1;PARP9;SIRT5;BDH2
prerank,nuclear localization sequence binding (GO:0008139),0.46590888039721023,1.2467351678294152,0.16268980477223427,0.5088799452366317,1.0,3/18,2.67%,IPO5;IPO4;CABP1
prerank,FMN binding (GO:0010181),0.5249841193133153,1.245952287761836,0.2039911308203991,0.5052871551082609,1.0,3/11,7.94%,NDOR1;NOS3;DUS2
prerank,3'-5' DNA helicase activity (GO:0043138),-0.47596139455457254,-1.242341591477341,0.18267419962335216,0.5145487308342972,1.0,6/16,14.58%,DHX9;WRN;ASCC3;ERCC3;FANCM;MCM6
prerank,mannose binding (GO:0005537),0.5053701209003927,1.2417310706157523,0.21020408163265306,0.5100815299810197,1.0,1/12,0.95%,MBL2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4775233367766324,1.2416565673260649,0.2029598308668076,0.5048201106088132,1.0,5/15,14.17%,SLA2;PIK3R5;SOCS1;PIK3R3;CCKBR
prerank,CXCR chemokine receptor binding (GO:0045236),0.5235428628736565,1.2406484793686035,0.22462203023758098,0.5021181067486971,1.0,1/11,2.70%,CXCL12
prerank,calcium channel activity (GO:0005262),0.3322888420752773,1.2398399659331165,0.08447937131630648,0.49881724882748746,1.0,20/84,14.43%,SLC24A4;SLC24A2;GRIN1;TRPC5;CACNA1A;CACNA1B;RYR2;CACNA2D1;CACNG2;CACNA1E;TRPM2;CACNB2;CACNG3;OPRM1;CACNG8;CACNB4;TRPC1;TMCO1;PSEN1;CACNA1I
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5382151016546415,-1.2378063828491541,0.19921875,0.5221714064997898,1.0,3/10,19.73%,NOX4;CYBA;NCF2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.371994614005916,-1.2376150567838498,0.15779467680608364,0.5188293408402825,1.0,10/42,15.73%,CCNL2;KAT2B;CCNT2;CCNL1;CCNH;CCNT1;CCNK;CCNYL1;CCND3;CNPPD1
prerank,kinesin binding (GO:0019894),0.42397327686516767,1.2350689389751133,0.17173913043478262,0.504484292450815,1.0,11/27,20.37%,ACTB;MAPK8IP2;SNCA;SPTBN5;MAPK8IP1;RAB29;ATCAY;TTBK2;CLSTN1;KIF1B;CROCC
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5356347506954062,1.232502758248462,0.23093681917211328,0.5056399596187882,1.0,4/10,9.69%,SLCO1C1;SLCO4C1;SLCO5A1;SLCO2B1
prerank,sterol binding (GO:0032934),-0.34637018218340954,-1.2315059705381974,0.1285140562248996,0.5305038228401244,1.0,16/56,12.63%,ABCA1;ANXA6;OSBPL8;SOAT1;GRAMD1C;INSIG2;OSBPL5;OSBPL11;SIDT1;VDAC1;NR1H3;NPC2;RORA;ERLIN1;OSBPL9;APOD
prerank,cadherin binding (GO:0045296),-0.2757589814258358,-1.2292336013423413,0.04208416833667335,0.5326982322956911,1.0,94/315,18.04%,PHLDB2;CALD1;PARVA;EGFR;AHNAK;AFDN;VCL;PI4KA;PDLIM5;CAST;MPP7;ASAP1;MPRIP;MYO1B;CTNNA1;ERC1;LIMA1;BAIAP2L1;CDH11;TLN1;NIBAN2;PACSIN2;FLNA;WASF2;DDX6;DLG1;ITGB1;SLK;SNX9;RAB10;ANXA2;PAK2;CDH1;ARVCF;TMOD3;ANXA1;TES;ZC3HAV1;LARP1;HDLBP;CHMP4B;CNN3;ZC3H15;ATXN2L;VASP;GCN1;KTN1;JUP;HNRNPK;CHMP5;GOLGA3;PLCB3;BAG3;PDXDC1;HCFC1;NOTCH3;GIPC1;PLIN3;ABI1;TXNDC9;ARGLU1;CAPZA1;ARFIP2;CEMIP2;CCT8;ATIC;GLOD4;TRIM25;STX5;MAPRE1;SERBP1;PCMT1;CAPZB;LASP1;CTTN;STAT1;NUDC;NUMB;ACVR1;NCK1;DDX3X;YWHAE;P2RX4;EMD;PAICS;ARHGAP18;VASN;MRE11;FXYD5;PICALM;PFKP;CC2D1A;S100A11;PTPN1
prerank,phosphatidylinositol binding (GO:0035091),-0.3246782299187582,-1.2273543120597623,0.11627906976744186,0.5337754298157628,1.0,30/91,21.39%,ITPR1;PARD3B;APPL2;ITPR2;SNX24;NUMA1;EEA1;PIGK;BCAS3;SNX9;ZFYVE1;FCHO2;PITPNA;PITPNC1;TULP3;PITPNM2;PLEKHF2;APPL1;SNX10;PARD3;ZFYVE16;SNX8;RUBCN;PICALM;ANKFY1;GPAA1;PLEKHF1;C2CD2L;MPPE1;PLEKHN1
prerank,myosin binding (GO:0017022),-0.35177889955793895,-1.2251435338411716,0.15384615384615385,0.535359349431509,1.0,12/55,12.22%,CALD1;KIRREL1;TRAK1;GSN;STXBP5;RAB10;ARFGEF1;SPATA6;RHOA;GIPC1;RAB11A;RALA
prerank,protein heterodimerization activity (GO:0046982),-0.29206821626992846,-1.2242174248951492,0.07326732673267326,0.5337928181942084,1.0,51/178,21.38%,ATP1A2;BMP6;TCF4;TPM1;ZHX2;ARNT;ADRA1B;IRAK3;EXT1;SAE1;MEF2A;ITGB1;BCL2;MIGA2;IRAK2;ZBTB1;HIF1A;PAFAH1B2;MEF2C;PSMF1;AGTR1;QTRT2;TCF3;BHLHE41;SRI;ATF6;KATNA1;HEXA;GCA;MICU1;RCC1;YWHAE;CYBA;BDKRB2;PRMT5;ADRA2A;BUD23;NR4A1;TOP2B;TLR4;NR4A2;RALGAPB;IRAK1;TPM2;P4HB;SMC1A;PPP2CA;DGKD;USF1;RALGAPA2;NAE1
prerank,death domain binding (GO:0070513),-0.5150965315443787,-1.2240265322955024,0.218018018018018,0.5305029289655679,1.0,6/11,28.20%,BCL2;DAP;DAPL1;IRGM;CRADD;TRADD
prerank,tRNA methyltransferase activity (GO:0008175),-0.4637320504321717,-1.2230693649415303,0.18923933209647495,0.528889219130421,1.0,10/16,33.29%,TRMT9B;METTL2A;METTL2B;THUMPD3;FTSJ1;LCMT2;TRMT44;TYW3;ALKBH8;TRMT12
prerank,pyridoxal phosphate binding (GO:0030170),-0.4462264420609141,-1.2207043819830146,0.20502901353965183,0.5310815931380248,1.0,14/20,41.56%,ABAT;PYGB;PYGM;PDXK;PLPBP;OAT;PSAT1;CBS;ACCS;CTH;PYGL;SHMT2;GLDC;SHMT1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.49025264117176715,1.2202573277907665,0.23678646934460887,0.5293991505608026,1.0,2/13,2.91%,PRKAR2B;RYR2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.4207263059509195,-1.2186994282095678,0.18860510805500982,0.5318728636085553,1.0,11/25,24.51%,TNKS2;ZC3HAV1;PARP10;PARP14;PARP9;PARP1;SIRT5;PARP4;PARP6;SIRT4;SIRT3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.39269364995474865,-1.2142051730098853,0.18884892086330934,0.5394264786639831,1.0,11/34,19.22%,UBE2N;UBE2E2;BIRC6;UBE2H;UBE2K;UBE2I;UBE2R2;UBE2B;UBE2E1;UBE2S;UBE2D3
prerank,phosphatase inhibitor activity (GO:0019212),-0.4462715653152815,-1.2136626663411094,0.2153558052434457,0.5373452304636411,1.0,8/20,27.32%,PTN;STYX;CABIN1;ANP32E;BOD1L1;PPP1R2;BOD1;SAG
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5165973587552132,-1.2130953673089173,0.23880597014925373,0.5349762078578701,1.0,8/11,36.83%,CFLAR;CASP12;CASP2;CASP6;PYCARD;CASP1;CASP4;CASP7
prerank,Wnt-activated receptor activity (GO:0042813),-0.4696169271695447,-1.2117919859266149,0.22244488977955912,0.53455486233058,1.0,4/15,6.01%,ROR1;PKD1;RYK;FZD2
prerank,estrogen receptor binding (GO:0030331),-0.39428389204543346,-1.2102000711275473,0.1996124031007752,0.5348697719209886,1.0,15/32,21.79%,PPARGC1B;LCOR;DCAF1;TRIP4;NSD1;NCOA6;NCOA1;MED1;PRMT2;WIPI1;MMS19;LATS1;CNOT1;PPID;ARID5A
prerank,glucuronosyltransferase activity (GO:0015020),0.4457501514818133,1.2089149718547332,0.23092369477911648,0.5517871336087904,1.0,3/19,5.63%,B3GAT1;B3GAT2;CSGALNACT1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.3159781199894181,-1.2083076577561562,0.12379110251450677,0.536473033140804,1.0,30/100,17.98%,GAB2;FCHSD2;MYO1B;ADAP2;SNX24;SH3PXD2B;GBF1;ARAP1;OSBPL8;MAPKAP1;OSBPL5;CYTH3;ZFYVE1;DAPP1;PLA2G4A;IQGAP2;KIF16B;WIPI1;SNX21;ARFIP2;GSDMD;OGT;ATG2A;PARD3;PLEKHA8;ZFYVE16;WDR45B;RUBCN;ATG2B;ANKFY1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.38217680641078616,-1.2073636906465341,0.177734375,0.5351416015895243,1.0,16/38,23.53%,GAB2;SORBS1;LRRK2;IRS1;AXIN1;SHC1;FRS2;MMS19;NCK1;NCK2;SH2B1;BLNK;PTPN11;PIK3R1;DLG5;SPAG9
prerank,solute:sodium symporter activity (GO:0015370),-0.4086705958692743,-1.206895289226425,0.21601489757914338,0.5327238994143378,1.0,4/27,10.92%,SLC5A3;SLC20A2;SLC4A10;SLC5A6
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.37848451105285197,-1.2054970129379263,0.18582375478927204,0.5328499142289622,1.0,18/34,28.16%,ERI3;DIS3L2;PAN3;CNOT8;XRN2;ERI2;EXOSC9;CNOT2;PAN2;EXOSC10;CNOT1;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.37681491659539806,-1.2034461683268864,0.19516728624535315,0.5342993193691085,1.0,8/35,12.43%,CLK1;ABL1;FRK;LYN;FER;ABL2;YES1;TEC
prerank,endopeptidase regulator activity (GO:0061135),-0.3661907425820896,-1.2031876629839586,0.1713747645951036,0.5313417896062638,1.0,8/40,11.79%,CAST;PROS1;TFPI;ITIH2;RECK;RENBP;SERPIND1;PSMF1
prerank,magnesium ion binding (GO:0000287),-0.29896653391283373,-1.2025761794961156,0.11068702290076336,0.5297521608420236,1.0,41/135,23.77%,EYA2;OPA1;CLYBL;DIS3L2;STK3;ABL1;LRRK2;IRAK3;PLSCR1;NUDT5;TDP2;MAP3K5;DHX36;WRN;MAP3K20;BRSK1;ABL2;RP2;PPA1;SIK1;ERN1;LATS1;MARK1;PDXK;MAP2K7;FOXK2;EPHX2;SIK3;XYLT2;PSPH;MSH6;NEK6;NME1;PGM1;MAST2;SIK2;SPHK1;GSS;CDC42BPG;XXYLT1;MVK
prerank,general transcription initiation factor binding (GO:0140296),-0.40337976751492244,-1.2005483742525205,0.22641509433962265,0.531446241661093,1.0,13/25,30.58%,AR;TBP;TAF13;GTF2B;TAF12;PSMC1;DRAP1;YEATS2;THRA;ESR1;BRF2;RUVBL2;GTF2A1
prerank,RNA binding (GO:0003723),-0.24320701082805082,-1.2003077540474116,0.00468384074941452,0.5287140468521584,1.0,522/1321,31.48%,BICC1;RBMS1;SAMD4A;ROCK2;FNDC3B;CELF2;SRRM2;AHNAK;RRBP1;LRP1;RBFOX2;RBMS3;SON;NSA2;ERI3;HOXB6;SMG6;TNS1;DCN;RBPMS;ANKRD17;DDX5;CELF1;FARS2;ANKHD1;CAST;EIF4G3;HNRNPH1;UBE2N;DIAPH1;RBM39;VIM;NUFIP2;CTNNA1;DICER1;SMG1;SNTB2;LUC7L2;TNRC6B;MBNL2;PABPN1;NUDT4;HNRNPR;TOP1;ZCCHC24;KMT2C;PRRC2C;PUM2;YTHDF3;FLNA;ZC3H7A;RSRC2;SYNCRIP;PCF11;TNRC6A;WDR33;MAP4;DDX17;KHDRBS1;ACIN1;CASC3;EIF4A2;DDX6;HUWE1;TRMT9B;BAZ2A;HMGB1;RBMS2;PPARGC1B;SCAF4;SRSF10;MOV10;EIF4ENIF1;RBM6;RBBP6;DDX46;FUS;GOLGB1;SEC23IP;CCT6A;ANXA2;NUDT5;RC3H1;ZC3H12C;STAT3;SCAF8;MEX3C;CS;NYNRIN;HNRNPM;TBCA;U2AF2;YLPM1;GFM1;STXBP1;IFIT2;PDCD11;PUS10;ANXA7;ADK;DHX9;TES;PTBP3;AKAP8L;SF3B1;DENR;CPSF3;SRSF6;ZC3HAV1;LARP1;SRBD1;PUM1;HDLBP;HNRNPUL1;HNRNPD;NUP42;ZC3H15;SIDT1;TUT4;RBM10;FUBP1;DCP1A;DHX36;PRPF6;SAFB2;PCBP2;KNOP1;DDX42;ATXN2L;PPARGC1A;SPATS2L;CAVIN1;CDC5L;HLTF;GCN1;CSDC2;KTN1;SMG7;NSUN6;CDK13;ABCF1;CHD2;UBE2I;LAS1L;GEMIN5;HNRNPK;MAP3K20;UBAP2L;SPATS2;CSNK1E;ARCN1;PNISR;ALG13;EIF4E;CHD3;PRPF3;FAM120A;UPF1;SLBP;DHX40;CSDE1;RCC1L;JUN;LSM14A;DDX60;SF3A1;RPGR;SF3B6;RPL11;RBM45;DAZAP1;PRRC2B;CLK3;CDK11B;AKAP1;YTHDC1;ASCC3;BCLAF1;SCAF11;FCF1;XRN1;DUSP11;RTF1;ZC3H4;ZBED4;XRN2;LGALS1;PARP1;DCP1B;ACAA2;DYNC1LI1;KHNYN;SF3A3;ALKBH1;ARF1;HSPA9;WDR43;TPR;ZYX;DIMT1;ZCRB1;ALDH6A1;SNRNP70;TRIM25;YBX3;EIF2AK4;CCAR1;APTX;SRFBP1;STRAP;DDX23;TDRD3;HTATSF1;GTPBP10;YBX1;KIF1C;MAPRE1;CWC22;CPNE3;SERBP1;DDX19B;TCERG1;APOBEC1;NSRP1;URB1;RBM42;EIF2AK2;TXN;ACO1;SEC63;RARS2;BMS1;PRKDC;NAA15;RBM5;SRSF1;ZC3H12B;EDC3;OTUD4;EXOSC9;ILF2;DDX3X;YWHAE;RRP36;NOP58;FAM32A;SREK1;MAK16;BRIX1;EFTUD2;RPP14;HELZ;NOM1;DNTTIP2;SNU13;R3HDM2;DDX27;MTREX;EXOSC10;PRR3;DYNC1H1;TYW5;NOP53;SFPQ;BUD23;HELB;MRPL39;NXF1;GANAB;NSUN2;OAS2;TENT5A;CNOT1;PRPF40B;DDX50;HSPE1;SLC25A11;EWSR1;SHFL;CDC42EP4;DDX31;ARHGEF1;WBP11;CSTF3;KRR1;RPN1;HNRNPU;PTPN1;EIF1AX;CHCHD1;VCP;MRPL3;RRP8;TRMT1L;GPATCH4;SNRPF;ALDH18A1;COL14A1;EIF3A;UTP3;ZRANB2;PARK7;MSI2;HNRNPA3;UTP6;ESF1;EIF4G1;MRPL1;SIDT2;RBM4;ELP5;SRSF7;KARS1;SRSF11;NFX1;PKM;TRIP6;H1-0;IFIT3;TERT;EIF3L;NUP98;RRP7A;P4HB;SMC1A;RBPMS2;SRRM1;UPF3B;NME1;CCDC9B;ASS1;RBM33;PSMC1;SRSF2;SURF6;XRCC6;ERAL1;MSN;TBL2;DHX57;EBNA1BP2;ZNF346;MRPL32;FBRSL1;CRKL;SSBP1;PYM1;LRRC47;LUC7L3;PRKRIP1;DALRD3;NAP1L4;CSTF1;MRPL10;ZC3H13;GTF2F1;XPO5;CCAR2;UTP18;LBR;CPSF4;NUDT21;RPUSD4;DDX41;AGO1;HDAC2;IMP3;MRPL43;TRNT1;WDR6;APEH;AATF;USO1;RTRAF;BOP1;BCCIP;EXOSC3;EIF3H;GAR1;CNOT4;DHX15;NONO;PPHLN1;ALDOA;PABPC4;NOA1;PARP12;PPP1R10;GNL3L;IREB2;TRMT1;FAM50A;NAP1L1;ARL6IP4;PRPF38A;UNK;NCBP3;DUS3L;CLUH;KDM1A;NKRF;PSTK;KIN;RBM28;RPL7L1;RSL1D1;FXR1;MTO1;TDRD7;EDF1;TRMT2A;HARS2;NCBP2;TWF2;PRRC2A;ENDOV;ELAC2;PCBP3;TSR1;PRPF8;CRNKL1;FYTTD1;NAT10;DHX58;LSM6;LUC7L;NOL12;PES1;NIP7;DHX37;RBM22;SRP72;CCT3;GNL3;PNLDC1;RBM19;MRPL22;PCBP4;EIF3C;ZC3H7B;CACTIN;LONP1;GTF2E2;POLR1G;RRS1;SUGP1;RPL22;SAFB;POLR2D;HNRNPL;GRN;ISY1;SLTM;PARN;NELFE;PIN4;CCDC124;RBM34;FASTKD1;ZFP36L2;MRPL12;POP4;IGHMBP2;ZNF106;PABPC4L;SUPV3L1;RBM18;NUDT1;KPNA2;CCDC47;TBL3;PNO1;SNRNP200;UTP4;RBM47;THOC2;POLRMT;ZC3H10;ZC3H18;RBM27;HNRNPUL2;SAMHD1;PEF1;ENO1;MPHOSPH10;MRPS24;MTPAP;CALR;SNW1;THRAP3;GDI2;NUDT7;SF3A2;TBRG4;PSIP1;USP36;CCDC86;FLYWCH2;DDX25;YWHAZ;ADARB1;UBE2L3;PINX1;UBA1;RPP38;MRPS26;TLR3;TRMT10C;IFIH1;SNRPA1;C1QBP;DHX33;SUGP2;LSM1;ZNF326;GTPBP1;GIGYF2;SRP19;SF3B4;MRM1;ERH;RDX
prerank,GABA receptor binding (GO:0050811),0.5009236782140285,1.2002488590255038,0.2388663967611336,0.5683662233967622,1.0,4/11,9.21%,GABARAPL1;GABARAP;SHISA7;LHFPL4
prerank,tubulin binding (GO:0015631),0.2752484527281994,1.1990191740113394,0.06369426751592357,0.5658601512527203,1.0,66/295,15.27%,DNM3;NAV3;EML5;SYBU;GIT1;PACRG;S100A9;S100A8;TTLL7;UNC5C;AGBL4;MAP1B;MAP2;STMN1;FGF13;REEP1;GABARAPL1;KIF1A;SNCA;HOOK1;KIF21B;MTUS1;DST;MAP6D1;PAK1;GABARAP;SPAG5;CEP44;TRIM36;NEFM;SNPH;MTCL1;MAPRE3;TERF1;KIFC2;CLIP2;STMN4;RMDN1;CAMSAP1;STMN2;NUSAP1;TPPP;TUBGCP3;ARHGEF2;KIF26B;REEP2;MID2;APC;DIP2B;CCDC88A;KIF19;EML6;DCTN1;SGIP1;RPS3;DIXDC1;EFHC2;MACO1;NDRG1;STMN3;GOLGA2;DCX;ARHGEF7;CAPN6;REEP3;TPPP3
prerank,actin binding (GO:0003779),-0.28609318982077114,-1.197756893329758,0.0963855421686747,0.5311773742908151,1.0,32/170,11.65%,CALD1;SYNE2;PARVA;PAWR;MICAL3;PHACTR1;SORBS1;DAG1;VCL;GSN;TPM1;PDLIM5;LIMA1;PHACTR2;ABL1;PRKN;LRRK2;SHROOM2;MICAL2;NCALD;ITGB1;PDLIM7;PLEKHH2;CORO7;SMTN;MAEA;IQGAP2;SYNPO2;ABL2;GIPC1;PDLIM2;CAPZA1
prerank,GTPase regulator activity (GO:0030695),-0.2806978443397902,-1.194755240537467,0.08167330677290836,0.5351326763364044,1.0,64/212,19.75%,RANBP3L;ALDH1A1;ARHGAP29;ARHGAP10;ARHGAP42;ERRFI1;ASAP3;SIPA1L1;ARHGAP28;ASAP1;STXBP5;ARHGAP20;LRRK2;ARHGEF10L;ARAP1;TBC1D16;SMAP1;ARHGAP24;BCR;SGSM2;DNM1L;PDE6D;RANBP2;SEC23A;NRP1;ARFGEF1;RAB3GAP1;GMIP;ARHGAP17;USP6NL;IQGAP2;ARFGAP1;ARFGAP3;TBC1D2B;TBC1D20;TBC1D8B;WASL;JUN;RP2;ARHGAP32;SEC23B;TBCK;GRTP1;TBC1D22B;TBC1D9;ACAP2;RAPGEF2;RASA1;ARRB1;ARHGAP18;DOCK1;ARHGEF6;RIC8B;TBCD;NPRL3;ARHGAP15;RHOH;TBC1D17;RANBP3;SIPA1L3;RALGAPB;RTKN;RABGAP1;TBC1D7
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3459308120251943,-1.1940987366133884,0.18886679920477137,0.5333789703513889,1.0,10/47,12.32%,SLC7A11;SLC7A2;SLC6A13;SLC47A1;PDPN;SLC1A5;SLC38A11;SLC6A1;SLC38A6;SLC22A4
prerank,cation transmembrane transporter activity (GO:0008324),0.35438796779007625,1.1928238218737313,0.18801652892561985,0.5763596235683813,1.0,8/48,9.57%,SLC7A5;SLC6A6;SLC7A1;SLC1A1;MFSD12;SLC7A8;SLC66A1;SLC36A1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.40461440462952525,-1.1907209118025122,0.21212121212121213,0.5380689552613044,1.0,7/27,11.44%,ITPR1;ITPR2;SLC41A1;CNNM2;SLC12A2;ZDHHC13;ATP2B1
prerank,calcium-release channel activity (GO:0015278),-0.4513774088503886,-1.185796660500272,0.24716981132075472,0.5468863584356832,1.0,6/17,12.34%,ITPR1;ITPR2;TPCN1;TPCN2;RASA3;PKD2
prerank,protein tyrosine kinase activity (GO:0004713),0.3073337199996694,1.1808226798373567,0.15020576131687244,0.6014445625241235,1.0,16/108,5.87%,FLT1;IGF1R;TEK;ERBB4;EPHA6;CSF1R;EPHB1;TIE1;EPHA5;KDR;NTRK2;WEE2;FLT3;AATK;SRMS;ALK
prerank,diacylglycerol kinase activity (GO:0004143),0.49030201827061715,1.1800958968950213,0.2818181818181818,0.5974642583390468,1.0,3/11,7.01%,DGKI;DGKH;DGKB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5107044009346764,1.1799894244662497,0.2718676122931442,0.5921122809620413,1.0,1/10,0.14%,ADARB2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.36590218238093974,-1.1775097742191283,0.21386138613861386,0.5641636070141351,1.0,18/42,25.52%,ABL1;IRS1;SHB;SHC1;PTPN3;VAV2;ABL2;YES1;FBXW7;YWHAE;NCK2;RASA1;PTPN11;PIK3R1;SHF;CRKL;SYK;SHC3
prerank,calcium:sodium antiporter activity (GO:0005432),0.5113696052499155,1.1773060953357481,0.2696629213483146,0.5935515339896376,1.0,3/10,4.70%,SLC24A4;SLC24A2;SLC8A1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.415052520595655,1.1769627018495707,0.24123711340206186,0.5888374738402344,1.0,4/21,6.89%,FGF10;FRS3;NPTN;FGF5
prerank,NADPH binding (GO:0070402),0.4638334659248824,1.1766839100451416,0.24336283185840707,0.5841387720926846,1.0,3/13,7.96%,NDOR1;DUS2;KCNAB1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.2897061720469849,-1.1742124245293433,0.13333333333333333,0.5685320153083091,1.0,39/147,16.74%,AKAP13;DENND4A;DOCK5;DOCK11;PLCE1;DENND2A;FARP1;ARHGEF17;SBF2;IQSEC2;BCR;ARFGEF1;RAB3GAP1;CYTH3;RAPGEF3;VAV2;RAB3IL1;HERC2;RAB3IP;RCC1L;ARHGEF18;FNIP1;DENND4C;MON1A;SERGEF;FGD1;DNMBP;DENND5A;FGD4;ANKRD27;RCC1;RAPGEF2;FARP2;SH3BP5L;NGEF;DOCK1;ARHGEF11;ARHGEF6;RIC8B
prerank,microtubule binding (GO:0008017),0.2772194046165358,1.174070456646067,0.12151394422310757,0.5854232821305393,1.0,57/222,17.80%,DNM3;NAV3;EML5;SYBU;S100A9;S100A8;MAP1B;MAP2;FGF13;REEP1;KIF1A;HOOK1;KNSTRN;KIF21B;MTUS1;DST;MAP6D1;SPAG5;CEP44;NEFM;SNPH;MTCL1;MAPRE3;TERF1;KIFC2;CLIP2;RMDN1;CAMSAP1;NUSAP1;TPPP;TUBGCP3;ARHGEF2;KIF26B;REEP2;MID2;APC;CCDC88A;KIF19;EML6;DCTN1;SGIP1;RPS3;MACO1;NDRG1;GOLGA2;DCX;CAPN6;REEP3;MACF1;CAMSAP3;STARD9;CLASP2;KIF21A;FHDC1;CCDC61;CRIPT;DNM1
prerank,growth factor activity (GO:0008083),0.3184872755613106,1.1714225944337222,0.16929133858267717,0.5869019787001549,1.0,10/74,10.22%,NRG3;IL7;NRG1;FGF10;IL12A;AMELX;FGF5;ENDOU;THPO;PDGFB
prerank,amino acid:sodium symporter activity (GO:0005283),-0.5035412688888363,-1.1694212361467695,0.28994082840236685,0.5773594269152789,1.0,4/11,11.00%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,insulin-like growth factor I binding (GO:0031994),-0.4737136245000987,-1.1682439084592295,0.28990825688073396,0.5767784809033514,1.0,6/13,8.22%,IGFBP2;IGFBP5;ITGAV;IGFBP3;IGFBP6;IGFBP4
prerank,phosphatase binding (GO:0019902),-0.2992513794602498,-1.1675026123139456,0.1588235294117647,0.5753412343138035,1.0,38/105,24.91%,EGFR;SMAD3;JAK1;DLG4;SHOC2;TBK1;CTSC;DLG1;SMAD2;STAT3;EIF2AK3;AP3B1;ANAPC5;MAP3K5;ANAPC7;JUP;ANAPC4;WNK1;TRAF2;MTMR3;TRPC4AP;SH3RF2;MAP2K7;CDC27;TRAF3;IKBKE;VCP;MVP;PIK3R1;STX17;KIFAP3;MAST2;PPP1R3C;PPP1R3F;GTF2F1;SIRPA;KIF3A;CRY2
prerank,phospholipase inhibitor activity (GO:0004859),-0.5201534525896102,-1.1662635857982346,0.2841121495327103,0.575060787862352,1.0,4/10,7.02%,ANXA4;ANXA5;ANXA2;ANXA1
prerank,death receptor activity (GO:0005035),0.48555578693179224,1.1648677369571616,0.2650862068965517,0.5985391590153235,1.0,5/11,23.27%,TNFRSF19;TNFRSF25;TNFRSF1A;TNFRSF10B;EDA2R
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5092179152727518,-1.1644210296897708,0.2894248608534323,0.5761631890721555,1.0,7/10,36.83%,CFLAR;CASP12;CASP2;CASP6;CASP1;CASP4;CASP7
prerank,cAMP response element binding (GO:0035497),-0.5141911469710388,-1.1639877450299825,0.27808471454880296,0.5739002757836197,1.0,4/10,10.31%,CREB3L2;CREB5;ATF2;JUN
prerank,actinin binding (GO:0042805),-0.4184177102917037,-1.1636511679818593,0.25576923076923075,0.571275229115203,1.0,8/21,14.52%,CACNA1C;DAG1;NFKB1;PDLIM5;CACNA1D;SYNPO2;PKD2;CSRP2
prerank,actin monomer binding (GO:0003785),0.4091846761789626,1.163304195599887,0.2468354430379747,0.5973976715714897,1.0,4/22,4.58%,MRTFA;TMSB4X;TMSB10;NOS3
prerank,fibroblast growth factor binding (GO:0017134),-0.4197968304430048,-1.162552557883112,0.2585858585858586,0.5708219515638915,1.0,13/21,28.70%,ITGAV;THBS1;GLG1;FGFR2;KL;FIBP;CEP57;ITGB3;FGFR4;GPC1;FGFRL1;S100A13;FGFBP3
prerank,telomeric DNA binding (GO:0042162),-0.37803289029132076,-1.1617329424203953,0.24521072796934865,0.5694885133830179,1.0,13/32,21.30%,SMG6;SMG1;HNRNPD;WRN;SMG7;UPF1;TELO2;CTC1;UPF3A;TERF2;TERT;STN1;XRCC6
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.3227880185990268,-1.160307666821078,0.20527306967984935,0.569685057102294,1.0,20/69,22.26%,KAT2B;CERS5;EP300;KAT6B;SOAT1;CREBBP;PLA2G4A;ZDHHC13;MOGAT3;MBOAT7;KAT8;NAA15;ESCO1;ASPG;GTF2B;ZDHHC1;ZDHHC16;HHAT;LPCAT3;SPHK1
prerank,voltage-gated calcium channel activity (GO:0005245),0.3660186808817125,1.1602918425825302,0.2360248447204969,0.5999416258478701,1.0,10/37,10.79%,CACNA1A;CACNA1B;CACNA2D1;CACNG2;CACNA1E;CACNB2;CACNG3;OPRM1;CACNG8;CACNB4
prerank,damaged DNA binding (GO:0003684),-0.35016911839220866,-1.158655498604638,0.21578947368421053,0.5703234314873484,1.0,21/44,33.13%,EP300;RBBP8;HMGB1;SMC6;CREBBP;NBN;DDB2;ERCC3;APTX;SDE2;DCLRE1A;PCNA;ERCC1;CRY2;OGG1;MPG;FANCG;NEIL3;RPA2;PNKP;DDB1
prerank,acetylation-dependent protein binding (GO:0140033),-0.42622617812520075,-1.1574153641781415,0.2569832402234637,0.5668252488650175,1.0,7/20,21.38%,MLLT3;BRD7;BAZ2A;BRD3;PHIP;ZMYND8;KMT2A
prerank,lysine-acetylated histone binding (GO:0070577),-0.42622617812520075,-1.1574153641781415,0.2569832402234637,0.5668252488650175,1.0,7/20,21.38%,MLLT3;BRD7;BAZ2A;BRD3;PHIP;ZMYND8;KMT2A
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.38488760439778225,-1.157285298548235,0.24954792043399637,0.563969863539639,1.0,10/31,19.22%,UBE2N;UBE2E2;BIRC6;UBE2H;UBE2K;UBE2R2;UBE2B;UBE2E1;UBE2S;UBE2D3
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.3954226161732081,-1.1528932069766127,0.2476894639556377,0.5717359490402912,1.0,8/26,27.32%,PTN;PPP1R1A;CABIN1;BOD1L1;PPP1R2;PPP1R14A;BOD1;SAG
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4606707851254249,-1.1521279243504428,0.2826923076923077,0.5705932028285265,1.0,7/15,29.77%,KMT2C;KMT2D;SETD3;KMT2A;PRDM9;CXXC1;WDR5
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.40355410412895787,-1.1520269636543132,0.24031007751937986,0.5676772111762663,1.0,5/25,4.47%,MICAL3;CYP26B1;CYP27A1;MICAL2;POR
prerank,signal sequence binding (GO:0005048),0.36420958253663643,1.1511144302456346,0.24842105263157896,0.6184888589215285,1.0,8/35,13.26%,IPO5;IPO4;CABP1;AP2M1;PEX5L;AP2B1;TIMM22;NFKBIA
prerank,PDZ domain binding (GO:0030165),-0.32151808902987167,-1.1510629545563895,0.21172022684310018,0.5669406251115654,1.0,12/61,7.19%,TGFBR3;ARHGAP29;CRIM1;PLEKHA2;SDC2;ERC1;PRKN;DLG4;SYNJ2;CXADR;FZD2;SLC22A5
prerank,cGMP binding (GO:0030553),0.46376453636512416,1.1468080067813455,0.28541666666666665,0.6244019228850053,1.0,3/11,6.20%,PDE10A;PDE2A;PDE11A
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.45502735535969774,1.145625609542244,0.3168724279835391,0.6220843018382106,1.0,3/14,12.77%,KCNJ3;KCND3;KCNJ8
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.25254876616211874,-1.1450583669770844,0.08884297520661157,0.5780349722783819,1.0,147/431,28.23%,ATP1A2;PRKAG2;RHOQ;TGFBR1;BMPR1A;TLK1;ABCA1;MYO1B;KSR1;STK3;ANXA6;ABL1;ENPP1;LRRK2;RHOJ;ATL3;TOP1;ABCD3;STK17B;N4BP2;IRAK3;ARL3;RND3;RAP1B;RAB10;MAP4K4;MRAS;RAB22A;CHD8;GLUD1;DHX9;SMC4;MAP3K5;CDC42;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;ATL2;BRSK1;RHOA;DMPK;RHOT1;HSPA14;CARS2;CDK11B;ARFIP2;DYNC1LI1;AK6;ARF1;RALA;HSPA9;PEX6;ABCD4;RHOBTB2;MKNK2;PNPLA8;SIK1;MYO1F;GTPBP10;PGK1;TBCK;RASL12;RAB21;GBP3;BMS1;MCM6;ACVR1;ERN1;LATS1;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;GBP7;GBP2;PXK;PFKP;HNRNPU;RHOBTB1;TUBB2A;RHOH;RHOC;MLKL;GBP6;EIF4G1;MSH6;NEK6;MTG2;TAOK1;NME1;BCKDK;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;RIT1;SIK2;SPHK1;RABL3;TUBB6;GSS;GALK1;ARL5A;CDC42BPG;TRNT1;RRM1;MVK;RHOT2;CLPX;RAB8A;RAB9A;NOA1;RAB7A;RPS6KA4;TAP1;RAB5A;TWF1;ABCF3;RRAGA;TWF2;TSR1;PRKCI;GNL3;DIRAS2;ABCB8;PIM1;LONP1;PRPS1;PRPS1L1;ARL4C;TUBA1C;MINK1;RAB39A
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.39751740210849873,1.143862534032768,0.25,0.6214779761385072,1.0,6/24,15.44%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14
prerank,nuclear import signal receptor activity (GO:0061608),0.4468329219907782,1.1426252772870624,0.28695652173913044,0.619636558458546,1.0,2/15,1.48%,IPO5;IPO4
prerank,syntaxin binding (GO:0019905),0.3225426238813004,1.142517625670274,0.20964360587002095,0.6148031857555146,1.0,11/61,7.62%,CACNA1A;SYT1;SYT6;SYT12;SNAP25;UNC13A;STXBP5L;SNPH;NAPG;SYNPR;SYT10
prerank,adenylyltransferase activity (GO:0070566),-0.4062975411188058,-1.1419707702274873,0.27734375,0.582422427797519,1.0,9/21,20.00%,TENT2;NMNAT2;ABL1;NMNAT3;PAPOLG;NMNAT1;OAS2;FLAD1;KARS1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.47122755609731193,-1.1418538641718092,0.2925430210325048,0.5796273030666969,1.0,7/12,28.16%,PAN3;CNOT8;CNOT2;PAN2;CNOT1;PNLDC1;PARN
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4785096870435481,-1.1417497634670837,0.31086142322097376,0.5767229620176584,1.0,2/11,1.07%,ITPR1;ITPR2
prerank,ion gated channel activity (GO:0022839),0.39462537913265233,1.1417215498280802,0.2811158798283262,0.6119009929219268,1.0,5/24,8.66%,ANO3;TMEM63B;TTYH2;ANO5;ANO4
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.45939593089941305,1.1412736509991037,0.2863636363636364,0.6080718237226245,1.0,4/12,13.00%,PDE4B;PDE2A;PDE4D;PDE4A
prerank,protein kinase binding (GO:0019901),-0.2460378844834725,-1.1374620982950183,0.08888888888888889,0.5836910989054278,1.0,152/479,24.20%,PRKAG2;GRK5;SASH1;TCF7L2;SMAD3;PTN;ERRFI1;ANK2;PKD1;LIMS1;MAPK4;PDLIM5;KIF13B;NBEAL1;ITGAV;NISCH;PDGFRB;PARD6G;KAT2B;IL31RA;FOXO3;PPP1R12A;GHR;ABL1;PRKN;PPM1D;IBTK;GSK3B;RPTOR;CNTLN;IRAK3;IRS1;KHDRBS1;MAPKAP1;IL15RA;DLG1;NR3C1;ITGB1;RND3;RBBP6;AXIN1;PAK2;SKI;SLC12A7;STAT3;UFL1;TRIP4;DUSP16;SHC1;NOX4;TPCN2;ADCY6;CDC42;EPHA4;NBR1;VDAC1;PTPRK;DACT1;ATF2;CCNK;WNK1;PLCG1;TOM1L2;RB1CC1;PTPN2;SLC12A2;TRAF2;RHOA;PRKCD;HIF1A;ADAM9;DNAJC3;PRKAB2;EXOC2;MAVS;KIZ;PARP1;ROR2;TRIM5;TELO2;RHOBTB2;TPR;SUFU;SIK1;TCF3;APPL1;RICTOR;MAML1;BECN1;MAPRE1;TRIB2;CDK5RAP1;ERCC6L2;DUSP1;ACVR1;CCND3;LATS1;CDC25B;PPP1CB;MAP2K7;DUSP10;TNIP2;RAB11FIP2;ADRA2A;CAVIN3;TOP2B;CACUL1;PRKACA;PTPN1;RHOBTB1;FBXW5;BLNK;TRAF6;RHOH;DACT3;MAP3K1;RHOC;MTCP1;PTPN11;NEK6;IRAK1;MAP2K6;MVP;SPRED2;PRKAG3;PIH1D1;USF1;CDK5RAP3;LRBA;GATA6;SMAD1;PRKAB1;MSN;TBL2;NBEAL2;MAP3K12;CIR1;DUSP7;PRKRIP1;TICAM1;NSF;PKIA;HSF1;MAPK7;SPAG9;CSPG4;BORA;AP2A1;SIRPA;BAG5;DACT2;PTPN23
prerank,adenyl ribonucleotide binding (GO:0032559),-0.25972767727617385,-1.135492113400922,0.14516129032258066,0.5857444906743337,1.0,91/291,24.03%,ATP1A2;PRKAG2;TGFBR1;BMPR1A;MPPED2;TLK1;ABCA1;MYO1B;KSR1;STK3;ABL1;ENPP1;TOP1;ABCD3;STK17B;N4BP2;IRAK3;MAP4K4;CHD8;GLUD1;DHX9;SMC4;MAP3K5;SYN3;DHX36;ABCD2;MARK4;ABCF1;WNK4;MAP3K20;WNK1;BRSK1;ME1;DMPK;HSPA14;CARS2;CDK11B;AK6;HSPA9;PEX6;ABCD4;MKNK2;PNPLA8;SIK1;MYO1F;PGK1;TBCK;MCM6;ACVR1;ERN1;LATS1;RAPGEF2;P2RX4;MARK1;PDXK;MTREX;DAPK1;PTPA;TARS1;SIK3;TAP2;OAS2;DAPK2;PXK;HMGCR;PFKP;HNRNPU;MLKL;EIF4G1;MSH6;NEK6;TAOK1;NME1;BCKDK;PRKAG3;CDK6;PFKM;MAST2;AKT2;MKNK1;PFKL;SIK2;SPHK1;RAPGEF4;GSS;GALK1;CDC42BPG;TRNT1;RRM1;MVK;CLPX
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3337355878596189,-1.132947789339395,0.24907063197026022,0.5888726395525596,1.0,23/49,31.47%,ZFAND6;RNF169;RAD23B;UBQLN1;BRCC3;PARP10;ZBTB1;ABRAXAS2;TNIP2;SPRTN;ZRANB3;IKBKE;VCP;WDR81;SHARPIN;BAG6;UBQLN4;PRPF8;ABRAXAS1;TNFAIP3;ZFAND2B;FAAP20;UFD1
prerank,leak channel activity (GO:0022840),-0.4191249175129622,-1.1283637624992862,0.2845849802371542,0.5972139632744409,1.0,3/18,6.27%,KCNK2;NALCN;KCNK5
prerank,solute:anion antiporter activity (GO:0140323),-0.44597042064703785,-1.1257467370205134,0.3140794223826715,0.6008448802454144,1.0,4/14,12.47%,SLC7A11;SLC26A7;SLC26A2;SLC4A3
prerank,Hsp70 protein binding (GO:0030544),0.36284736125377115,1.1250551116988485,0.2545824847250509,0.645260614494785,1.0,9/31,13.23%,PACRG;SNCA;SACS;FICD;CYP2E1;MVD;IQCG;RNF207;RPS3
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.33592138072668026,-1.1242178613174165,0.248565965583174,0.6016281363631333,1.0,12/49,16.04%,ATP1A2;MPPED2;DUSP16;PRUNE1;PTPN22;DUSP11;PXYLP1;PPP1CB;SACM1L;EPHX2;ACP2;DUSP10
prerank,sodium channel regulator activity (GO:0017080),0.351889656655577,1.123546565453648,0.2792207792207792,0.6440242521177447,1.0,9/37,17.62%,FGF12;FGF14;FGF13;SCN4B;SGK3;ATP2B4;SCN2B;GPLD1;PKP2
prerank,LRR domain binding (GO:0030275),-0.44420110131301027,-1.122832000318296,0.2998236331569665,0.602216534789883,1.0,5/14,11.46%,PAWR;ROBO1;ERC1;ZXDC;LRRFIP2
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.25878743156214173,-1.1215369144140606,0.15368852459016394,0.6025260051336706,1.0,71/269,18.52%,FHIT;EGFR;SMAD3;VCL;SMAD6;UBE2N;PRKN;JAK1;ARIH1;GSK3B;SNCAIP;CASC3;HM13;USP7;SMC6;SMAD2;DNM1L;SNX9;AXIN1;SKI;TRIP4;BCL2;MID1;RNF8;PCBP2;UBE2K;JKAMP;PPARGC1A;UQCRC1;HLTF;PTPN22;TXNIP;HERC2;TRAF2;JUN;SPOPL;HIF1A;RPL11;PARP9;CCDC50;RALA;HSPA9;CUL3;PIAS4;RB1;FBXW7;PATZ1;BECN1;SLF1;LTBR;DTX3L;TRIB2;STAT1;USP2;UBE2B;USP13;YWHAE;CUL2;FAF2;NDUFS2;ARRB1;TRAF3;IKBKE;AUP1;RNF20;DERL1;PRKACA;AMBRA1;TRAF6;VCP;TANK
prerank,ubiquitin protein ligase binding (GO:0031625),-0.2582086456065632,-1.1176457198332364,0.1550695825049702,0.6096188720945892,1.0,67/254,18.52%,FHIT;EGFR;SMAD3;VCL;SMAD6;UBE2N;PRKN;JAK1;ARIH1;GSK3B;SNCAIP;CASC3;HM13;USP7;SMC6;SMAD2;DNM1L;SNX9;AXIN1;SKI;BCL2;MID1;RNF8;PCBP2;UBE2K;JKAMP;PPARGC1A;UQCRC1;HLTF;PTPN22;TXNIP;HERC2;TRAF2;JUN;SPOPL;HIF1A;RPL11;CCDC50;RALA;HSPA9;CUL3;PIAS4;RB1;FBXW7;PATZ1;BECN1;SLF1;LTBR;TRIB2;USP2;UBE2B;USP13;YWHAE;CUL2;FAF2;NDUFS2;ARRB1;TRAF3;IKBKE;AUP1;RNF20;DERL1;PRKACA;AMBRA1;TRAF6;VCP;TANK
prerank,adrenergic receptor binding (GO:0031690),0.4262983237798028,1.117306292155679,0.301255230125523,0.6558000206289399,1.0,5/16,12.59%,ADRB1;MAGI2;GRK2;UCHL1;PDE4D
prerank,insulin-like growth factor binding (GO:0005520),-0.43965027401627005,-1.116756441277164,0.3339622641509434,0.6086921795721383,1.0,6/15,8.22%,IGFBP2;IGFBP5;ITGAV;IGFBP3;IGFBP6;IGFBP4
prerank,phosphate ion binding (GO:0042301),0.48331690965746454,1.114072747714469,0.350104821802935,0.6592997659453183,1.0,1/10,3.36%,PDE2A
prerank,high voltage-gated calcium channel activity (GO:0008331),0.4710320241998919,1.1121155437398227,0.31446540880503143,0.6595627247571502,1.0,4/10,10.79%,CACNA1A;CACNA1B;CACNB2;CACNB4
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.42183481741706247,1.1118903748112854,0.3004694835680751,0.6499447143467975,1.0,5/17,8.39%,EPHA6;EPHB1;EPHA5;EFNB3;EPHA10
prerank,ephrin receptor activity (GO:0005003),0.42183481741706247,1.1118903748112854,0.3004694835680751,0.6499447143467975,1.0,5/17,8.39%,EPHA6;EPHB1;EPHA5;EFNB3;EPHA10
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.3673231949046901,1.1115330910818113,0.2845528455284553,0.645912739583902,1.0,7/31,11.72%,HCN1;SLC12A6;KCNK10;KCNK9;KCNK1;SLC12A3;KCNA2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4192358115320303,1.1111916736437246,0.3103448275862069,0.6418042087576473,1.0,3/18,7.86%,GAS6;SNCA;RPS6KA1
prerank,cation channel activity (GO:0005261),0.29321007525523285,1.1085298788070947,0.23246492985971945,0.6438345485470479,1.0,14/94,8.42%,HCN1;SLC24A4;SLC24A2;GRIN1;TRPC5;RYR2;UNC80;TMEM63B;KCNK10;CACNA1E;TRPM2;KCNK9;CACNB2;KCNK1
prerank,MAP kinase kinase activity (GO:0004708),-0.4258406245506899,-1.1066118973170485,0.328740157480315,0.6314839875350584,1.0,9/15,36.51%,LRRK2;MAP2K4;MAP2K1;MAP2K7;MAP2K6;MAPK14;MAP2K3;MAPKAPK3;MAP2K2
prerank,serotonin receptor activity (GO:0099589),0.3899061125295843,1.1065638425846906,0.32574031890660593,0.6349709071272988,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3899061125295843,1.1065638425846906,0.32574031890660593,0.6349709071272988,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3899061125295843,1.1065638425846906,0.32574031890660593,0.6349709071272988,1.0,2/22,3.45%,CHRM3;HTR2C
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.43934267191024245,-1.105117788830479,0.34714003944773175,0.6322423495538841,1.0,2/14,0.95%,SLC7A11;SLC1A3
prerank,endopeptidase activity (GO:0004175),-0.25445868610653016,-1.1035434532112862,0.2,0.6333156932139987,1.0,46/257,15.13%,TRABD2B;ADAMTS2;ADAMTS10;ADAMTS12;THSD4;ADAMTSL3;ADAMTS6;USP24;ADAMTSL5;PCSK5;HTRA3;PLAT;USP7;CTSC;CTSH;ADAMTS5;DPP4;F3;DDI2;ECE1;ADAMTSL4;ADAMTS9;NRDC;USP33;MMP14;ADAM9;SENP1;USP47;MBTPS2;ADAM19;FAP;ADAMTS15;MMP2;ADAM33;NLN;CASP2;USP12;USP11;USP46;RHBDF1;USP35;PSMB2;USP2;ADAMTS17;USP13;MBTPS1
prerank,endoribonuclease activity (GO:0004521),-0.3532771527315648,-1.102661598069321,0.3203125,0.6323622587625842,1.0,8/32,14.72%,SMG6;DICER1;ZC3H12C;NYNRIN;CPSF3;KHNYN;ZC3H12B;ERN1
prerank,nuclear export signal receptor activity (GO:0005049),-0.48170869258074,-1.098222571672549,0.37087378640776697,0.6404453769297666,1.0,4/11,10.44%,XPO4;EIF4ENIF1;NUP42;NUP214
prerank,mannosyltransferase activity (GO:0000030),0.38258602041272227,1.0970522586543994,0.3123644251626898,0.6549832095418484,1.0,6/21,12.40%,TMTC2;ALG3;PIGM;ALG1;DPY19L1;ALG8
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.46971014964580465,-1.0953115411593,0.34523809523809523,0.6444674478572313,1.0,3/11,9.37%,EGFR;MAP3K5;MAP3K20
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.30591742942883154,-1.094314090333524,0.29239766081871343,0.6439003792097141,1.0,22/72,19.90%,GSN;SVIL;MYO1B;ADAP2;GSDME;SLC9A1;MAPKAP1;ANXA2;KCNJ2;FCHO2;ACTN2;PLCD1;TULP3;SNX21;GSDMD;FZD7;PARD3;MARK1;PICALM;FRMPD4;AVIL;VILL
prerank,metalloexopeptidase activity (GO:0008235),-0.32459949230084656,-1.094279513445941,0.30842911877394635,0.6408433826201733,1.0,12/51,17.11%,CPQ;AEBP1;XPNPEP1;ANPEP;MMP14;LAP3;AGBL3;NPEPPS;CPM;CPXM2;LNPEP;CPXM1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4821286640937952,-1.0914074174834638,0.373134328358209,0.6452441771419369,1.0,1/10,0.40%,DPYSL3
prerank,histone deacetylase binding (GO:0042826),-0.28617026873532964,-1.086172844829263,0.25996204933586337,0.6558131983446416,1.0,25/88,18.35%,GLI3;KAT2B;HDAC4;BCOR;NCOR1;PRKN;MEF2A;LCOR;AKAP8L;DHX36;SP2;DACT1;CHD4;MIER1;NIPBL;MEF2C;HES1;BHLHE41;HDAC1;YWHAE;SFPQ;CAMTA2;TOP2B;ZMYND15;TRAF6
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.34317237376952003,-1.0843703988862599,0.32495164410058025,0.657329698601236,1.0,16/33,28.16%,ERI3;DIS3L2;CNOT8;XRN1;XRN2;ERI2;EXOSC9;PAN2;EXOSC10;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,hormone receptor binding (GO:0051427),-0.43221274121888564,-1.0837667955605115,0.3707865168539326,0.6559346900159608,1.0,4/14,22.07%,JAK1;NCOA6;TYK2;PTHLH
prerank,nucleosomal DNA binding (GO:0031492),0.39304528600515465,1.0834737631033924,0.35152838427947597,0.6861174807059844,1.0,5/21,8.78%,ACTB;HMGA2;SMARCB1;HNRNPC;H3-3A
prerank,channel activity (GO:0015267),0.3394367898177856,1.0820329331166652,0.3141683778234086,0.6850101557520141,1.0,3/41,2.98%,AQP9;AQP11;ASIC4
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.2882503531385312,-1.0806718564103701,0.29213483146067415,0.660890387555757,1.0,28/91,20.57%,GSN;SVIL;MYO1B;ADAP2;SH3PXD2B;GBF1;GSDME;SLC9A1;MAPKAP1;ANXA2;KCNJ2;FCHO2;ACTN2;PLCD1;TULP3;KIF16B;WIPI1;SNX21;GSDMD;FZD7;PARD3;MARK1;WDR45B;PICALM;FRMPD4;AVIL;VILL;WIPI2
prerank,phosphatidate phosphatase activity (GO:0008195),0.43479541309539915,1.0759742924096694,0.3624454148471616,0.6970901190913157,1.0,4/13,8.86%,PLPPR1;PLPPR5;PLPPR4;PLPP4
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.38085780813514847,-1.074522948792547,0.37375745526838966,0.6736989513072487,1.0,9/21,17.47%,WASF2;ARFGEF1;AKAP8L;PRRC1;ACBD3;AKAP1;WASF1;AKAP9;PRKACA
prerank,bHLH transcription factor binding (GO:0043425),-0.39217780563909754,-1.07448337220488,0.33072407045009783,0.6705914705477869,1.0,5/19,12.85%,FHL2;SMAD3;CREBBP;TCF3;BHLHE41
prerank,C2H2 zinc finger domain binding (GO:0070742),0.4478098684763945,1.0736880194256422,0.3722772277227723,0.6986649262082014,1.0,2/11,3.68%,LEF1;HMGA2
prerank,nuclear receptor coactivator activity (GO:0030374),-0.31186147702198797,-1.073416151155075,0.32934131736526945,0.6704990153191261,1.0,13/52,12.88%,ZMIZ1;PPARGC1B;SS18;MED17;MED12;ENY2;PPARGC1A;NCOA6;NCOA1;MED1;CALCOCO1;DCAF6;CCAR1
prerank,protein phosphatase binding (GO:0019903),-0.26967840713733443,-1.0715373292313461,0.2813102119460501,0.6722158245711323,1.0,39/117,24.95%,EGFR;JAK1;DLG4;SHOC2;SLC9A1;TBK1;STRN3;STAT3;EIF2AK3;AP3B1;ANAPC5;MAP3K5;ANAPC7;SMG7;JUP;ANAPC4;ANKLE2;TRAF2;MTMR3;PPP1R3B;SH3RF2;MAP2K7;CDC27;BOD1L1;PTPA;TRAF3;IKBKE;VCP;MVP;PIK3R1;STX17;KIFAP3;PPP1R3C;SPHK1;PPP1R3F;GTF2F1;SIRPA;KIF3A;MASTL
prerank,single-stranded RNA binding (GO:0003727),0.3204909567108465,1.0693661460906683,0.3391812865497076,0.7059611397071938,1.0,6/43,9.62%,ADARB2;ZFR2;SNRPC;RBM11;STRBP;DDX11
prerank,ribonuclease P RNA binding (GO:0033204),0.456915824340714,1.0687922443142477,0.39232409381663114,0.70251855087764,1.0,3/10,12.31%,RPP40;RPP30;POP5
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3633009827029011,1.0671060103178813,0.3575883575883576,0.7023655097700858,1.0,3/24,4.11%,CAMK2A;CAMKV;CAMK4
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.37930793175650757,-1.066899165815079,0.3493282149712092,0.6812426844950372,1.0,11/20,23.94%,USP7;SENP3;SENP1;USP47;SENP5;COPS2;USP50;DESI2;SENP2;USP9X;EIF3H
prerank,retinoic acid receptor binding (GO:0042974),-0.4108781133561563,-1.0668920434320612,0.3634686346863469,0.6781003064727651,1.0,8/17,21.79%,RARG;NSD1;NCOA6;MED1;PRMT2;CNOT1;NR4A2;ARID5A
prerank,endopeptidase inhibitor activity (GO:0004866),-0.28519459532485025,-1.0663301744759708,0.32567049808429116,0.6763896627016706,1.0,15/82,11.79%,TIMP3;COL4A3;CAST;ROCK1;BIRC6;SERPING1;PROS1;TFPI;ANXA2;ITIH2;RECK;RENBP;NGF;SERPIND1;PSMF1
prerank,lipid phosphatase activity (GO:0042577),0.4231674930667142,1.0660247384871895,0.3866943866943867,0.700419674211061,1.0,7/14,19.58%,PLPPR1;PLPPR5;SGPP2;PLPPR4;PLPP6;SGPP1;PLPP7
prerank,calcium channel inhibitor activity (GO:0019855),-0.45230456301589134,-1.0658363988709487,0.4103585657370518,0.674559839009232,1.0,1/11,0.25%,ITPR1
prerank,protein homodimerization activity (GO:0042803),-0.2259541014630557,-1.061760142178578,0.23540489642184556,0.6823563642076368,1.0,196/589,27.74%,CPQ;FOXP2;NR2F2;SMAD3;APPL2;BMPR1A;PDGFRA;TPM1;LRP6;AOX1;NADK2;RBPMS;MAPK4;ZHX2;GHR;CRYL1;ARNT;ENPP1;LRRK2;NPR3;TPST1;XPNPEP1;NR6A1;EEA1;FBLN5;KIT;ABCD3;FLNA;IRAK3;EXT1;HM13;SLK;DNM1L;SNX9;EIF2AK1;AXIN1;SNX6;DPP4;NUDT5;ZBTB16;VPS4B;STAT3;GLCE;FGFR2;MKLN1;MMUT;BCL2;MIGA2;CAMK2D;IRAK2;CDADC1;TRIM8;CRPPA;MID1;RNF8;MAP3K5;ECE1;CHMP4B;CHMP4A;S100A10;UBA5;CAMK2G;WRN;ABCD2;ZBTB1;JUP;PRMT2;PDGFC;TARS2;S100A6;SMAD4;PAFAH1B2;TBX18;TRIM5;PSMF1;NRF1;FAP;ACSL6;PAXX;HES1;ATIC;QTRT2;PKD2;TPR;TCF3;IL6R;BHLHE41;APPL1;EFEMP2;UPB1;SOX6;TXN;GBP3;APOE;TPD52L1;STAT1;VEGFA;ZNF318;GCA;ACVR1;ERN1;DPYD;MSH3;IL17D;PGRMC1;GLIPR2;PDXK;EPHX2;RAB11FIP2;NECTIN3;PTPA;TYW5;SFPQ;ADRA2A;CUBN;SMCHD1;CCDC66;GBP2;ACOX1;NQO2;S100A11;ANO1;ATP5IF1;PRMT8;CEP57;MYOM1;PARK7;PSPH;MGLL;MSH6;TERF2;IRAK1;GNPTG;PEX7;NAGA;KARS1;TPM2;CARNMT1;SNF8;SPPL3;TERT;PML;SLC39A13;RBPMS2;S100A1;DGKD;USF1;KMT2A;BNIP3;MAP3K12;ALS2;SSBP1;GALM;ST6GAL1;PRDM9;RABL3;F11R;GSS;PTH1R;GSTM2;NUDT21;HIP1R;SLC8B1;CYP2R1;TFAP4;PON3;MAP3K13;MZF1;SLIT2;TRIM68;TAP1;PHB2;GGCT;CBS;FBXO4;LDB1;BCL2L2;TRPC6;PHETA1;ST3GAL2;FXR1;RPE;LPL;RRAGA;NFS1;WARS1;SPPL2A;ZBTB7B;S100A13;SMIM1;ADRB2;RABEP1;PRPS1;PRPS1L1;CIP2A;PEX11B
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3656483813424855,-1.060926485180763,0.3657142857142857,0.6813902888069792,1.0,8/26,14.17%,SLC6A13;SLC16A12;SLC6A12;SLC16A6;SLC16A9;SLC5A6;SLC6A1;SLC27A1
prerank,CoA hydrolase activity (GO:0016289),-0.4086680043545231,-1.059622017220895,0.38330170777988615,0.6816155919483293,1.0,6/16,23.25%,HIBCH;ACAA2;ACOT11;ACOT9;ACOT8;ACOT6
prerank,chemokine receptor activity (GO:0004950),0.36310996276018015,1.0589291444125712,0.3717948717948718,0.7145970253738054,1.0,4/24,9.26%,GPR35;ACKR4;GPR17;GPR75
prerank,thioesterase binding (GO:0031996),-0.4507455057090049,-1.0585552684762265,0.3816046966731898,0.68136490039817,1.0,7/11,22.24%,CDC42;TRAF2;ADRA2A;TRAF3;TRAF6;HAUS7;TRAF5
prerank,nuclease activity (GO:0004518),-0.30770854645456586,-1.0574247723630719,0.34146341463414637,0.6813752077764188,1.0,19/52,29.59%,DIS3L2;ENPP1;N4BP2;PLSCR1;WRN;RNASE12;REXO5;XRN2;REXO1;MRE11;RNASE4;NME1;EXOG;OGG1;PDE12;DNASE1L1;DIS3;PARN;SAMHD1
prerank,sulfotransferase activity (GO:0008146),-0.3426031293222296,-1.0573147491032684,0.3603082851637765,0.6785974961127196,1.0,9/33,19.07%,UST;TPST1;HS3ST3A1;HS2ST1;CHST15;SULT1A1;CHST11;HS6ST1;CHST12
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3253446534952672,-1.0568224725300177,0.34879406307977734,0.6770362319642689,1.0,15/38,24.68%,SH3PXD2B;ZFYVE1;PLA2G4A;KIF16B;WIPI1;SNX21;ATG2A;PARD3;WDR45B;ATG2B;PLEKHF1;WIPI2;PLEKHA4;JPH2;SNX12
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.34231165285287224,-1.0557287630718093,0.38293216630196936,0.6768954467216064,1.0,19/33,33.49%,PRKN;ARIH1;RNF217;RNF19A;TCERG1;AUP1;TRAF6;RNF14;DCUN1D3;PARK7;ARIH2;RNF144A;SIAH2;PPARA;DCUN1D5;UBA2;RNF180;ANKIB1;DCUN1D4
prerank,endonuclease activity (GO:0004519),-0.3079027878494729,-1.0547493799425411,0.361376673040153,0.6765067299454052,1.0,11/49,16.79%,SMG6;DICER1;N4BP2;ZC3H12C;NYNRIN;CPSF3;KHNYN;ZC3H12B;ERN1;MRE11;ZRANB3
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.30522775713711336,-1.0524787119241084,0.3514056224899598,0.6793266280045898,1.0,11/55,12.32%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC38A11;SLC16A9;SLC38A6;SLC22A4
prerank,N-methyltransferase activity (GO:0008170),-0.3864497200222912,-1.0519427844843883,0.40040241448692154,0.677774737009113,1.0,11/20,32.07%,ZCCHC4;SETD3;TRMT11;N6AMT1;DIMT1;METTL15;TRMT1L;TRMT1;HNMT;NNMT;FDXACB1
prerank,protein tyrosine kinase binding (GO:1990782),0.28861151199216295,1.0491353572986875,0.31392931392931395,0.7371072657503661,1.0,7/71,5.48%,NRG3;GRM5;GRB14;NRG1;DOCK4;GAS6;PITPNM1
prerank,semaphorin receptor activity (GO:0017154),-0.444292584676388,-1.04866487771288,0.40264650283553877,0.6833088600467411,1.0,5/11,16.00%,PLXNA2;NRP1;PLXNB2;PLXND1;PLXNB1
prerank,cytokine activity (GO:0005125),0.2614290689064558,1.046491676669918,0.35247524752475246,0.7389971454219335,1.0,16/131,10.54%,KITLG;IL17F;MIF;IL7;NRG1;CXCL12;BMP8A;IL12A;SCGB3A1;TGFB2;WNT7B;TIMP1;EPO;CCL2;BMP3;SCG2
prerank,Notch binding (GO:0005112),-0.3722500690717156,-1.046266722568182,0.41346153846153844,0.6865080182467059,1.0,4/22,12.57%,SNED1;JAG1;CCN3;CUL3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2764790034429967,1.0455777727890785,0.3525773195876289,0.7365827849364135,1.0,11/85,10.38%,AARS2;ABHD2;ENPP2;LYPLA1;LIPE;CA2;PLAAT1;PTRH2;PLA2G12A;ABHD8;ESD
prerank,dipeptidyl-peptidase activity (GO:0008239),0.4390683398592984,1.0448460059478326,0.402020202020202,0.73370933709557,1.0,2/10,6.05%,DPP10;DPP6
prerank,potassium ion antiporter activity (GO:0022821),-0.4088540401225934,-1.0427204453494807,0.40421792618629176,0.6925024964796277,1.0,4/15,6.17%,SLC24A3;SLC9A1;SLC9A8;SLC9A2
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.36452516185682277,-1.0391476804314197,0.3973384030418251,0.695713539414666,1.0,8/21,20.88%,CDK8;CDK7;CDK13;CCNK;CDK11B;CDK10;CDK2;CDK6
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.36452516185682277,-1.0391476804314197,0.3973384030418251,0.695713539414666,1.0,8/21,20.88%,CDK8;CDK7;CDK13;CCNK;CDK11B;CDK10;CDK2;CDK6
prerank,translation elongation factor activity (GO:0003746),0.4117248061980618,1.0384170748395594,0.394,0.7464282608387889,1.0,6/14,17.75%,EEF1B2;TUFM;EIF5A2;EEF1A2;EEF1A1;EEF2
prerank,myosin V binding (GO:0031489),0.40699231056558255,1.0378051320391324,0.42829076620825146,0.7434306730800411,1.0,3/15,7.15%,RAB3C;RAB6B;RAB39B
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3512140248580833,-1.037478068779982,0.4216101694915254,0.6971974006891515,1.0,16/27,33.49%,PRKN;ARIH1;RNF217;RNF19A;AUP1;TRAF6;RNF14;DCUN1D3;ARIH2;RNF144A;SIAH2;PPARA;DCUN1D5;RNF180;ANKIB1;DCUN1D4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.422965484701878,-1.0371152250270512,0.39921722113502933,0.6951939337509058,1.0,7/12,30.58%,TBP;STAT1;HDAC1;GTF2B;TBPL1;RUVBL2;GTF2A1
prerank,calcium channel regulator activity (GO:0005246),0.3280914114967165,1.0370444697831545,0.4004237288135593,0.740506536276438,1.0,8/37,13.76%,NRXN1;PRKG1;NRXN2;SLC30A1;SGK3;CACNG8;CALM1;CALM2
prerank,TBP-class protein binding (GO:0017025),-0.3668286135395332,-1.034774133501665,0.4091778202676864,0.6982804864629943,1.0,11/21,30.58%,TAF13;GTF2B;TAF12;PSMC1;DRAP1;YEATS2;THRA;ESR1;BRF2;RUVBL2;GTF2A1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.28300687552830595,-1.0339314871410528,0.395910780669145,0.6973776204220503,1.0,23/78,24.06%,USP24;CFLAR;USP7;CTSC;CTSH;PIGK;CASP12;USP33;USP47;CASP2;USP12;USP11;USP46;USP35;USP2;USP13;USP34;CTSF;GPAA1;CTSL;USP18;USP9X;USP28
prerank,N-acetyltransferase activity (GO:0008080),-0.380984143814214,-1.0332726244209423,0.42115384615384616,0.6960800979402294,1.0,4/19,14.47%,KAT2B;EP300;SAT1;ESCO1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.34275700031376893,1.0332574974267534,0.4215885947046843,0.7457350697650368,1.0,4/30,7.86%,SPOCK1;GAS6;SNCA;RPS6KA1
prerank,RNA stem-loop binding (GO:0035613),-0.4160637355120402,-1.0327016630619694,0.44045368620037806,0.6946944713755479,1.0,4/12,14.85%,RC3H1;DHX9;CSDE1;DDX3X
prerank,transition metal ion binding (GO:0046914),-0.2264149653203624,-1.031736546573368,0.32448979591836735,0.6942965027146992,1.0,99/397,20.02%,AGMO;SMAD3;LARGE1;MPPED2;AOX1;LIMS1;SEC24D;GLI2;B4GALT1;MOXD1;CBLB;ZEB1;MDM4;PAPPA;HDAC4;ABL1;PRKN;ENPP1;ARIH1;KDM7A;XPNPEP1;ZCCHC4;EEA1;PLSCR1;SKI;RC3H1;TDP2;SEC23A;NSD1;PHF8;ASAH2;CDADC1;TRIM8;ZFYVE1;TES;KDM5B;ACO2;RNF8;ECE1;ANPEP;UBA5;WRN;ACER3;SLU7;PHF2;CHD4;CHD3;USP33;MNAT1;ENPP3;ME1;ABL2;FAM20C;NAPEPLD;BBOX1;SOD3;PPM1M;MSRB3;FBXL19;NPEPPS;PIAS4;ADAM33;KDM1B;CZIB;PCK2;SIRT5;UPB1;GLO1;ESCO1;KDM3A;PRDM2;P2RX4;RXRA;LNPEP;PDXK;KDM2A;LOXL3;TYW5;GTF2B;TARS1;ZFP37;NQO2;BAZ1B;RASSF1;PTPN1;RABGGTB;XYLT2;SOD2;NEK4;GALNT1;PARK7;APIP;B4GALT7;ZMYND8;NFU1;TIMP2;ETHE1;QPCTL;RNF11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4321134894231374,1.0279424116511515,0.44234800838574423,0.7557405856428409,1.0,11/11,56.82%,DDAH1;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;ARG2;PADI2;DDAH2
prerank,protein kinase inhibitor activity (GO:0004860),0.31069752227196223,1.0273731402186204,0.4049586776859504,0.7524934692964454,1.0,13/42,16.15%,YWHAB;CAMK2N1;INKA1;SNCA;DUS2;SPRY4;SOCS1;MAPK8IP1;CEP43;CIT;CIB1;CDKN1A;CDKN1B
prerank,cholesterol binding (GO:0015485),-0.29995064958641826,-1.0269513871993812,0.40718562874251496,0.7035056100982251,1.0,12/47,12.63%,ABCA1;ANXA6;OSBPL8;SOAT1;GRAMD1C;OSBPL5;SIDT1;VDAC1;NR1H3;NPC2;ERLIN1;APOD
prerank,ribonuclease P activity (GO:0004526),0.428386331031404,1.026075147662441,0.43829787234042555,0.7514418866736892,1.0,3/11,12.31%,RPP40;RPP30;POP5
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.4005175533821227,-1.0243724011616904,0.44,0.7073888321736763,1.0,2/14,11.71%,DHRS3;AKR1A1
prerank,store-operated calcium channel activity (GO:0015279),0.43714257431784465,1.0233216076270253,0.41841004184100417,0.754431637729535,1.0,2/10,11.89%,TRPC5;TRPC1
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2846267562930029,-1.0195202847584273,0.4130019120458891,0.7164450920101547,1.0,20/71,14.98%,EYA2;PTPN13;EYA1;EYA4;PTPN14;CDC14A;TNS2;PTPN9;PTPRS;PTPN21;PTPN3;PTPRK;PTPN22;PTPN12;PTPN2;DUSP11;MTMR3;DUSP1;CDC14B;CDC25B
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.37018233088250413,1.019075709206595,0.458,0.7613914412017992,1.0,5/18,14.17%,SLA2;PIK3R5;SOCS1;PIK3R3;CCKBR
prerank,syntaxin-1 binding (GO:0017075),0.3569270109122899,1.0154912171181607,0.4179431072210066,0.7659336905887196,1.0,6/22,10.56%,SYT1;SNAP25;UNC13A;SNPH;SYNPR;CPLX1
prerank,wide pore channel activity (GO:0022829),-0.354417974248437,-1.0151560766890813,0.42610364683301344,0.7245870246622493,1.0,3/23,8.72%,GJB6;GJA1;GJB2
prerank,E-box binding (GO:0070888),-0.32662154645579256,-1.014387226893283,0.4361904761904762,0.7237211930648185,1.0,10/34,24.88%,TCF4;ZEB1;HES1;TCF3;BHLHE41;ATOH8;PRMT5;TFAP4;SNAI1;TWIST1
prerank,zinc ion binding (GO:0008270),0.23064059811912424,1.0131732696833002,0.3858267716535433,0.7675113914220013,1.0,46/293,11.74%,MT2A;MMP12;MME;GLRA1;S100A9;S100A8;GRIN2A;SHANK3;PDE2A;TRIM2;GRIN2B;QPCT;PPARG;PHEX;RPS27;SNCA;ENPP2;MT1B;MT1G;MT1X;MT1M;MT1F;MT1E;MT1H;MT1A;SNRPC;CA2;NUDT12;KLF4;MYT1;TIMP1;MMP16;PITRM1;MSRB2;ZDHHC15;TMEM163;RNF112;ARHGEF2;DPF3;TRIM24;SMPDL3A;SMPD1;ZNF22;IKZF5;THAP1;SLC30A5
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2901525217094557,1.01309811090306,0.41015625,0.7629796977539968,1.0,13/55,14.16%,SLC24A4;SLC24A2;GRIN1;TRPC5;RYR2;ATP2B3;TRPM2;CACNB2;TRPC1;TMCO1;PSEN1;ATP2B4;ATP2B2
prerank,cytokine receptor binding (GO:0005126),-0.27066565471007026,-1.012022430453759,0.43538767395626243,0.7267357118150916,1.0,8/83,5.30%,TGFBR3;SMAD3;IL34;IL6ST;JAK1;PIBF1;IL13RA1;SMAD2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4037305050098637,1.0091300697401506,0.4090909090909091,0.7693532452790701,1.0,6/13,25.52%,RANBP1;CCDC88A;GDI1;ARHGDIG;SH3BP4;EIF5
prerank,nucleotidyltransferase activity (GO:0016779),-0.3666447440070801,-1.0088112920359398,0.44021739130434784,0.7323796518298841,1.0,5/19,13.98%,TENT2;NUDT5;CRPPA;TUT4;REV1
prerank,gap junction channel activity (GO:0005243),-0.3591587175637077,-1.008295084528361,0.43359375,0.7307389898508758,1.0,3/22,8.72%,GJB6;GJA1;GJB2
prerank,tRNA binding (GO:0000049),-0.30300105448415965,-1.0080491023786056,0.4416826003824092,0.72843754600321,1.0,21/43,33.71%,FARS2;TRMT9B;NSUN6;ALKBH1;EIF2AK4;TYW5;NSUN2;ELP5;KARS1;TERT;DALRD3;RPUSD4;TRNT1;PSTK;NAT10;IGHMBP2;TRMT10C;MRPS27;PUS1;ALKBH8;CARS1
prerank,hormone activity (GO:0005179),0.2929081154363611,1.0075982622475728,0.4351464435146444,0.7689622373890715,1.0,13/54,20.07%,AMH;TRH;ADCYAP1;NMB;SST;POMC;GRP;PNOC;VGF;EDN1;CCL25;METRN;AGT
prerank,"DNA binding, bending (GO:0008301)",0.400977234915807,1.0074655094575689,0.45397489539748953,0.7647304911863075,1.0,3/14,7.01%,LEF1;HMGA2;TERF1
prerank,MHC class II protein complex binding (GO:0023026),0.42167644946636307,1.006767204806771,0.4551569506726457,0.762053855506594,1.0,4/11,17.04%,HSPA8;HSP90AB1;ATP1B1;HSP90AA1
prerank,acylglycerol lipase activity (GO:0047372),0.42519956573244866,1.0060706175949479,0.44469525959367945,0.7593004757156367,1.0,2/11,5.48%,ABHD2;LIPE
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.31848320522233314,-1.0047725071968439,0.4369114877589454,0.7340790334453158,1.0,18/35,30.58%,FOXP1;BAZ2A;NR3C1;TAF4;TBP;STAT1;HDAC1;SNAPC3;GTF2B;PARK7;PIH1D1;DRAP1;AGO1;TBPL1;TAF1C;RRN3;RUVBL2;GTF2A1
prerank,beta-tubulin binding (GO:0048487),0.32114672256395005,1.0003403908249942,0.44668008048289737,0.7704166468206672,1.0,5/31,5.97%,PACRG;TTLL7;FGF13;GABARAPL1;GABARAP
prerank,neuropeptide hormone activity (GO:0005184),0.3460409573409369,1.0001550642513108,0.4491525423728814,0.7663077693384034,1.0,4/22,11.62%,ADCYAP1;NMB;GRP;PNOC
prerank,endopeptidase activator activity (GO:0061133),0.4258053052005502,0.9996329551185668,0.4475374732334047,0.7632263331829424,1.0,3/10,21.76%,PSENEN;PSME3;APH1B
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.27449547040461414,0.9979176820213355,0.4426229508196721,0.763713551821646,1.0,16/73,17.97%,HCRTR1;LGR5;SORCS3;SORCS1;APLNR;HCRTR2;F2R;GRPR;OPRK1;CCKBR;NPR1;NPSR1;CALCRL;ADCYAP1R1;CYSLTR1;EDNRB
prerank,growth factor receptor binding (GO:0070851),-0.2627677731149863,-0.9955462565905552,0.4715909090909091,0.7549185160257228,1.0,18/95,15.36%,EFEMP1;PDGFRA;FGF1;PDGFRB;IL6ST;PIBF1;PLSCR1;SHC1;FRS2;NCSTN;FER;PDGFC;KL;IL6R;VEGFA;ERN1;VEGFD;ITGA5
prerank,acetylcholine receptor activity (GO:0015464),0.3473480869688206,0.9924732575762888,0.4519015659955257,0.7742768543541841,1.0,1/22,1.73%,CHRM3
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3272642377417001,-0.9916876131683787,0.4723809523809524,0.7617375502601285,1.0,4/29,7.01%,SLC13A3;SLC1A5;SLC26A7;SLC26A2
prerank,lysine N-methyltransferase activity (GO:0016278),-0.3503689462733819,-0.9909261117211341,0.47265625,0.7608012254948554,1.0,7/20,19.36%,SETD7;SETD3;SETD2;EHMT1;METTL21A;EEF2KMT;KMT5A
prerank,leucine zipper domain binding (GO:0043522),-0.4258861484113913,-0.9873220315531952,0.48398576512455516,0.7672640528779228,1.0,2/10,2.80%,PAWR;ERC1
prerank,nucleotide diphosphatase activity (GO:0004551),-0.40152669249686346,-0.9860248345576693,0.4701195219123506,0.7677974413643741,1.0,3/14,3.50%,FHIT;ENPP1;NUDT4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4091894704775188,-0.977657137013214,0.4981132075471698,0.7875482479155482,1.0,4/11,18.35%,SASH1;ROR2;TCF3;TRAF6
prerank,myosin II binding (GO:0045159),-0.4365446210523134,-0.9774206276181957,0.512014787430684,0.785136838426592,1.0,2/10,2.45%,GSN;STXBP5
prerank,outward rectifier potassium channel activity (GO:0015271),-0.41915578530037684,-0.9766332500252723,0.48349514563106794,0.784031925029347,1.0,2/11,1.32%,KCNK2;KCNT2
prerank,sequence-specific mRNA binding (GO:1990825),0.42579672162559223,0.9744985886754101,0.4860813704496788,0.8192148557716797,1.0,2/10,6.85%,LARP6;ETF1
prerank,phosphatidylcholine transporter activity (GO:0008525),0.36573647077092186,0.9728035990345099,0.4780793319415449,0.8193102309546959,1.0,4/17,5.48%,PLTP;ATP10A;ATP10B;PITPNM1
prerank,hyaluronic acid binding (GO:0005540),-0.4347969393987823,-0.9727732215704764,0.5281954887218046,0.7912848153158532,1.0,6/10,34.45%,CEMIP;IMPG2;C1QBP;LYVE1;CHODL;CD44
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.28367845211977555,-0.9724595299070049,0.5069860279441117,0.7889388406129052,1.0,12/54,14.81%,NGLY1;HDAC8;HDAC4;ASPA;ASAH2;ACER3;MIER1;NTAN1;SIRT5;UPB1;HDAC1;ASPG
prerank,filamin binding (GO:0031005),-0.42054639295410784,-0.9724124605890423,0.5037878787878788,0.7860498593851941,1.0,2/11,10.00%,DPYSL3;SYNPO2
prerank,galactosyltransferase activity (GO:0008378),-0.41088327893331433,-0.9721418322686509,0.4951267056530214,0.7837976578523739,1.0,8/11,35.77%,B4GALT1;A4GALT;B4GALT5;B4GALT7;B4GALT3;A3GALT2;B3GALT6;B4GALT2
prerank,exoribonuclease activity (GO:0004532),0.3983507564737953,0.971431446017922,0.5020576131687243,0.818354791127101,1.0,1/12,0.97%,EXOSC5
prerank,protein kinase regulator activity (GO:0019887),-0.25106201654542787,-0.9665045261860806,0.5334685598377282,0.7954505389762198,1.0,19/95,15.88%,PRKAG2;PARVA;CCNL2;CCNT2;CCNL1;CCNH;RPTOR;CCNT1;TAOK3;CCNK;GPRC5C;WNK1;CCNYL1;DNAJC3;GMFB;CCND3;NCK1;CNPPD1;SH3BP5L
prerank,SUMO binding (GO:0032183),-0.39533641726149865,-0.9660575125995651,0.5095419847328244,0.7936064128888717,1.0,4/13,20.28%,HERC2;SERBP1;SIMC1;PML
prerank,cardiolipin binding (GO:1901612),-0.4268205061974518,-0.9646799264814471,0.5301645338208409,0.7941095209069903,1.0,5/10,21.39%,OPA1;GSDME;GSDMD;STOML2;PLEKHN1
prerank,iron ion binding (GO:0005506),-0.2910613107799766,-0.964175616913998,0.4897959183673469,0.7924748382692756,1.0,15/48,20.98%,AGMO;AOX1;FTO;KDM7A;PHF8;ACO2;PHF2;EGLN3;ALKBH1;KDM3A;TYW5;NFU1;ETHE1;FDX1;FXN
prerank,protein kinase C binding (GO:0005080),-0.2940836691606282,-0.9635087116059096,0.52,0.7913754677139454,1.0,9/43,10.53%,GRK5;PDLIM5;ITGAV;PARD6G;ABL1;IRS1;ADCY6;DACT1;ADAM9
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3714005826911801,0.9623863563331393,0.4989339019189765,0.8379794386674745,1.0,3/16,7.53%,SLC18A3;SLC25A42;SLC7A8
prerank,neurexin family protein binding (GO:0042043),0.4108766256906247,0.9623612541180158,0.5111111111111111,0.8332916204032351,1.0,2/10,6.42%,NLGN1;SYTL2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.2783184723770066,-0.961696030332363,0.5174537987679672,0.7932260826064549,1.0,5/53,3.12%,SLC7A11;SLC7A2;SLC1A3;SLC47A1;SLC1A5
prerank,phospholipase C activity (GO:0004629),-0.32624086362352284,-0.9614116131454334,0.5201465201465202,0.7910058111387219,1.0,8/25,16.71%,PLCE1;PLCD3;EDNRA;PLCG1;PLCB3;PLCD1;BDKRB2;PLCL1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.299395777717337,0.9593060963600398,0.5095137420718816,0.8369949359003166,1.0,5/37,6.27%,AARS2;VARS1;VARS2;GARS1;RARS1
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.42205257916140615,-0.9579269751122006,0.511070110701107,0.7968945304452794,1.0,2/10,2.20%,B4GALT1;B3GALT1
prerank,chloride transmembrane transporter activity (GO:0015108),0.3641501275308532,0.9561026030339791,0.5367965367965368,0.8408163688252677,1.0,2/16,4.33%,SLC4A1;SLC1A1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.36452813311414517,0.9557113974943813,0.508298755186722,0.8371250280868474,1.0,7/16,25.45%,MACROD2;RPS3;CD38;ADPRS;SARM1;ADPRH;TDG
prerank,receptor tyrosine kinase binding (GO:0030971),0.27435569483159,0.9553439739357262,0.5212765957446809,0.833436410618376,1.0,6/56,5.48%,NRG3;GRB14;NRG1;DOCK4;GAS6;PITPNM1
prerank,sterol transfer activity (GO:0120015),0.3580553309494935,0.9552853469288448,0.5031315240083507,0.8289174697254215,1.0,2/17,5.56%,PLTP;GRAMD1B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.3308847025113751,-0.9549014288686213,0.5325884543761639,0.8012727148297257,1.0,6/23,10.26%,PLCE1;PLCD3;EDNRA;PLCG1;PLCB3;PLCD1
prerank,omega peptidase activity (GO:0008242),0.2518840370043931,0.9515096479898834,0.5412474849094567,0.83440821845234,1.0,27/89,19.11%,USP44;OTUD7A;USP29;USP53;USP14;USP49;ASRGL1;UCHL1;GGT7;YOD1;UCHL3;GGH;GGT1;USP32;USP22;OTUB2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,cholesterol transfer activity (GO:0120020),0.3591776181176227,0.9506537080392046,0.5121951219512195,0.8320613645649251,1.0,2/16,5.56%,PLTP;GRAMD1B
prerank,tau protein binding (GO:0048156),-0.29352188199104834,-0.9492790143868111,0.5450980392156862,0.8126828132696492,1.0,15/40,21.04%,ROCK2;EP300;ROCK1;GSK3B;MARK3;SMAD2;MARK4;PPP2CB;BRSK1;APOE;MARK1;PICALM;PRKAA1;TAOK1;PPP2CA
prerank,phosphatidylglycerol binding (GO:1901611),0.38277359010113887,0.94819003943303,0.5377777777777778,0.8342023472146051,1.0,2/13,1.59%,PLTP;MME
prerank,phosphoric diester hydrolase activity (GO:0008081),0.29835677010570194,0.9464559396129985,0.5729847494553377,0.8343083213175497,1.0,8/35,10.84%,GPCPD1;PLCXD3;ENPP2;PDE11A;PLCB4;SMPDL3A;APEX1;SMPD1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.31913876765742555,0.9448299286220004,0.5288270377733598,0.8345196931024379,1.0,5/26,11.70%,B4GALNT1;CSGALNACT1;CHSY3;B3GALT5;B3GNT2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.29343806427298974,-0.9447679835706565,0.5429141716566867,0.8211998047538746,1.0,13/40,20.13%,PCMTD2;DNMT3A;COMT;SETD3;N6AMT1;METTL2A;METTL2B;PCMT1;TPMT;THUMPD3;PRMT8;RRP8;CARNMT1
prerank,deubiquitinase activity (GO:0101005),0.2508859671072262,0.9432895090349183,0.5685071574642127,0.8341206430895209,1.0,26/88,19.11%,USP44;OTUD7A;EIF3F;USP29;USP53;USP14;USP49;UCHL1;YOD1;UCHL3;USP32;USP22;OTUB2;MINDY1;MINDY2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,dynactin binding (GO:0034452),0.3958810034918491,0.9430001844555547,0.5345528455284553,0.8304903994746462,1.0,3/12,8.93%,BICD1;BICDL1;SPTBN5
prerank,retinoid X receptor binding (GO:0046965),-0.39947543872347324,-0.9418289531528761,0.532319391634981,0.8258236256094121,1.0,5/11,21.79%,RARG;NSD1;NCOA6;NR4A2;ARID5A
prerank,serine-type peptidase activity (GO:0008236),0.24767353084530314,0.9413187943755466,0.5970149253731343,0.8305545098230319,1.0,10/96,11.24%,MASP2;PCSK1;PCSK2;RHBDF2;PCSK6;ENDOU;PREP;PCSK7;TMPRSS4;PROC
prerank,steroid hydroxylase activity (GO:0008395),-0.3627936452840015,-0.9392955033172601,0.5287569573283859,0.8293489702960433,1.0,3/16,9.27%,CYP7B1;CYP27A1;CYP1B1
prerank,snRNA binding (GO:0017069),-0.2886015653343859,-0.9392886498576616,0.562753036437247,0.8263522441858498,1.0,16/42,32.00%,CCNT2;CCNT1;RNPC3;GEMIN5;SNRNP70;COIL;EFTUD2;SNU13;HNRNPU;NCBP2;PRPF8;LSM11;RBM22;CDK9;SNRPA1;RBM41
prerank,phosphatase activity (GO:0016791),-0.2609314837251625,-0.9391956695212061,0.564453125,0.8235845210764745,1.0,20/73,19.55%,ATP1A2;PLPP3;DUSP16;NT5M;PRUNE1;PTPN22;DUSP11;APTX;PXYLP1;PPP1CB;ENOPH1;SACM1L;EPHX2;ACP2;DUSP10;LPIN2;LPIN3;INPP5K;PSPH;HDDC2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.31350841377095123,0.9372929628519464,0.5279503105590062,0.8365309786963085,1.0,7/27,17.14%,POLR1H;POLR2J;POLR2B;POLR2I;MED20;POLR3A;POLR2G
prerank,telomerase RNA binding (GO:0070034),-0.3243899741705142,-0.93697609847886,0.527831094049904,0.826249345160611,1.0,10/22,30.55%,SMG6;DHX36;SMG7;XRN1;EXOSC10;HNRNPU;TERT;GAR1;PARN;PINX1
prerank,ferrous iron binding (GO:0008198),0.33319511949427216,0.9352540599032919,0.5583864118895966,0.8371356624721685,1.0,7/21,18.31%,FTH1;SNCA;FTL;ISCU;ALKBH3;FECH;EGLN1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.39952110465203705,-0.9330230462735805,0.5575868372943327,0.8332952361546015,1.0,3/11,24.07%,PPP1R1A;PPP1R2;PPP1R14A
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.40089913848503556,-0.9286740337548471,0.576427255985267,0.8413808793775365,1.0,8/11,59.79%,CHRNA4;CHRNA7;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,chemoattractant activity (GO:0042056),0.3133509106942612,0.9198492603949057,0.5516528925619835,0.8726183180942095,1.0,5/26,10.54%,MIF;FGF10;GPNMB;PDGFB;SCG2
prerank,ion channel inhibitor activity (GO:0008200),-0.2918865664836251,-0.9190362451572739,0.5930232558139535,0.8623391711990109,1.0,5/35,9.42%,ITPR1;VTI1B;CAMK2D;WNK4;WNK1
prerank,cysteine-type peptidase activity (GO:0008234),-0.2525828382902904,-0.91839481966456,0.6064030131826742,0.8609267208040351,1.0,22/73,25.32%,USP24;USP7;CTSC;CTSH;USP33;USP47;CASP2;USP12;USP11;USP46;USP35;USP50;USP2;USP13;ATG4D;USP34;CTSF;CTSL;USP18;USP9X;USP28;CASP6
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3892100380973312,0.9176381488430818,0.5634408602150538,0.8737975712488284,1.0,3/11,6.45%,RYR2;RYR3;TRPM2
prerank,DNA polymerase binding (GO:0070182),-0.33828240077036364,-0.9173447064506177,0.5861386138613861,0.8605948172041114,1.0,10/18,35.32%,SMG6;HMGB1;NABP2;FANCI;PCNA;NAT10;LONP1;FANCD2;RAD51;SMARCA4
prerank,phospholipase activity (GO:0004620),-0.25181086677801406,-0.9172441280007019,0.6240458015267175,0.8578659531559943,1.0,15/67,19.19%,PLCE1;SEC23IP;DDHD1;PLA2G4A;PLCB3;ABHD3;NAPEPLD;PNPLA8;PNPLA7;ASPG;PLCL1;ABHD12;SMPD4;ABHD6;MGLL
prerank,cytokine receptor activity (GO:0004896),-0.24556352649342236,-0.9166199883774847,0.6257088846880907,0.8563180877704686,1.0,14/83,16.18%,LEPR;IL6ST;IL31RA;GHR;CCR9;IL15RA;IL13RA1;F3;IL17RA;CNTFR;IL17RD;IL6R;IFNGR1;CMKLR1
prerank,aminopeptidase activity (GO:0004177),-0.31024681001223314,-0.9162213039276625,0.598019801980198,0.8543399851588778,1.0,7/26,15.63%,XPNPEP1;CTSH;ANPEP;MMP14;LAP3;NPEPPS;LNPEP
prerank,proton transmembrane transporter activity (GO:0015078),0.28000262445134977,0.9154807099557036,0.5936842105263158,0.8748003487028945,1.0,14/39,21.28%,COX7A1;NDUFA4;COX4I1;COX6A1;ATP6V1F;COX6B1;DMAC2L;UQCRH;NNT;COX10;COX8A;CLCN3;CLCN4;COX5B
prerank,microtubule plus-end binding (GO:0051010),0.33476693755960985,0.9134780866606463,0.6,0.8755189088504219,1.0,10/20,19.69%,KNSTRN;DST;MAPRE3;CLIP2;APC;DCTN1;CLASP2;KIF18A;TTBK2;CLASP1
prerank,ATP hydrolysis activity (GO:0140603),-0.2765231729507725,-0.9098092852071565,0.6080808080808081,0.8670173324713827,1.0,11/41,18.42%,RNF213;ABCA4;VPS4B;VWA8;DHX9;ABCD2;CHD3;ATP2B1;DDX3X;SMCHD1;VCP
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3923921854931038,0.9094676246867339,0.5717391304347826,0.8814566508086336,1.0,1/10,0.28%,MECOM
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.38405833194670774,-0.9090972069229124,0.581888246628131,0.8656493501202537,1.0,7/11,32.30%,NUDT4;NUDT5;NUDT1;NUDT11;NUDT7;NUDT16;NUDT16L1
prerank,serine-type endopeptidase activity (GO:0004252),0.24520618567991867,0.9076731856809391,0.6609808102345416,0.8815699578079967,1.0,8/80,11.24%,MASP2;PCSK1;PCSK2;RHBDF2;PCSK6;PCSK7;TMPRSS4;PROC
prerank,chemokine activity (GO:0008009),0.29227614639852206,0.907432449252188,0.597165991902834,0.8777876877587465,1.0,6/31,20.51%,CXCL12;CCL2;CCL25;CKLF;CCL13;CCL19
prerank,chloride channel inhibitor activity (GO:0019869),-0.39610419730109214,-0.9042009666915519,0.5814393939393939,0.8747781174879546,1.0,6/10,27.28%,VTI1B;WNK4;WNK1;STX8;STX1A;STX7
prerank,methyltransferase activity (GO:0008168),-0.2738079264073093,-0.9034753841428105,0.62109375,0.8735132038260188,1.0,15/46,20.49%,COQ3;COMT;NSUN3;TRMT11;N6AMT1;EHMT1;PRMT5;BUD23;NSUN2;PRMT8;RRP8;NTMT1;FTSJ1;CARNMT1;COQ5
prerank,cation:chloride symporter activity (GO:0015377),-0.38483582907529457,-0.9033423027689447,0.615234375,0.8708597748600087,1.0,5/10,20.33%,SLC12A7;SLC12A2;SLC6A1;SLC12A8;SLC12A9
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3547930810703402,-0.9022277800610715,0.5807692307692308,0.870527226636767,1.0,6/15,17.35%,EEA1;SNX9;ZFYVE1;SNX10;ZFYVE16;PICALM
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.39010792477847056,-0.9014305721020012,0.586073500967118,0.8694781267869837,1.0,1/10,0.21%,PRKAG2
prerank,heme binding (GO:0020037),-0.25291623009470476,-0.899327841891488,0.6666666666666666,0.8714893837634454,1.0,9/65,9.27%,PTGIS;CYP26B1;CYP27A1;CYB5B;CYB5R4;EIF2AK1;NOX4;PGRMC2;CYP1B1
prerank,ribonuclease activity (GO:0004540),-0.25539378767301796,-0.8981101127045175,0.6747474747474748,0.8714787871294767,1.0,12/56,15.99%,SMG6;DIS3L2;DICER1;ZC3H12C;NYNRIN;CPSF3;RNASE12;KHNYN;ZC3H12B;EXOSC9;ERN1;EXOSC10
prerank,antiporter activity (GO:0015297),0.3248865371651958,0.8972086189564578,0.6052631578947368,0.8986953491252961,1.0,5/20,12.51%,SLC35A1;ATP1A3;SLC25A14;SLC35C1;SLC35E4
prerank,MAP kinase activity (GO:0004707),-0.35778577269502404,-0.8930071701647608,0.5967741935483871,0.8803339273755694,1.0,5/14,25.76%,MAPK4;MAPK6;MAPK7;MAPK9;MAPK14
prerank,potassium ion leak channel activity (GO:0022841),0.34618848959372883,0.8928517868396489,0.625,0.9049024675852614,1.0,4/15,8.42%,KCNK13;KCNK10;KCNK9;KCNK1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2503171002887821,-0.8918852213165853,0.6694386694386695,0.8800812595663247,1.0,12/70,18.37%,GXYLT2;LARGE1;B4GALT1;B3GALT1;EXT1;B3GLCT;POGLUT2;OGT;HEXA;CHPF2;CHSY1;GCNT2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3609356742574426,0.8901357459011215,0.6132264529058116,0.9071600804836554,1.0,1/13,1.05%,DNASE1
prerank,U6 snRNA binding (GO:0017070),0.3511159161142959,0.8883864418692545,0.625,0.90687463329416,1.0,8/14,27.26%,LSM4;LSM2;LSM7;LSM3;PRPF4;DDX39B;EIF5A;LSM8
prerank,epidermal growth factor receptor binding (GO:0005154),0.30308979356399407,0.8874092460765024,0.6260683760683761,0.9048052129827466,1.0,5/25,12.15%,ERBB4;HIP1;LINGO1;CCDC88A;ARF4
prerank,protein phosphatase regulator activity (GO:0019888),-0.26038007356768805,-0.8864995925012115,0.6883629191321499,0.8896153343129373,1.0,20/53,27.68%,PTN;SHOC2;PPP1R7;PPP4R2;CABIN1;ANKLE2;DMPK;PPP2R5E;EIF2AK2;PPP2R5D;BOD1L1;PTPA;PPP2R5C;PPP2R1B;PPP4R1;PPP1R2;PPP2R2C;BOD1;SAG;PPP1R15B
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.31655588101762866,-0.8863140205496116,0.6247689463955638,0.8870054146272957,1.0,2/21,0.52%,PDE1A;PDE5A
prerank,O-acyltransferase activity (GO:0008374),0.2938696433235572,0.8835415418248651,0.6416666666666667,0.9098470710295803,1.0,8/30,16.72%,MBOAT1;LPCAT2;DGAT2;PLAAT1;GPAM;MOGAT1;SOAT2;PIGW
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3449104924275276,0.881974278332751,0.6352459016393442,0.9093383541272753,1.0,3/15,5.81%,SLC17A6;SLC1A1;SLC1A2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.24105843321077217,-0.8802535365735586,0.7033582089552238,0.897740564044948,1.0,35/74,33.77%,PI4KA;NADK2;FAM20A;GK5;DGKA;NADK;ADK;PANK2;FAM20C;DCAKD;PIK3C3;RFK;PDXK;PIK3CD;FCSK;SHPK;PKM;DGKD;GALK2;SPHK1;DGKK;GALK1;MVK;ETNK1;DOLK;POMK;SPHK2;PI4KB;PIK3C2A;HK2;TKFC;PAPSS1;HYKK;COASY;TRPT1
prerank,lipase activity (GO:0016298),-0.2644273490357304,-0.878265862404863,0.6686274509803921,0.8994689640451221,1.0,13/43,26.17%,SEC23IP;DDHD1;ABHD5;ABHD3;PNPLA8;PLA1A;ABHD12;ABHD6;MGLL;SMPD2;DAGLB;PNPLA2;LPL
prerank,protein kinase C activity (GO:0004697),0.3457077822714635,0.8770794982011296,0.6124197002141327,0.9164464312316731,1.0,3/14,6.50%,PRKCH;PKN1;PRKCQ
prerank,metalloaminopeptidase activity (GO:0070006),-0.3377031848751202,-0.876197365582587,0.6498054474708171,0.9011710000460723,1.0,5/16,15.63%,XPNPEP1;ANPEP;MMP14;NPEPPS;LNPEP
prerank,adenylate cyclase binding (GO:0008179),0.3749094400469364,0.8744075811190136,0.640495867768595,0.9181915975965027,1.0,5/10,14.31%,AKAP6;CAP2;CALM1;CALM2;CALM3
prerank,ADP binding (GO:0043531),-0.2926261965116994,-0.8737942377965567,0.639921722113503,0.903367327373805,1.0,9/25,27.56%,PRKAG2;GLUD1;ME1;PGK1;ERN1;MSH6;TAP1;GCLC;LONP1
prerank,protein phosphatase 2A binding (GO:0051721),0.2996568354285617,0.873697193203846,0.6552462526766595,0.9152973741039596,1.0,6/23,14.55%,ADCY8;DAB2IP;GRIN3A;FOXO1;CTTNBP2NL;MFHAS1
prerank,phosphatidic acid binding (GO:0070300),-0.3224364193488127,-0.8729312402769489,0.6429872495446266,0.9024482249662611,1.0,7/19,15.68%,OPA1;PACSIN2;MAPKAP1;PITPNC1;GSDMD;RAPGEF2;MARK1
prerank,snoRNA binding (GO:0030515),-0.2888265740602758,-0.8726308712108957,0.6760828625235404,0.9002205384069536,1.0,16/30,32.30%,NUDT4;NUDT5;BMS1;PRKDC;NOP58;SNU13;UTP6;IMP3;GAR1;TSR1;DHX37;NUDT1;TBL3;NUDT7;NUDT16;NUDT16L1
prerank,ATPase activator activity (GO:0001671),0.31059583904802635,0.8702443783201418,0.6548856548856549,0.918927598197717,1.0,8/20,22.32%,DNAJC15;ATP1B1;DNAJA2;DNAJB2;AHSA1;DNAJC19;DNAJA1;ATP1B2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.303506217431449,-0.8698780065902187,0.6501831501831502,0.9037050734759201,1.0,2/23,0.52%,PDE1A;PDE5A
prerank,GTPase activity (GO:0003924),-0.20575771965435982,-0.8666271775092427,0.845703125,0.9079153168376792,1.0,58/192,26.43%,RHOQ;OPA1;LRRK2;RHOJ;ATL3;RND3;DNM1L;RAP1B;ABCA4;MRAS;RAB22A;GFM1;MMUT;TBC1D24;CDC42;ATL2;RHOA;RHOT1;RAB11A;GNA14;RALA;GNAS;RHOBTB2;GTPBP10;RASL12;GNG5;GFM2;ARHGDIB;RAB21;GBP3;BMS1;DNAJC27;DDX3X;EFTUD2;GNB1;GBP7;GBP2;RHOBTB1;RHOH;RHOC;GBP6;MTG2;RAB24;RIT1;RABL3;NKIRAS1;GNAZ;GPN3;RHOT2;RAB8A;RAB9A;SAR1B;RAB7A;IRGM;RAB5A;RRAGA;TSR1;MFN2
prerank,palmitoyltransferase activity (GO:0016409),0.2912088824240904,0.8634243597456206,0.6741071428571429,0.9301337096236894,1.0,6/28,15.44%,ZDHHC22;ZDHHC17;GOLGA7;ZDHHC15;ZDHHC4;ZDHHC14
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.37344212284419553,-0.8632313360361663,0.666058394160584,0.9121091912354787,1.0,2/10,9.18%,CXADR;JUP
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.35343428935048943,0.8620709653163905,0.6484210526315789,0.9287348337824742,1.0,3/13,17.31%,MIF;IDI1;EBP
prerank,exonuclease activity (GO:0004527),-0.2559121065124034,-0.8595182586633382,0.7022132796780685,0.9173693984280825,1.0,11/46,16.40%,ENPP1;APEX2;CPSF3;WRN;REXO5;ENPP3;XRN2;REXO1;EXOSC9;EXOSC10;MRE11
prerank,neuropeptide receptor binding (GO:0071855),-0.3424837637291197,-0.8580842575242366,0.6717557251908397,0.917567364907315,1.0,5/14,43.43%,AGRP;NMU;PPY;NPY;APLN
prerank,fatty acid synthase activity (GO:0004312),0.3682762015574764,0.8571521649751338,0.638671875,0.9350828895306528,1.0,2/10,7.45%,ELOVL7;ELOVL4
prerank,protein kinase activator activity (GO:0030295),-0.24113054127961492,-0.8536515584167383,0.75,0.9236996727654319,1.0,17/60,20.64%,PRKAG2;STK3;FAM20A;CAB39L;RPTOR;PAK2;IGF2;MAP2K1;GPRC5C;WNK1;ABI1;RICTOR;DDX3X;AFAP1L2;MTCP1;TAOK1;CAB39
prerank,disordered domain specific binding (GO:0097718),-0.299397692966369,-0.8502615859154349,0.6893939393939394,0.9278938751208554,1.0,6/23,13.17%,NUMA1;SMAD2;TEAD2;RB1;FN1;FKBP8
prerank,ephrin receptor binding (GO:0046875),-0.30277262246660935,-0.8483189578481143,0.7103825136612022,0.9290206760542032,1.0,4/21,6.93%,EFNB2;ABL1;SHC1;LYN
prerank,nucleotidase activity (GO:0008252),0.33516490828434775,0.8474325805037438,0.6853448275862069,0.9516736744389233,1.0,3/15,12.71%,NT5DC2;NT5C;BPNT2
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3642467325587109,-0.8463672914481007,0.6596153846153846,0.9300829097489282,1.0,5/10,24.26%,EHHADH;ECHDC2;ECHDC3;ECI1;AUH
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.32736020907989466,-0.8455058629093587,0.6735459662288931,0.9260176067505317,1.0,3/16,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.32736020907989466,-0.8455058629093587,0.6735459662288931,0.9260176067505317,1.0,3/16,7.13%,ATP6V1B2;ATP6V0D1;ATP6V0A4
prerank,endodeoxyribonuclease activity (GO:0004520),-0.30860286668656567,-0.845192490137112,0.7018867924528301,0.923775027078727,1.0,6/20,26.38%,RBBP8;MRE11;ZRANB3;EXOG;ERCC1;ENDOV
prerank,mRNA 5'-UTR binding (GO:0048027),0.2905125858756075,0.8440070697889926,0.7194092827004219,0.95469481048338,1.0,7/24,15.56%,LARP6;RPL41;RPL5;RPS7;RPS14;UTP23;MYH10
prerank,hexosyltransferase activity (GO:0016758),0.21928047421284874,0.842548297144063,0.8253968253968254,0.9533479767764982,1.0,12/101,10.06%,TMTC2;MFNG;B4GALNT1;CSGALNACT1;FUT9;CHSY3;PIGM;B3GALT5;B4GALT6;ALG1;MGAT4C;DPY19L1
prerank,clathrin adaptor activity (GO:0035615),0.33109173230960964,0.838440387607799,0.6666666666666666,0.9574063512416353,1.0,3/15,8.95%,AP2M1;HIP1;AP2B1
prerank,peptidase activator activity (GO:0016504),0.2986104033859427,0.837924540696704,0.7071129707112971,0.9541020624773925,1.0,2/22,4.98%,MAL;PSENEN
prerank,3'-5' exonuclease activity (GO:0008408),-0.2499007737319628,-0.8340091017615018,0.7504990019960079,0.9427865290463018,1.0,17/45,28.16%,ERI3;DIS3L2;WRN;CNOT8;XRN2;ERI2;EXOSC9;PAN2;EXOSC10;MRE11;USB1;ANGEL2;EXOSC3;PNLDC1;PDE12;DIS3;PARN
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.31594127533423205,0.8331558623630767,0.7017543859649122,0.9592856196973091,1.0,1/16,2.35%,BCO1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3511759278706103,0.8329203766592173,0.6735537190082644,0.955381342689109,1.0,4/11,17.60%,HMGA2;APEX1;RPS3;APLF
prerank,NAD+ binding (GO:0070403),0.34850394198496226,0.8323381485567766,0.7248908296943232,0.9521039036683661,1.0,4/12,10.20%,HADH;SIRT1;HPGD;UXS1
prerank,kinase activator activity (GO:0019209),-0.27363203391775204,-0.8320164905908815,0.7317554240631163,0.9434853230281192,1.0,5/30,13.39%,PRKAG2;RPTOR;GPRC5C;WNK1;MOB1B
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.2928842883091699,-0.828750035612681,0.71875,0.9467561194882751,1.0,10/23,23.64%,SH3PXD2B;GBF1;MAPKAP1;KIF16B;WIPI1;WDR45B;WIPI2;PLEKHA4;HIP1R;JPH2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.22269809322785916,0.828396348672077,0.8340248962655602,0.9558265869918473,1.0,23/83,19.11%,USP44;OTUD7A;USP29;USP53;USP14;USP49;UCHL1;YOD1;UCHL3;USP32;USP22;OTUB2;USP48;USP31;USP30;OTUB1;USP42;OTULIN;USP8;UCHL5;ATXN3;OTUD7B;JOSD1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.317264696883655,-0.8240448782578156,0.7452830188679245,0.9527573316775876,1.0,7/16,29.95%,SLC13A3;SLC1A5;SLC25A11;SLC38A7;SLC25A22;SLC13A5;SLC1A6
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.30549185397918777,-0.8224638264180162,0.7201492537313433,0.9529149710503241,1.0,5/17,23.25%,ACAA2;ACOT11;ACOT9;ACOT8;ACOT6
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2865797531709472,-0.818925849915607,0.7306967984934086,0.9566178533195224,1.0,6/22,20.61%,ATP6V1B2;ATP6V0D1;ATP6V0A4;ATP2A2;TCIRG1;ATP2A3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.3168744004821117,0.8184382889031924,0.7064989517819706,0.9704598936292269,1.0,2/14,10.01%,MAL;NOD1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3000354339094595,0.818190296824957,0.7366255144032922,0.9666103111887295,1.0,1/20,0.24%,DLG2
prerank,G protein-coupled receptor binding (GO:0001664),-0.20356442553676757,-0.8125118238966291,0.9087301587301587,0.9651819095485626,1.0,24/132,18.96%,LRP6;WNT4;RNF43;PRKN;WNT5B;WNT6;FLNA;RYK;WNT9A;GRK3;USP33;TULP3;ARHGEF12;GNA14;AGTR1;GNAS;FZD7;USP4;PTCH1;ARRB1;ARHGEF11;WNT5A;FZD1;MYOC
prerank,kinase inhibitor activity (GO:0019210),-0.25953563318582046,-0.812082134226368,0.7656565656565657,0.9629156120855948,1.0,10/33,22.54%,PARVA;LRP6;TAOK3;DNAJC3;GMFB;NCK1;SH3BP5L;RHOH;CDKN1C;PRKRIP1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.27150291241531377,0.8117653856161964,0.7697095435684648,0.9745146456806207,1.0,6/28,13.22%,RPP40;APEX1;RPP30;POP5;DROSHA;RNASEH2A
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.28464783582439074,0.811591681149034,0.7549234135667396,0.9704744858438955,1.0,2/22,3.84%,DUSP6;PPM1F
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3531808368278407,-0.8105514135961756,0.7047970479704797,0.9627948623303214,1.0,1/10,2.52%,KAT2B
prerank,voltage-gated anion channel activity (GO:0008308),-0.32178598681171633,-0.8089282772001671,0.7203883495145631,0.9628401768952097,1.0,6/15,24.01%,CLCN2;VDAC1;ANO1;GPR89B;GPR89A;CLCN6
prerank,GTP binding (GO:0005525),-0.19564224109702422,-0.8050196003885367,0.9321357285429142,0.9668443708783595,1.0,57/172,30.42%,RHOQ;ANXA6;LRRK2;RHOJ;ATL3;ARL3;RND3;RAP1B;RAB10;MRAS;RAB22A;GLUD1;CDC42;ATL2;RHOA;RHOT1;ARFIP2;DYNC1LI1;ARF1;RALA;RHOBTB2;GTPBP10;RASL12;RAB21;GBP3;BMS1;GBP7;GBP2;RHOBTB1;TUBB2A;RHOH;RHOC;GBP6;MTG2;NME1;RIT1;RABL3;TUBB6;ARL5A;RHOT2;RAB8A;RAB9A;NOA1;RAB7A;RAB5A;RRAGA;TSR1;GNL3;DIRAS2;ARL4C;TUBA1C;RAB39A;RANBP17;TUBB2B;GNL1;ADSS1;ARF6
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2655420591230766,-0.803689826881142,0.789272030651341,0.9663190954915465,1.0,7/28,19.96%,LRRK2;PRKAA2;MAP2K4;MAP2K1;MAP2K7;PRKACA;MAP2K6
prerank,microtubule minus-end binding (GO:0051011),-0.3269901159801245,-0.8028917978382469,0.7518382352941176,0.9648447834051902,1.0,7/13,30.47%,NUMA1;TUBGCP6;TUBGCP2;TUBGCP4;HAUS7;CAMSAP2;HAUS4
prerank,Hsp90 protein binding (GO:0051879),0.2584275052901901,0.8018379362966875,0.7863247863247863,0.9838233028736993,1.0,10/33,18.99%,PACRG;KDR;NPAS2;CYP2E1;UNC45B;RPS3;PTGES3;CHORDC1;AHSA1;NOD2
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.18524540368826029,-0.8016290263046784,0.9664031620553359,0.9641279657335133,1.0,66/248,24.95%,RHOQ;OPA1;LRRK2;RHOJ;ATL3;RND3;DNM1L;RAP1B;RNF213;ABCA4;VPS4B;MRAS;VWA8;RAB22A;GFM1;MMUT;DHX9;TBC1D24;CDC42;ABCD2;ATL2;CHD3;RHOA;RHOT1;ATP2B1;RAB11A;GNA14;RALA;GNAS;RHOBTB2;GTPBP10;KIF1C;RASL12;GNG5;GFM2;ARHGDIB;RAB21;GBP3;BMS1;DNAJC27;DDX3X;EFTUD2;GNB1;SMCHD1;GBP7;GBP2;RHOBTB1;VCP;RHOH;RHOC;GBP6;MTG2;RAB24;RIT1;TOR1A;RABL3;NKIRAS1;GNAZ;GPN3;RHOT2;CLPX;RAB8A;RAB9A;SAR1B;RAB7A;IRGM
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.26559527559237983,-0.7986741551945568,0.781651376146789,0.9664957795017287,1.0,4/27,6.17%,SLC41A1;SLC9A1;SLC9A8;SLC9A2
prerank,motor activity (GO:0003774),0.22938082709958335,0.7985323687273608,0.8657024793388429,0.9850989185469324,1.0,15/60,20.00%,MYO1E;KIF1A;KIF21B;KIFC2;MYL6;MYO6;KIF26B;KIF19;KIFC3;STARD9;DNAH3;KIF21A;KIF18A;KIF1B;KIF26A
prerank,protein phosphatase activator activity (GO:0072542),-0.3255012425850017,-0.7979692719933847,0.7416829745596869,0.9647501117672633,1.0,5/13,18.02%,IGFBP3;PPP2R5E;PPP2R5D;PTPA;PPP2R5C
prerank,NADP binding (GO:0050661),0.25726223005874116,0.7967167330133472,0.8012958963282938,0.9838013324506956,1.0,8/32,17.56%,NDOR1;NOS3;DUS2;KCNAB1;HSD11B1;DHCR7;TM7SF2;NNT
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.26273100962052576,-0.7957852636751777,0.7950191570881227,0.965658624803602,1.0,3/29,4.08%,PRKAG2;KAT2B;RPTOR
prerank,double-stranded RNA binding (GO:0003725),0.2217870278955501,0.7954809059824902,0.8538622129436325,0.9817287629288887,1.0,10/70,13.36%,TFRC;ADARB2;ZFR2;HSP90AB1;DUS2;STRBP;LRRFIP1;HSPD1;DROSHA;RFTN1
prerank,O-methyltransferase activity (GO:0008171),0.3450240648033122,0.7934662097932206,0.7489451476793249,0.9807904999246859,1.0,5/10,20.34%,CMTR2;CMTR1;BCDIN3D;MEPCE;ASMT
prerank,MAP kinase phosphatase activity (GO:0033549),-0.3332701328217335,-0.7930905585335577,0.7486338797814208,0.9672374830462951,1.0,4/12,22.44%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,hydro-lyase activity (GO:0016836),-0.24217175422110943,-0.7923965343803376,0.8075396825396826,0.965488434031926,1.0,21/41,32.91%,GMDS;ACO2;EHHADH;ACO1;ECHDC2;HACD4;ECHDC3;ECI1;PARK7;APIP;UROS;AUH;IREB2;CBS;ENO3;TBXAS1;ENO1;CDYL;FAHD2A;CYP2S1;ALAD
prerank,transaminase activity (GO:0008483),-0.33233929880356594,-0.7895832500538434,0.7561475409836066,0.9671720580321576,1.0,5/11,34.73%,ABAT;OAT;PSAT1;GOT1;GOT2
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3043116992320165,-0.7873963545128678,0.7733333333333333,0.9678693865980653,1.0,6/15,32.01%,PI4KA;PIK3C3;PIK3CD;PI4K2B;PI4KB;PIK3C2A
prerank,kinase activity (GO:0016301),-0.2028657008254987,-0.7871132413492362,0.9169811320754717,0.9654728011151786,1.0,29/109,21.07%,PI4KA;NADK2;ABL1;LRRK2;GK5;GSK3B;DGKA;MAP4K4;NADK;TRRAP;LYN;MTOR;EPHA4;PANK2;PGK1;DCAKD;PIK3C3;RFK;CSNK2A1;PDXK;PIK3CD;PRKD1;FCSK;ITPKC;IRAK1;TAOK1;SHPK;BCKDK;DGKD
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3088052567180316,0.7869597685697847,0.775,0.9876069554986172,1.0,3/14,12.31%,RPP40;RPP30;POP5
prerank,GDP binding (GO:0019003),0.22185772588479308,0.785021074828018,0.8811881188118812,0.9864509080394912,1.0,15/63,17.97%,RIT2;DIRAS1;NME2;RAB4A;RAB35;MIEF1;RASEF;HRAS;RAP1A;GNAI1;RAB29;RAP2B;RAB31;RALB;RERG
prerank,titin binding (GO:0031432),0.31384177787790823,0.7788824775962455,0.7442827442827443,0.992652092406506,1.0,4/13,14.31%,TCAP;CALM1;CALM2;CALM3
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.31184184586670505,0.7787368816880249,0.7649572649572649,0.9886493121171582,1.0,1/13,1.91%,PIP5K1B
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2723859598474586,-0.7784768171249541,0.793168880455408,0.9762479363435017,1.0,6/24,14.23%,OSBPL8;OSBPL5;PLA2G4A;ARFIP2;GSDMD;PLEKHA8
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.32067640840030087,-0.7776700855805929,0.7661596958174905,0.974504715351588,1.0,6/12,36.20%,CTSH;BCL2L13;ATP2A3;APAF1;PYCARD;CASP1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.3206906157991948,-0.7750579753913412,0.7843511450381679,0.9756334985964402,1.0,3/12,19.26%,PIEZO2;TMC4;TMC6
prerank,gamma-tubulin binding (GO:0043015),-0.27531074960857876,-0.773231869929424,0.8133595284872298,0.9755867310028296,1.0,7/21,14.85%,TUBGCP6;TUBGCP2;MARK4;BRSK1;RAD51D;BRCA2;DDX3X
prerank,nucleoside-diphosphatase activity (GO:0017110),0.31574637643798353,0.7730728788672033,0.7547169811320755,0.9933145452487019,1.0,5/12,23.37%,SLC25A42;ENTPD3;ENTPD1;ENTPD5;ENTPD7
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.31189847490234845,-0.7707471565657381,0.7848837209302325,0.9765159097862388,1.0,5/13,20.39%,AGPAT4;ABHD5;GPAT4;LPCAT1;GPAT3
prerank,N-acyltransferase activity (GO:0016410),-0.24882748668261268,-0.7707391696441196,0.8268839103869654,0.973698487229656,1.0,3/32,3.30%,CERS5;EP300;NMT2
prerank,5'-nucleotidase activity (GO:0008253),0.31285332173545005,0.7704361975857149,0.7875536480686696,0.9930592769402283,1.0,2/13,9.52%,NT5DC2;NT5C
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3303164663895011,-0.7701416032492123,0.7615526802218114,0.9718120475361328,1.0,5/11,25.94%,PRMT2;PRMT5;PRMT8;PRMT9;FBXO11
prerank,anion:anion antiporter activity (GO:0015301),0.2937241600057186,0.7694094454105846,0.7871396895787139,0.9902869130214719,1.0,1/17,0.53%,SLC4A1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.27804892671686754,0.7677243439138222,0.7792207792207793,0.9886672883900826,1.0,2/21,11.50%,GRIK2;P2RX7
prerank,exopeptidase activity (GO:0008238),0.2270607089536544,0.7631919453632345,0.8797595190380761,0.9915420584508803,1.0,4/50,6.05%,DPP10;MME;METAP2;DPP6
prerank,symporter activity (GO:0015293),0.3308822754134918,0.7624119475511556,0.8065934065934066,0.9885198937811835,1.0,1/10,3.76%,MFSD2A
prerank,histone deacetylase activity (GO:0004407),-0.27476431249015787,-0.7621855315556654,0.7934990439770554,0.9806215531744492,1.0,13/19,38.08%,HDAC8;HDAC4;MIER1;HDAC1;HDAC2;SIRT3;HDAC3;MIER2;HDAC10;MIER3;HDAC5;SIRT6;SUDS3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.26075713834929326,-0.7615724539521251,0.831758034026465,0.9786710417005817,1.0,7/27,17.81%,SLC26A7;SLC39A14;SLC26A2;SLC22A6;SLC5A5;SLC25A11;ANO1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.3160075329566855,0.7606691799115646,0.7871853546910755,0.9868348139267852,1.0,12/12,68.42%,ELOVL4;OPN4;GNAT2;OPN1SW;OPN5;RHO;OPN1MW;OPN1MW3;RRH;GPR52;GPR88;OPN3
prerank,guanyl ribonucleotide binding (GO:0032561),-0.18160941082217463,-0.7590658470183733,0.9856262833675564,0.9794199396251412,1.0,38/196,19.51%,PDE5A;RHOQ;MPPED2;ANXA6;LRRK2;RHOJ;ATL3;ARL3;RND3;RAP1B;RAB10;MRAS;RAB22A;GLUD1;RAB12;CDC42;ATL2;RHOA;RHOT1;ARFIP2;DYNC1LI1;ARF1;RALA;RHOBTB2;GTPBP10;RASL12;RAB21;GBP3;BMS1;RAPGEF2;GBP7;GBP2;RHOBTB1;TUBB2A;RHOH;RHOC;GBP6;MTG2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.308612421363588,-0.7588265730778625,0.7751371115173674,0.976927302038851,1.0,2/14,7.01%,SLC26A7;SLC26A2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.33362208873189714,-0.7577736006942629,0.7733812949640287,0.9728612231089809,1.0,4/10,22.44%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.33362208873189714,-0.7577736006942629,0.7733812949640287,0.9728612231089809,1.0,4/10,22.44%,DUSP16;DUSP1;DUSP10;DUSP7
prerank,ATPase regulator activity (GO:0060590),0.23418862991455192,0.7571049462600222,0.8780487804878049,0.9877376646686079,1.0,14/38,22.55%,HSPBP1;DNAJC15;BRSK2;ATP1B1;PFN1;DNAJA2;DNAJB2;AHSA1;BAG2;DNAJC19;DNAJA1;BAG1;ATP1B2;FNIP2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.2925259516179507,0.7566409021966632,0.798728813559322,0.9843359130494425,1.0,1/15,0.53%,SLC4A1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.25297668342893126,0.7539824898280386,0.870020964360587,0.9838892355227163,1.0,7/27,17.14%,POLR1H;POLR2J;POLR2B;POLR2I;MED20;POLR3A;POLR2G
prerank,chemokine receptor binding (GO:0042379),0.23651899681133134,0.7435529837279643,0.8822314049586777,0.9939678057283818,1.0,7/35,22.93%,CXCL12;CCL2;CCL25;CKLF;CCL13;CCL19;ITCH
prerank,alpha-tubulin binding (GO:0043014),0.24171138770459197,0.7425280144438496,0.8896103896103896,0.9911670943644766,1.0,11/31,21.31%,PACRG;TTLL7;SNCA;TRIM36;DIP2B;EFHC2;ARL8A;FYN;TRPV4;CDK5R1;HDAC6
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.29699306916654816,-0.7392848705235681,0.8093457943925234,0.9941655599255196,1.0,1/13,0.48%,SLC7A2
prerank,BMP binding (GO:0036122),-0.3138290907878293,-0.7361074733078314,0.8040665434380776,0.9952896246699318,1.0,2/11,11.09%,NBL1;GREM2
prerank,mRNA methyltransferase activity (GO:0008174),0.29442258093224155,0.7294133446875923,0.8034188034188035,1.0,1.0,4/12,21.55%,CMTR2;CMTR1;METTL8;METTL3
prerank,DNA replication origin binding (GO:0003688),-0.2507311990511492,-0.7291231336033418,0.8631984585741811,1.0,1.0,15/23,44.86%,DHX9;MCM9;MCM6;ORC1;MCM4;MCMDC2;CDC45;POLA1;MCM2;MCM7;MCM5;MCM10;GRWD1;ORC3;CDC6
prerank,metallocarboxypeptidase activity (GO:0004181),-0.24949686724008904,-0.7279278136560302,0.8808193668528864,0.9997650457032979,1.0,5/26,17.11%,AEBP1;AGBL3;CPM;CPXM2;CPXM1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2590945697287939,-0.7278535400811992,0.8576779026217228,0.997052919228937,1.0,7/22,21.16%,RNF169;PARP10;ZBTB1;SPRTN;ZRANB3;IKBKE;WDR81
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.28263326515161535,0.7255086641683149,0.8298319327731093,1.0,1.0,4/14,15.32%,ISCU;ISCA2;ETFDH;RSAD2
prerank,GTPase inhibitor activity (GO:0005095),0.2864263374923236,0.7241065416014847,0.8679653679653679,1.0,1.0,2/13,8.56%,IPO5;GPS2
prerank,phosphatase activator activity (GO:0019211),-0.2859332112944428,-0.7235414502995587,0.8326996197718631,0.9992039903090252,1.0,6/14,22.80%,FRS2;PPP2R5E;PPP2R5D;PPP2R5C;BMP2;GTF2F1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.23510517404464518,0.720675575280289,0.8881856540084389,1.0,1.0,8/29,17.11%,DUSP6;SIRT1;DIRAS1;PTPRJ;ATF7;GCH1;MAPKAPK2;TNIP1
prerank,NF-kappaB binding (GO:0051059),-0.2501090608443205,-0.7206232924703848,0.898406374501992,1.0,1.0,3/24,4.84%,EP300;GSK3B;ANXA4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.23687769760761856,-0.7167889257742861,0.8886827458256029,1.0,1.0,7/29,17.27%,GANC;ACER3;HEXD;GUSB;PGGHG;GANAB;ABHD10
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.29775161767419955,0.715715399759333,0.8477801268498943,1.0,1.0,3/12,8.48%,TENT5C;TENT4A;PAPOLB
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.194124960608017,0.7150616217133161,0.9577167019027484,0.9995858321364792,1.0,20/75,21.42%,HADHA;HADH;KCNAB1;HSD17B7;PHGDH;HPGD;PRXL2B;ABCC4;BDH1;KDSR;RDH11;HSD17B10;LDHB;IMPDH1;LDHA;NSDHL;RDH10;UGDH;HSD17B4;HSD3B7
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2984890945898459,-0.7149313719224917,0.8448275862068966,1.0,1.0,4/12,19.37%,VEGFA;VEGFD;ITGA5;ITGB3
prerank,pyrophosphatase activity (GO:0016462),-0.20584371204053536,-0.7104549399158254,0.9359223300970874,1.0,1.0,22/50,32.30%,ENPP1;NUDT4;NUDT5;DHX9;PRUNE1;ENPP3;PPA1;DDX3X;ENTPD6;RNGTT;ALPL;PPA2;DOLPP1;NUDT1;NUDT11;PLPP1;PLPP5;NUDT7;CILP;FITM2;NUDT16;NUDT16L1
prerank,lysophospholipase activity (GO:0004622),0.24881050383017297,0.7060351381842189,0.8879492600422833,1.0,1.0,2/20,4.89%,ENPP2;LYPLA1
prerank,CARD domain binding (GO:0050700),0.28485039356428676,0.7057444103072112,0.8414376321353065,1.0,1.0,3/14,11.59%,CARD19;NOD1;BCL10
prerank,receptor antagonist activity (GO:0048019),0.2677595111598905,0.7041788422856531,0.8558951965065502,0.9990938732167239,1.0,1/17,2.62%,FST
prerank,gated channel activity (GO:0022836),-0.2798065417936408,-0.7033283182193182,0.8776699029126214,1.0,1.0,1/14,1.06%,PIEZO2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.29619473094091153,0.7033227055037115,0.8340425531914893,0.9960931100857314,1.0,2/11,5.53%,SLC25A42;SLC25A23
prerank,MHC protein binding (GO:0042287),-0.25102241330880093,-0.6995674007770143,0.8834586466165414,1.0,1.0,7/20,35.69%,TAP2;DERL1;TAP1;CD81;ATP5F1A;LAG3;TAPBP
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.28738194598738975,0.696874584159653,0.8525641025641025,0.9984158116740677,1.0,2/12,5.53%,SLC25A42;SLC25A23
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.2879137077315954,0.6964349703489349,0.8794178794178794,0.9949333517328803,1.0,6/12,21.69%,ISCU;ISCA2;ISCA1;CISD2;CIAPIN1;CISD1
prerank,translation initiation factor activity (GO:0003743),-0.21895501323586616,-0.6938843267603917,0.9296875,1.0,1.0,14/36,31.42%,EIF4G3;EIF4A2;EIF4E;EIF3A;EIF4G1;EIF3L;EIF2B4;EIF2B5;EIF4E3;EIF3H;EIF3C;EIF3M;COPS5;EIF2B1
prerank,histone methyltransferase binding (GO:1990226),-0.29300819279606427,-0.6927132148868728,0.8542056074766355,1.0,1.0,3/11,14.13%,LCOR;CBX1;PHF1
prerank,carbohydrate kinase activity (GO:0019200),0.28979660646193195,0.6908284673451495,0.8438133874239351,0.9963377892171645,1.0,1/11,3.26%,KHK
prerank,voltage-gated chloride channel activity (GO:0005247),-0.30528461995802136,-0.6891113381076513,0.8595194085027726,1.0,1.0,3/10,24.01%,CLCN2;ANO1;CLCN6
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.20628498542779908,-0.6870248307648656,0.9643564356435643,1.0,1.0,7/46,14.24%,LARGE1;B3GALT1;EXT1;B3GLCT;MGAT3;OGT;HEXA
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.26297048262316164,0.6866989147763572,0.875268817204301,0.9963462973619693,1.0,2/15,8.27%,ACKR4;GPR17
prerank,aspartic-type endopeptidase activity (GO:0004190),0.28106633392972913,0.6855872903543629,0.884453781512605,0.9936479183914113,1.0,1/12,1.49%,SPPL2B
prerank,deoxyribonuclease activity (GO:0004536),0.27187861296595667,0.6844199522586646,0.9029535864978903,0.9909668493305113,1.0,4/14,17.60%,APEX1;RPS3;DFFB;APLF
prerank,tumor necrosis factor receptor binding (GO:0005164),0.2807957217994426,0.678936125684204,0.868995633187773,0.9919424172508322,1.0,2/12,7.04%,TRAF1;TRIM37
prerank,chloride channel regulator activity (GO:0017081),-0.2710322852079461,-0.6781076581935795,0.8859315589353612,1.0,1.0,7/14,31.15%,VTI1B;WNK4;WNK1;STX8;STX1A;STX7;SGK1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.23682399831118556,-0.6767734485337789,0.9013282732447818,1.0,1.0,12/22,38.67%,RBMS3;DHX36;EXOSC9;CPEB1;NUDT21;CPSF1;ZFP36L2;EXOSC8;RBM24;ELAVL1;MEX3D;ILF3
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.29193904140693533,-0.6759112217338011,0.877431906614786,1.0,1.0,1/11,2.66%,SLC5A3
prerank,death receptor binding (GO:0005123),-0.26198417262538404,-0.6722265642689631,0.8831168831168831,1.0,1.0,2/15,9.79%,EDA;NGF
prerank,ubiquitin-dependent protein binding (GO:0140036),0.2862913838114455,0.6710171539738863,0.8586278586278586,0.9945749748895055,1.0,6/10,25.82%,DNAJB2;ANKRD13A;DNAJC2;USP15;ANKRD13D;LAPTM5
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.23846720155714302,-0.6662449963464402,0.9001919385796545,1.0,1.0,6/20,20.39%,AGPAT4;ABHD5;GPAT4;MOGAT3;LPCAT1;GPAT3
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.27236278156936833,0.6652655706123839,0.911504424778761,0.9953117356803161,1.0,4/12,18.98%,PIK3R3;ATM;IPMK;PIK3R6
prerank,peptide hormone receptor binding (GO:0051428),0.2752731304487821,0.6627190060007301,0.8886363636363637,0.9932930854594211,1.0,1/11,7.52%,ADCYAP1
prerank,DNA polymerase activity (GO:0034061),-0.23167824156875944,-0.6541002334878936,0.930188679245283,1.0,1.0,13/22,38.89%,POLM;REV1;POLE4;TERT;POLN;PRIMPOL;POLE2;POLH;POLA1;POLE;POLD4;REV3L;POLE3
prerank,glutathione transferase activity (GO:0004364),0.2241794586750928,0.6495082933321744,0.9470198675496688,0.998972620615501,1.0,2/23,8.05%,GSTA4;GSTM5
prerank,C-C chemokine binding (GO:0019957),-0.2287367268386716,-0.6492022023394459,0.9353049907578558,1.0,1.0,15/22,54.92%,CCR9;CX3CR1;CCR5;ACKR1;CCR2;CXCR4;CCRL2;CXCR6;CCR1;ZFP36;CCR10;CXCR5;ACKR3;CCR6;CXCR2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.20227035566244075,0.6491485266804662,0.9554140127388535,0.9954476421112552,1.0,3/38,10.04%,SPOCK1;SERPINB8;SLPI
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.20690181353483297,-0.6489027122679552,0.9724409448818898,1.0,1.0,17/35,33.77%,FTO;TRMT9B;PUS10;TARS2;ALKBH1;QTRT2;FTSJ1;LCMT2;DTWD1;DUS3L;ELAC2;DTWD2;MRPL58;TYW3;QRSL1;TRMT12;TRPT1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2518008727027606,-0.6486653640879632,0.9254302103250478,1.0,1.0,5/15,20.39%,AGPAT4;ABHD5;GPAT4;LPCAT1;GPAT3
prerank,WW domain binding (GO:0050699),-0.22625234601247032,-0.6474602730194287,0.9482439926062847,1.0,1.0,9/26,34.38%,PMEPA1;RAPGEF2;TCEAL9;WBP11;WBP1;TCEAL8;DAZAP2;TCEAL1;TRAF4
prerank,P-type ion transporter activity (GO:0015662),0.2661676045974941,0.6471352773795104,0.8818565400843882,0.9931595418444604,1.0,4/12,19.24%,ATP2B3;ATP2B4;ATP2B2;ATP2C1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2507841443751064,-0.6448022938271,0.933206106870229,1.0,1.0,3/16,15.39%,MTMR12;MTMR3;SACM1L
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.26419906490898937,-0.6438264143573499,0.9207547169811321,1.0,1.0,1/12,2.20%,B3GALT1
prerank,carboxypeptidase activity (GO:0004180),-0.20460155975307426,-0.6421000530921522,0.9626865671641791,1.0,1.0,6/35,17.11%,AEBP1;AGBL3;CPM;CTSA;CPXM2;CPXM1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.2565425822840212,-0.6385359886049524,0.9142857142857143,1.0,1.0,6/14,35.63%,MTHFR;ALDH1L1;ALDH4A1;PYCR2;AASS;PYCR3
prerank,C-C chemokine receptor activity (GO:0016493),0.22406317761458766,0.635379952290729,0.9291845493562232,0.9969225127127529,1.0,2/21,9.26%,ACKR4;GPR75
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.26326149706444535,0.627242460188114,0.9145299145299145,0.9979172472334127,1.0,3/11,15.46%,SGMS1;AASDHPPT;SAMD8
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2666084538750244,0.6233710836342721,0.9041394335511983,0.9964213428868881,1.0,2/10,13.11%,APEX1;POLD1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.23188837037999244,0.6226430550615183,0.9582417582417583,0.9931785593883556,1.0,4/17,16.64%,PECR;TECR;DHCR7;TM7SF2
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2637846482011415,-0.6181043024572954,0.9287054409005628,1.0,1.0,6/11,32.88%,NABP2;CTC1;TERF2;STN1;RPA2;HNRNPA2B1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.25697208811698863,0.6150666963618274,0.9182389937106918,0.9898183715603035,1.0,1/11,1.66%,HSPBP1
prerank,adenyl nucleotide binding (GO:0030554),0.25697208811698863,0.6150666963618274,0.9182389937106918,0.9898183715603035,1.0,1/11,1.66%,HSPBP1
prerank,transferrin receptor binding (GO:1990459),-0.26357167697422035,-0.610376059741321,0.9446494464944649,1.0,1.0,1/10,8.17%,RGMA
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.23814450416236635,-0.6096910905877911,0.945054945054945,1.0,1.0,5/15,27.77%,SH3PXD2B;PLA2G4A;PLEKHF1;JPH2;SAP30L
prerank,MHC class I protein binding (GO:0042288),-0.25067150995401916,-0.607797572497761,0.9436893203883495,1.0,1.0,5/13,35.69%,TAP2;DERL1;TAP1;ATP5F1A;TAPBP
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.25507709007705504,-0.607682072104304,0.9443447037701975,1.0,1.0,6/11,36.40%,NAA15;NAA16;NAA80;NAA25;NAA40;NAA10
prerank,ribosome binding (GO:0043022),-0.18002394238145678,-0.6033961822387839,0.9920792079207921,1.0,1.0,16/46,31.68%,YTHDF3;GEMIN5;SERBP1;NAA15;CPEB1;SHFL;PYM1;BAG6;NAA16;SRP72;EIF3C;IGHMBP2;CCDC47;C1QBP;SRP19;MRPS27
prerank,ribosomal large subunit binding (GO:0043023),-0.25884319890675106,-0.6012684512901413,0.9446564885496184,1.0,1.0,4/11,35.57%,MRRF;LTN1;DHX33;NPM1
prerank,pseudouridine synthase activity (GO:0009982),-0.2401745373457464,-0.5967060095300609,0.9647495361781077,1.0,1.0,8/13,42.04%,PUS10;PUS3;RPUSD4;PUS1;PUS7L;PUSL1;RPUSD2;RPUSD3
prerank,purinergic nucleotide receptor activity (GO:0001614),0.22974233671225047,0.5867379217289801,0.9694323144104804,0.9985186908660136,1.0,2/15,11.50%,P2RY1;P2RX7
prerank,phospholipase A2 activity (GO:0004623),0.1951404051238918,0.5834907396745673,0.9824561403508771,0.9961953865077664,1.0,5/26,19.73%,PLAAT1;PLA2G12A;PNPLA3;PLA2G4E;PRDX6
prerank,ribosomal small subunit binding (GO:0043024),-0.2209938440778294,-0.5813071237192954,0.9727626459143969,1.0,1.0,5/17,27.56%,LARP1;DDX3X;NME1;ERAL1;PIM1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.2086846663481266,-0.5751900934375902,0.9669260700389105,1.0,1.0,12/21,38.89%,POLM;REV1;POLE4;POLN;PRIMPOL;POLE2;POLH;POLA1;POLE;POLD4;REV3L;POLE3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.19336443450883925,0.5750665322092225,0.9768421052631578,0.9956088206483904,1.0,6/28,18.95%,TRAF1;TRIM37;DAB2IP;MADD;TMBIM1;RIPK1
prerank,aspartic-type peptidase activity (GO:0070001),-0.25163270402459126,-0.5747250825643365,0.9448669201520913,1.0,1.0,1/10,7.42%,DDI2
prerank,microtubule motor activity (GO:0003777),0.16947248941557286,0.5726035128706395,0.9873417721518988,0.9928185149324842,1.0,12/51,20.00%,KIF1A;KIF21B;KIFC2;KIF26B;KIF19;KIFC3;STARD9;DNAH3;KIF21A;KIF18A;KIF1B;KIF26A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2282754902690813,0.5725362460031808,0.950207468879668,0.9892881195507744,1.0,5/14,18.81%,YOD1;MINDY1;MINDY2;ATXN3;OTUD7B
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.24582936687171808,-0.5704459383232734,0.9559386973180076,1.0,1.0,2/11,11.71%,AKR1B1;AKR1A1
prerank,methyl-CpG binding (GO:0008327),-0.1982155346493383,-0.567793017512609,0.9794007490636704,1.0,1.0,10/22,33.87%,MBD2;PRMT5;CXXC5;MBD3;CXXC4;ZBTB4;TET3;ZBTB38;ERH;ZBTB21
prerank,protein phosphatase 1 binding (GO:0008157),-0.1977229954229901,-0.5511282010810594,0.9806576402321083,1.0,1.0,5/21,22.78%,SHOC2;PPP1R3B;SH3RF2;PPP1R3C;PPP1R3F
prerank,copper ion binding (GO:0005507),0.1679484766798138,0.547347799372634,0.9938524590163934,0.9929604875909283,1.0,6/42,16.48%,AOC2;SNCA;ATOX1;SNCB;COX17;COA6
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.2140697445410735,-0.5392687317740393,0.9754716981132076,1.0,1.0,2/14,13.06%,MTMR12;MTMR3
prerank,triglyceride lipase activity (GO:0004806),-0.18798006277208612,-0.5262329694881506,0.9922928709055877,1.0,1.0,4/20,26.17%,ABHD5;DAGLB;PNPLA2;LPL
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.22112242844766145,-0.5126465096802807,0.9765765765765766,1.0,1.0,5/10,36.40%,NAA15;NAA16;NAA80;NAA25;NAA10
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.19677923557828386,-0.49946742649513304,0.9923076923076923,1.0,1.0,5/14,27.09%,DTYMK;NME6;NME1;CMPK2;AK1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.21561625560802464,-0.49728035076693383,0.9770992366412213,1.0,1.0,4/10,34.04%,PML;ANKRD13B;FAAP20;IDE
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.16888888495283388,-0.4920102346859042,0.9962335216572504,1.0,1.0,9/24,34.32%,DTYMK;NME6;ITPKC;NME1;IP6K2;CMPK2;AK1;AK7;PPIP5K2
prerank,single-stranded DNA helicase activity (GO:0017116),-0.17998093004617005,-0.4913457047720864,0.9902723735408561,1.0,1.0,10/19,43.70%,DHX9;MCM6;HELB;HELQ;RAD51;MCM2;MCM7;MCM5;DSCC1;CHTF18
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.18322982593416212,-0.4866730773649992,0.9923518164435946,1.0,1.0,5/17,27.09%,DTYMK;NME6;NME1;CMPK2;AK1
prerank,RNA methyltransferase activity (GO:0008173),-0.17456282451318617,-0.48119389766974635,0.9943502824858758,0.9989981772182275,1.0,7/19,33.29%,TRMT9B;TGS1;FTSJ1;LCMT2;TYW3;MRM2;TRMT12
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.20147415967784665,0.4794290679575261,0.9957627118644068,1.0,1.0,2/10,14.18%,PIK3R3;ATM
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.17624269632144773,0.4636733895775854,0.9959677419354839,0.9994936669347229,1.0,2/15,17.41%,PLA2G12A;PLA2G4E
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.19268807922944287,0.45260014218236955,0.9897750511247444,0.9968358846478215,1.0,4/10,24.18%,YOD1;ATXN3;STAMBP;CYLD
prerank,solute:proton symporter activity (GO:0015295),-0.16647779700389084,-0.4361425376712257,1.0,1.0,1.0,6/16,33.63%,SLC33A1;SLC25A3;CTNS;SLC2A10;SLC17A5;SLC11A2
prerank,CCR chemokine receptor binding (GO:0048020),-0.12782264638186086,-0.3832547509914791,1.0,0.9995959774854303,1.0,2/28,11.86%,NES;CNIH4
